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Although  the  brain  is  the  master  regulator  of  all  bodily  functions,  peripheral  nerves  provide  
a  means  by  which  the  brain  communicates  to  all  tissues,  regulates  organ  function,  and  
maintains  systemic  homeostasis.    Metabolic  homeostasis  relies  on  the  maintenance  of  
energy   balance   which   is   governed   in   large   part   by   the   brain   and   adipose   tissue.    
Disruption  of  communication  between  these  two  organs  can  lead  to  a  metabolic  state  of  
energy   excess  or   insufficiency,   i.e.   energy   imbalance.     Energy   balance   is  maintained  
when  energy  intake,  governed  by  appetite,  food  intake  and  nutrient  absorption,  equates  
energy  expenditure,  which   is   influenced  by  physical  activity,  basal  metabolic   rate,  and  
thermogenesis.  Over   the   last   few  decades,  surgical  and  chemical  denervation  studies  
have   demonstrated   how   maintenance   of   brain-­adipose   communication   through   both  
sympathetic   efferent   and   sensory   afferent   nerves   helps   regulate   adipocyte   size,   cell  




storing  adipose  tissue  becomes  thermogenically  active  and  expends  energy).  However,  
the   factors   that   regulate   peripheral   nerve   health   and   remodeling,   defined   to   include  
neuropathy   (nerve   death)   and   plasticity   (neurite   outgrowth),   within   the   adipose   organ  
have  not  been  well  explored.  Peripheral  neuropathy  is  a  condition  of  nerve  die-­back  that  
begins   in   the   skin   and   travels   inwards.      Here   we   have   shown   that   underlying  
subcutaneous  adipose   tissues  also   display   peripheral   neuropathy  with   conditions   that  
range  from  obesity  and  diabetes   to  aging  and  certain  diets.    Under  all  aforementioned  
conditions  the  tissue  also  exhibited  a  loss  of  locally  produced  neurotrophic  factors,  which  
we  have  now  implicated  in  the  mechanism  of  adipose  neuropathy.    Exercise  is  able  to  at  
least  partially   reverse  adipose  neuropathy,  and   is  associated  with  an   increase   in   local  
neurotrophic   factor   expression.   Furthermore,   AAV-­mediated   gene   delivery   of   this  
neurotrophic  factor  was  shown  to  increase  innervation  in  subcutaneous  adipose  tissue  in  
a   murine   model   of   diabetic   peripheral   neuropathy.      Interestingly,   exercise   and   cold  
stimulation  are  both  able  to  increase  gene  and  protein  expression  of  pan-­neuronal  and  
synaptic  markers  in  adipose  tissue,  suggesting  increased  innervation  of  the  tissue.  We  
have   also   demonstrated   that   in   adipose   tissue,   a   neurotrophic   factor   is   produced   by  
immune   cells   in   the   stromovascular   fraction,   under   stimulation   from   noradrenergic  
signaling.  Deletion  of  this  neurotrophic  factor  from  myeloid  lineage  immune  cells  leads  to  
a   striking   and   specific   ‘genetic   denervation’   of   white   adipose   tissue  only,   sparing   the  
spinal  nerves,  neuromuscular  junction,  brain,  and  brown  adipose  tissue.  Therefore,  we  
believe  we  have  uncovered  a  novel  mechanism  for  how  adipose  tissue  metabolic  health  
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I.  Energy  balance    
Energy,   in   the   form   of   ATP,   is   the   currency   of   the   body.   In   most   mammalian  
systems,  this  currency  is  mainly  acquired  through  the  intake  of  nutrients  (food  and  drink)  
which  are  metabolized  and  stored  as  either  glycogen,  or  as  triglycerides  in  adipose  depots  
throughout  the  body.  When  the  body  needs  energy,  these  stored  lipids  are  mobilized  and  
undergo  fatty  acid  oxidation  to  produce  ATP.  In  a  sense,  this  process  can  be  viewed  as  
‘burning’   fuel   to   create   energy.   To  maintain   a   state   of   energy   balance   and  metabolic  
health,   the   brain   works   in   concert   with   adipose   tissues   to   store   and   expend   energy.  
Energy   homeostasis   is   the   continuous  harmonization   between  energy   intake   (EI)   and  
energy  expenditure  (EE).  EI  is  driven  chiefly  by  the  hypothalamus,  the  energy  regulatory  
region  of  the  brain  that  controls  appetite  by  influencing  food  consumption.  By  contrast,  
EE  is  driven  by  multiple  factors  including  individual  basal  metabolic  rate  (BMR)  conferred  
by   our   cell’s   mitochondrial   activity,   physical   activity   (exercise),   and   thermogenesis.  
Multiple  organs  of  the  body  are  involved  in  maintaining  energy  balance,  including  the  gut,  
liver,   adipose,   and   skeletal   muscle.   Communication   between   the   brain   and   these  
peripheral  organs   is  essential   to  maintain  energy  balance,  and   is  orchestrated  by  both  
circulating/endocrine  factors  as  well  as  the  peripheral  nervous  system  (PNS).  
Arguably  the  most  important  organs  in  maintaining  metabolic  health  are  adipose  




as  both  a  site  of  energy  storage  as  well  as  energy  expenditure.  The  two  classic  types  of  
adipose  tissue  are  white  adipose  tissue  (WAT)  and  brown  adipose  tissue  (BAT),  each  
morphologically   specialized   to   either   serve   as   a   site   of   energy   storage   or   energy  
expenditure,  respectively.  Lipid  storage  in  WAT  is  more  efficient  than  storage  of  protein  
and  carbohydrates,  as  lipids  store  more  kCal  per  gram  than  protein  or  carbohydrates  and  
can  be  easily  mobilized   for   energy.  Storage  of   energy   as   lipids   allows   for  maintained  
bodily   functions   during   periods   of   food   scarcity.   This   is   an   important   adaptation   in  
mammalian   survival   and   evolution.      WAT   is   evolutionarily         While   WAT   serves  
predominately   to   store   fuel,   BAT   serves   as   the   organ   for   adaptive   thermogenesis,   a  
process  that  utilizes  lipid  fuels  to  drive  heat  production.  To  this  end,  adipocytes  of  WAT  
and  BAT  differ  as  they  have  evolved  to  fulfill  their  purpose.  WAT  adipocytes  contain  one  
large  lipid  droplet  and  little  else,  with  all  cellular  machinery  pressed  against  one  side  of  
the  cellular  membrane.  On   the  other  hand,  BAT  adipocytes  are  comprised  of  multiple  
small  lipid  droplets  which  increases  surface  area  to  allow  ready  release  of  fatty  acids  for  
fuel.    This  pattern  of  lipid  droplet  accumulation  is  termed  multilocular.    BAT  adipocytes  
are  also  densely  packed  with  mitochondria,  from  whence  heat  is  dissipated,  due  to  their  




Adaptive   thermogenesis   requires   neuronal   stimulation,   and   the   action   of  
catecholamine  neurotransmitters  such  as  norepinephrine  (NE,  also  called  noradrenaline).  
When  activated  by  the  sympathetic  nervous  system  (SNS),  BAT  activates  UCP1,  which  
uncouples  the  mitochondrial  electron  transport  chain  and  instead  of  producing  ATP,  the  
end  product  is  the  dissipation  of  the  proton  gradient  as  heat.  Although  UCP1  is  a  unique  
marker   of  BAT,   it   can  also   be   induced   in  WAT  under   certain   conditions   such  as   cold  
stimulation   (or  noradrenergic  stimulation).  This  process   is  known  as   ‘browning’  as   the  
WAT  begins  to  take  on  a  BAT  morphology,  including  the  appearance  of  multilocular  cells  
within   the   depot   (Fig.   1).      This   process   results   in   thermogenesis   from   WAT   and  
fundamentally   increases   energy   expenditure.   There   are   also   situations   where   WAT  
becomes   thermogenically   active,   exhibits   increased   activity   of   UCP1,   resulting   in  
Figure   1:   Catecholamine   induced   browning   of   white   adipose   tissue   (WAT).  
Sympathetic   nerves   release   norepinephrine   (NE)   which   binds   to   beta   adrenergic  
receptors   on   adipocytes.   This   initiates   a   signaling   cascade   that   results   in   the  
transcription  of  browning  genes,  including  UCP1;;  and  lipolysis,  allowing  free  fatty  acids  
(FFAs)  to  be  taken  up  by  mitochondria  and  enter  the  vasculature  where  they  can  be  


















increased  energy  expenditure,  but  does  not   take  on  a  multilocular  morphology.  These  
thermogenicaly  active  cells  are  paucilocular  cells  that  look  lite  WAT  adipocytes  but  can  
still  burn  calories.  
  The   plasticity   of   certain  WAT   depots   to   undergo   browning   or   UCP1-­mediated  
thermogenesis  is  truly  remarkable  in  its  ability  to  shift  from  an  energy  storing  organ  to  one  
that  can  expend  energy,  dependent  on  physiological  or  environmental  needs  of  the  body.    
Certain  anatomical   locations  of  WAT  (in  mouse)  more  readily  undergo  browning  more  
than  others  (ie:  subcutaneous,  perirenal),  and  in  humans  the  majority  of  BAT  cells  are  the  
inducible/recruitable  type  that  appear  in  WAT.    Importantly,  the  ability  of  adipose  tissue  
to  respond  appropriately  to  stimuli  is  dependent  on  proper  brain-­adipose  communication.    
Although   we   have   known   that   brown   fat   thermogenesis   in   mammals   is   under  
neural   control   since   the   early   1960s   [1-­4]   we   are   still   striving   to   fully   understand   the  
mechanisms   involved   in   maintaining   adipose   innervation,   including   demonstrating  
synaptic  connections  in  cells  of  the  adipose  organ.    
Considering  the  different  physiological  roles  of  BAT  and  WAT,  their  distinct  gene  
expression  profiles  (ie:  BAT  highly  expresses  UCP1,  WAT  highly  expresses  leptin  and  
adiponectin),  and   their  differing  developmental  signatures   [5],   it   is  assumed  that   these  
organs   would   have   different   secretory   profiles,   which   would   affect   nearby   cells   in   a  
paracrine  or  autocrine  manner.  Current  literature  appears  to  support  this  notion  [6,  7]  We  
also  know  that  some  of  these  secreted  molecules,  known  as  adipokines,  can  affect  distal  
organs  through  entering  the  circulation  and  acting  in  an  endocrine  manner  [8]  and  that  




molecules  [9,  10].  Partitioning  of  dietary  fats  between  WAT,  BAT  and  brain  is  the  focus  of  
the  first  research  chapter  of  this  thesis.  
  
II.  Brain-­adipose  communication  
How  does  the  brain  communicate  with  adipose  tissue?  In  similar  fashion  to  most  
brain-­organ  communication,  the  endocrine  system  and  the  peripheral  nervous  system  are  
essential  for  proper  brain-­adipose  communication.  Nerves  of    the  sensory  and  autonomic  
nervous  system  transmit  information  from  the  periphery  to  the  brain  (afferent)  and  from  
the  brain  to  the  periphery  (efferent),  respectively.    
Numerous  studies  over  the  past  several  decades  have  clearly  demonstrated  the  
importance  of  peripheral  nerves  in  regulating  BAT  and  WAT  thermogenesis.    In  response  
to   a   cold   environment,   one   that   threatens   thermal   homeostasis,   cold-­sensing   sensory  
nerves   in   the   skin   relay   this   environmental   information   to   the   brain.   In   turn,   the   brain  
especially   the   hypothalamus   (the   energy   regulatory   center),   responds   by   increasing  
sympathetic  outflow  to  adipose  tissues,  stimulating  UCP1-­mediated   thermogenesis  via  
release  of  NE  [4,  11].  NE  acts  on  beta-­adrenergic  receptors  on  adipocytes,  which  initiates  
an  intracellular  signaling  cascade  that  ends  in  the  transcription  of  lipolytic  (in  WAT)  and  
thermogenic  genes  (in  both  WAT  and  BAT)  and  increases  EE.    Other  modes  of  EE,  such  
as  diet  induced  thermogenesis,  the  post-­prandial  heat  production  that  accounts  for  5-­15%  





Innervation  of  Adipose  Tissues  
   Innervation  of  Brown  Adipose  Tissue  (BAT)  
The  notion  that  neural  innervation  exists  in  adipose  tissues  is  not  a  new  one;;  from  
an  anatomical  and  functional  perspective,  all  tissues  of  the  body  should  be  innervated  –  
an  idea  supported  since  at  least  the  late  1800s.    Cardiac  tissue  and  blood  vessels  were  
found  to  be  widely  innervated,  as  well  as  pericardial  white  adipose  tissue  (WAT;;  which  is  
a  very   ‘brown’  depot),   in  small   rodents  as  early  as   the  1890s   [13].  Direct  evidence  of  
innervation  of  brown  adipose  tissue  (BAT;;  in  mice  and  rats)  was  demonstrated  in  the  mid-­
20th  century  [14].  Interestingly,  even  in  the  1950s  Sidman  and  Fawcett  made  a  statement  
that  would  be  equally  relevant  today.    They  wrote,  “Relatively  little  attention  has  been  paid  
in  recent  years   to   the   influence  of   the  nervous  system  on  adipose  tissue  even  though  
detailed  experimental  studies  on   this  subject  are   to  be   found   in   the  (literature).”     They  
went   on   to   cite   a   number   of   studies   in   the   1930s   that   presented   evidence   for   the  
importance  of  adipose  nerves;;  and  themselves  stated  that  mixed  nerve  types  innervate  
BAT  and  that  many  nerve  fibers  were  not  associated  with  blood  vessels  but  made  direct  
contact  with  adipose  cells  [14].  Similarly  timed  investigations  argued,  with  the  support  of  
fluorescent  microscopy,  that  the  sympathetic  innervation  found  in  BAT  was  restricted  to  
the  vasculature  and  was  mainly  vasoregulatory  in  function  [15];;  although,  the  existence  
of  parenchymal  nerve  fibers  in  adipose  tissue  was  at  least  becoming  more  accepted  a  
year  later  [16].      
Soon  after,  Bargmann  et  al.   [17]   in   the   late  1960s  used  electron  microscopy   to  




BAT  vasculature  but  that  they  also  extended  into  the  parenchymal  space.    Interestingly,  
as   we   describe   below,   this   parenchymal   innervation   of   adipose   was   rediscovered   in  
recent  years  with  whole  depot  imaging  techniques.  Bargmann  et  al.  [17]  were  also  able  
to  see  both  non-­myelinated  and  myelinated  paravascular  (their  anatomical  term)  nerve  
bundles,   but  more   importantly,   they   found   that   small   unmyelinated  axons  were   tightly  
associated  with   fat  cells   themselves.  Interestingly,   the  axon  terminals  of   these  nerves,  
some  of  which  were   “embedded   in   invaginations”   of   the   adipocyte   surface,   contained  
synaptic   vesicles   that   the   authors   presumed   to   contain   catecholamines   [17].   This  
presumption   was   based   on   the  mounting   evidence   for   catecholamine   release   driving  
adaptive   thermogenesis   in  BAT   in  multiple  mammalian  species   [18-­20],   findings  which  
also   underscored   that   NE   was   essential   for   this   process   instead   of   the   previously  
hypothesized  epinephrine/adrenaline  [21]  [22].      
Based   on   these   studies,   it   became   accepted   that   cold-­induced   thermogenesis  
caused  an   increase  of  NE  release  to  BAT,  which  resulted   in   lipolysis  and  activation  of  
uncoupling  protein  1  (UCP1).  However,  if  we  look  back  to  some  of  the  original  findings  
regarding  adipose  innervation  [16],  there  may  be  another  mechanism  to  consider.  Early  
fluorescent  microscopy  imaging  of  BAT  and  WAT  innervation  argued  for  numerous  nerve  
fibers  surrounding  the  vasculature,  predominantly  around  arteries  and  arterioles  [15,  16].  
Given   this   perspective,   an   alternative   hypothesis   could   be   that   cold-­induced  
thermogenesis  does  not  result  in  an  increase  in  the  concentration  of  circulating  NE,  nor  
might  it  result  in  an  increase  in  direct  sympathetic  drive  to  WAT  and  synaptically  released  
NE.    Instead  there  could  be  stimulation  of  vasodilation  to  tissues  due  to  vasoregulatory  




tissue  per  volume  of  blood,  but  instead  an  increased  volume  of  blood  that  would  thereby  
deliver   more   catecholamine.   This   idea   could   provide   a   vascular   mechanism   for   how  
obese  adipose  tissues   loses   thermogenic  capacity,  given   the  vasculature  damage  that  
occurs  due  to  chronic  inflammation  and  the  relative  loss  of  vascular  supply  to  adipocytes  
due  to  expanding  adipose  mass  coupled  with  a  lack  of  new  angiogenesis,  as  reviewed  
by  Stapleton,  et  al.    [23].  
These  early  microscopy   studies   could   not   benefit   from   the  use  of   fluorescently  
labeled  antibodies  targeting  markers  of  sympathetic  innervation  as  they  did  not  yet  exist,  
thus   instead   they   employed   formaldehyde   gas   to   form   highly   fluorescent   isoquinoline  
derivatives  formed  from  the  presence  of  monoamines  (including  NE)  [16].  The  resulting  
observations  indicated  neurotransmitters  in  axon  terminals  of  BAT  and  WAT  nerves,  and  
may  have  actually  been  a  more  specific  result  than  what  we  get  with  antibody  staining  
today,  given  the  potential  for  off-­target  and  non-­specific  binding  of  the  antibodies.    The  
downside  of  this  formaldehyde  gas  technique  was  the  inability  to  distinguish  the  subtype  
of  monoamine  they  were  fluorescing.  
Innervation  of  White  Adipose  Tissue  (WAT)  
The  observation  of  Bargmann  et  al.  [17]  that  each  adipocyte  comes  in  contact  with  
nerve   fibers   in   the   parenchyma   is   consistent   with   what   we   and   others   have   recently  
reported  in  WAT    [24-­26].  Earlier  studies  using  True  Blue  as  a  retrograde  neural  tracer  
(crystal  implants  in  WAT)  showed  sensory  innervation  in  inguinal  subcutaneous  WAT  (i-­
scWAT),  as  evidenced  by  tracing  back  to  the  T13/L1-­L3  dorsal  root  ganglia  (DRG)  [27].  




virus-­1  (HSV-­1),  has  also  been  used  to  trace  sensory  nerve  projections  from  i-­scWAT  and  
intraperitoneal   epididymal   WAT   (eWAT),   through   the   same   T13/L1   DRG   in   Siberian  
hamsters  [28].  Together,  these  studies  and  others  like  them  have  indicated  that  adipose  
has  bi-­directional  communication  with  the  brain  –  through  both  afferent  sensory  fibers  and  
efferent  sympathetic  fibers.    However,  the  role  of  sensory  innervation  in  WAT  continued  
to   be   largely   understudied   in   lieu   of   sympathetic   nervous   system   (SNS)   innervation  
studies   in   the   intervening   years.      This   made   sense   given   the   importance   of   NE   for  
thermogenesis  and  lipolysis.    More  recently,  new  studies  have  revisited  the  function  of  
adipose  sensory  nerves.  Long-­form  leptin  receptor  (ObRb)  was  found  on  DRG  neurons  
traced   from   i-­scWAT,   suggesting   leptin   could   potentially   communicate   with   sensory  
nerves   in  adipose  via   the  DRG  [29].  Furthermore,  SNS-­stimulated   lipolysis,  as  well  as  
intra-­adipose  injection  of  free  fatty  acids  such  as  eicosanoidpentaenoic  acid  (EPA)  and  
arachidonic   acid   (AA),   could   increase   adipose   afferent   nerve   activity   [30].   This   was  
capable   of   triggering   BAT   thermogenesis,   an   effect   that   was   abolished   with   surgical  
denervation  of  i-­scWAT  [30].    
Although   early   microscopy   studies   provided   evidence   of  WAT   innervation   and  
hypothesized   that   these   nerves   were   of   SNS   origin   [16],   irrefutable   proof   of   SNS  
innervation   of   WAT   came   from   the   seminal   studies   of   Youngstrom   &   Bartness,   who  
demonstrated  bidirectional  innervation  of  WAT  [31].  Using  the  retrograde  fluorescent  tract  
tracer   FluoroGold   injected   into   i-­scWAT   and   eWAT,   as   well   as   the   anterograde  
fluorescent   tract   tracer   DiI,   they   determined   that   the   SNS   ganglia   also   at   T13/L1-­L3  
innervated  both  fat  pads.  These  studies  further  showed  that  there  was  innervation  of  the  




previously  demonstrated  in  the  mid  1900s.  The  specificity  of  the  tracing  was  confirmed  
by  surgical  denervation  of  the  fat  depots  and  by  injecting  the  tracers  directly  into  blood  
vessels.  Furthermore,  using  pseudorabies  virus  (PRV)  retrograde  tracing  from  i-­scWAT,  
which  can  only   trace  sympathetic  neurons   that  are  synaptically  connected,   they  could  
create  hierarchical  connectome  that  mapped  neuronal  pathways  from  the  tissue  to  the  
brain   [32].   For   the   next   2   decades,   the   work   of   Timothy   Bartness   would   continue   to  
pioneer  our  understanding  of  adipose  innervation  in  rodent  models  [33].    
  
Lessons  from  adipose  denervation  studies  
Multiple  methods   for   and   consequences  of  denervation   of  WAT  and  BAT  have  
been  reported  in  the  literature,  and  have  been  described  in  detail  in  recent  reviews  [34,  
35].  Of   these,  surgical  denervation   is  considered   the  most  effective  at  eliminating   total  
neural   input   and   output,   as   the   nerve   bundles   innervating   the   tissue   are   physically  
resected.   However,   surgical   denervation   is   generally   non-­specific   to   nerve   type   (as  
sensory   and   sympathetic   nerve  bundles   tend   to   travel   together),   can  be  a   technically  
challenging  method,  and  can  cause  undesirable  effects  as  nerves  bundles  that  innervate  
adipose   depots   often   innervate   other   tissues   and   can   run   along   the   vasculature.   An  
alternative   approach   is   chemical   denervation.   Chemical   denervation   can   provide   a  
selective   and   localized   means   of   removing   nerve   supply   to   WAT   depots.   The   first  
selective   chemical   denervation   drug  was   6-­hydroxydopamine   (6-­OHDA)   [36]   which   is  
taken  up   into  NE  storage  vesicles   leading   to  oxidative  damage   to   the  membrane  and  




nerves   while   leaving   sensory   nerves   intact   [34].      Later,   some   chemical   denervation  
studies   using   the   chemical   guanethidine   had   been   used   to   produce   chemical  
sympathectomy.  This  drug  works  by  displacing  NE  from  postganglionic  sympathetic  nerve  
endings,  and  decreases  reuptake  of  NE  by  nerve  terminals.  When  locally  administered,  
it  can  deplete  a  tissue  of  NE,  effectively  depleting  sympathetic  tone.  It  has  been  used  to  
provide  direct  evidence  of  the  role  of  NE  in  WAT,  as  local  injection  of  guanethidine  to  i-­
scWAT   resulted   in   increased   fat   pad   size   due   to   adipocyte   hyperplasia   in   Siberian  
hamsters  [37].  This  denervation  experiment  helped  provide  a  mechanism  by  which  the  
SNS  regulates  body  mass,  which   is   to  regulate  adipocyte  dynamics  and  cell  size.  The  
current  preferred  sympathetic  denervation  drug  is  6-­OHDA,  as  subsequent  preparations  
of  guanethidine  proved  less  reliable  [35].    
For   chemical   denervation   of   sensory   nerves,   capsaicin   is   typically   used,  which  
activates  vanilloid  receptors  on  unmyelinated  and  myelinated  sensory  nerves.  The  over-­
activation   of   the   receptors   causes   an   influx   of   calcium   and   sodium   resulting   in   an  
excitotoxic   effect   [34].   The   efficacy   of   capsaicin-­mediated   sensory   denervation   is  
validated   by   a   reduction   in   calcitonin   gene-­related   peptide   (CGRP)  and   Substance   P  
content,   and  although   it   is   not   as   effective   as   surgical   denervation,   this  method  does  
appear  to  leave  sympathetic  efferent  nerves  intact  [38].  
Denervation  of  BAT  
  Some  of   the  most  elegant  studies  demonstrating   the   importance  of  neural  control   for  
adipose   tissue   metabolism   and   function   involved   surgical   denervation   of   BAT.   By  




linked  to  a  lack  of  brain-­adipose  communication.  Indirect  evidence  for  sympathetic  control  
of  lipolysis  had  been  demonstrated  by  studies  showing  an  increased  rate  of  NE  turnover  
(NETO)  in  both  BAT  and  WAT  following  cold  exposure  in  rats  [39].    Increased  NETO  in  WAT  
has   also   been   demonstrated   with   fasting   in   rats   [40].     Denervation   studies   have   added  
credence  to  these  findings.  Unilateral  and  bilateral  denervation  of  intrascapular  (iBAT)  is  
technically  less  difficult  than  denervation  of  WAT  depots  since  nerve  bundles  innervating  
iBAT   are   more   easily   visualized   and   anatomically   defined   (5   intercostal   nerves   that  
unilaterally  innervate  iBAT)  [41]  than  those  innervating  WAT  depots  [35],  and  originate  
mainly  from  the  stellate  ganglion  [42].    Bilateral  denervation  of  iBAT  resulted  in  greatly  
impaired   thermogenesis   and   reduced   overall   energy   expenditure,   increased   body   fat  
mass   [43],  and   ‘whitening’  of   the   tissue   [44].  Furthermore,  experiments  with  unilateral  
iBAT   denervation   showed   decreased   presence   of   tyrosine   hydroxylase   (TH)   [44]   and  
UCP1  [45]  only   in   the  denervated   fat  pad  compared  to   the   intact  contralateral  pad.      In  
studies   where   sympathetic   drive   to   BAT   increased   total   energy   expenditure,   surgical  
denervation  blunted   the  effect   [44,  46].  This  surgical  denervation  of  BAT  was  done  by  
severing  the  large  nerve  bundles  transiting  to  BAT,  as  anatomically  defined  [41],  while  
leaving  nearby  vasculature  intact  [47].  Furthermore,  bilateral  chemical  sympathectomy  of  
iBAT  increased  NETO  in  i-­scWAT  [47],  demonstrating  adipose  tissue  crosstalk  with  brain  
in   the   attempt   to   reestablish   energy   homeostasis.   Chemical   denervation   of   sensory  
innervation  to  iBAT  also  impaired  thermogenesis  [48],  demonstrating  the  need  for  sensory  
feedback  from  iBAT  for  proper  thermogenic  function.    





      Denervation  of  WAT  
      There  are  metabolically  relevant  consequences  of  losing  the  nerve  supply  to  WAT.  
Surgical   denervation   of   WAT   led   to   increased   fat   pad   mass   and   white   adipocyte  
proliferation  and  differentiation,  as  demonstrated  in  both  rat  [49]  and  Siberian  hamsters  
[50-­52].  The  i-­scWAT  fad  pad  is  innervated  by  multiple  nerve  bundles  entering  the  tissue  
at   multiple   locations.   Surgical   denervation   of   i-­scWAT   was   accomplished   by   tracking  
these  nerves  under  4x  magnification  to  their  terminal  location  and  bisecting  the  nerves  at  
that  area  [50].  Retroperitoneal  WAT  (rWAT)  is  perhaps  more  easily  surgically  denervated  
by  lifting  the  kidney  and  cutting  the  three  nerve  bundles  right  before  they  enter  the  fat  pad  
[51].   These   experiments   underscored   the   importance   of   innervation   for   regulating  
hypertrophy  versus  hyperplasia,  as  well  as   for  controlling   levels  of   lipolysis.  However,  
surgical   denervation   could   not   reveal   which   nerves   are  most   essential   in  maintaining  
proper  body  mass  and  metabolic  health,  as  the  technique  denervates  both  sympathetic  
and   sensory   nerves   and   causes   disturbance   of   vasculature.   Furthermore,   surgical  
denervation  at  the  level  of  the  ganglia  would  not  work  because  the  ganglia  that  innervate  
WAT  is  not  as  discrete  as  the  one  that  innervates  BAT,  so  denervation  of  other  off-­target  
tissues  would  occur  leading  to  indirect  effects  on  metabolism.    
        The  Bartness   lab  and  others  have  subsequently  used  chemical  denervation   to  
gain  a  deeper  understanding  of  which  nerves  act  in  adipose  depots  and  how.  Chemical  
sympathectomy   (with   6OHDA)   of   one   fat   pad   increased   total   body   fat   and   increased  
adipocyte  number  in  the  contralateral  fat  pad  in  rats  and  mice  [53].  One  interpretation  of  
these  data  would  be  that  sensory  feedback  from  the  denervated  pad  led  to  effects  in  the  




peripherally   administered   leptin   could   reduce   fat   pad   size   independent   of   innervation  
status   [53],   confirming   that   endocrine   and   neuronal   effects   mediate   adiposity.   In  
subsequent  studies,  6-­OHDA  denervation  of  sympathetic  nerves  in  one  or  both  fat  depots  
reduced  the  NE  content  and  inhibited  NETO  in  other  WAT  pads  as  well  as  in  iBAT  [54].    
      Over  and  over,  sympathetic  denervation  of  WAT  resulted  in  increased  depot  mass  
characterized   by   an   increase   in   cell   number   and   a   decrease   in   lipolysis,   as   recently  
reviewed  [34].  On  the  other  hand,  sensory  denervation  of  iWAT  and  eWAT  increased  fat  
pad  mass  via  hypertrophy  instead  of  hyperplasia,  providing  a  means  of  differential  control  
of   WAT   by   sympathetic   versus   sensory   nerves   [38,   52].      The   next   step   in   our  
understanding  must  be  to  delineate  how  different  neuropeptides  and  neurotransmitters  
exert  these  effects,  and  whether  sensory  nerve  products  potentially  modulate  the  effects  
of  NE  from  SNS  nerves.  
  
III.  Immune  cells  and  adipose  tissue  
The  stromal  vascular  fraction  (SVF),  and  role  of  immune  cells  in  adipose  tissue    
Adipose  tissue   is  a  greatly  heterogeneous  organ  that  maintains  a  multitude  of  diverse  
cells   types   (Fig.2).   The  non-­adipocyte   cell   fraction   of   adipose   tissue   is   known  as   the  
stromal   vascular   fraction   (SVF).   The   SVF   contains   multipotent   stem   cells   (known   as  
adipose-­derived   stem/stromal   cells);;   various   progenitor   cells   including   endothelial  
precursor   cells   and   preadipocytes   (that   can   undergo   white   or   brown   adipogenesis);;  
pericytes;;  and  a  wide  diversity  of   immune  cells.  Adipose  SVF  immune  cell  populations  




dendritic  cells,  mast  cells,  neutrophils,  eosinophils,  and  innate  lymphatic  cells  (ILCs);;  as  
well  as  adaptive  immune  cells,  such  as:  several  subsets  of  T  cells,  natural  killer  cells,  and  
B  cells.  Although,  many  of  these  immune  cells  are  known  to  play  a  role  in  adipose  tissue  
health,  this  review  focuses  predominantly  on  monocytes/macrophages,  as  they  represent  
the  most  abundant  type  of  leukocyte  in  adipose  tissue  [55]  and  directly  relate  to  the  later  
chapters  of  the  thesis.  
Role  of  macrophages  and  monocytes  in  adipose  tissue  
Macrophages  and   their   undifferentiated  precursors,  monocytes,   are   critical   leukocytes  
that  function  in  both  the  innate  and  adaptive  immune  response.    The  role  of  macrophages  
in   adipose   tissue   has   been   well   studied   for   the   past   15   years,   yet   new   information  
regarding   this   complex   relationship   is   constantly   arising.   Historically,   these   adipose  
resident  macrophages  have  been  delineated  into  two  types,  pro-­inflammatory  or  M1  type  
and   anti-­inflammatory   or   M2   type   macrophages.   In   this   simplified   scheme,   M1  
macrophages  are  responsible  for  initiating  the  healing  process  during  acute  inflammation  
that   occurs   during   tissue   injury,   by   releasing   pro-­inflammatory   cytokines   to   recruit  
phagocytic  macrophages  to  an  injured  site.  When  a  tissue  is  injured  unhealthy  cells  will  
undergo  apoptosis,  cells  undergoing  apoptosis  secrete  cytokines  that  recruit  phagocytic  
cells  to  the  injury  site  in  order  to  clear  up  the  debris  and  allow  for  cell  renewal/tissue  repair  
to  happen.  These  phagocytic  macrophages  further  secrete  pro-­inflammatory  cytokines  to  
recruit  monocytes  and  macrophages  to  injured  tissue.  In  adipose  tissue,  dead  or  dying  
adipocytes   become   surrounded   by   macrophages   which   from   “crown-­like”   structures  
around   the   cell   as   they   phagocytose   it.   Once   cellular   debris   has   been   cleared,   the  




inflammatory   one.   This   polarizes   macrophages   from   an   M1   phenotype   to   an   M2  
phenotype.  M2  macrophages  are  now  responsible  for  initialing  the  regeneration  program,  
by   secreting   the   appropriate   growth   factors   to   aid   in   cell   renewal   and   tissue   repair.  
However,   under   unhealthy   conditions   macrophages   contribute   to   a   chronic   state   of  
inflammation.  When  tissue  injury  is  constantly  present,  as  in  states  of  obesity  where  cells  
continuously   become   hypoxic   and   die,  M1  macrophages  maintain   a   pro-­inflammatory  
cytokine  secretome  in  order  to  keep  recruiting  cells  and  handle  the  debris  clearance.  This  
results   in   an   imbalance   of   M1   to   M2   macrophages   and   a   reduced   efficiency   in  
regeneration  of  healthy  tissue.  In  adipose  tissue,  this  chronic  low-­grade  inflammation  has  
been  linked  to  contributing  to  insulin  resistance  (IR),  and  the  development  of  metabolic  
syndrome,   as   reviewed   by   [56].   Another   consequence   of   obesity   and   the   influx   of  
macrophages  is  the  development  of  macrophage  foam  cells.  Foam  cells  are  formed  as  
macrophages  clearing  debris  from  dying  adipocytes  (formation  of  crown  like  structures)  
accumulate  excess  free  fatty  acids  [55]  and  cholesterol  [57].  This  accumulation  of  lipids  
results   in  a   foamy  cytosol,  hence  the   term  foam  cell,  and  has  been  suggested   to  alter  
macrophage  metabolism   resulting   in   a   pro-­inflammatory   shifted   secretory   profile   that  
contributes  to  IR  and  atherosclerotic  lesions  in  humans  and  mice  [57,  58].    
Many  studies  have  proposed  manipulating  the  M1  to  M2  ratio  of  adipose  resident  
macrophages  in  order  to  alleviate  states  of  chronic  inflammation  and  reestablish  a  healthy  
adipose   organ.   However,   success   limited   by   our   understanding   of   the   complexity   of  
macrophage   phenotypes.   Genetics   contributes   to   the   ability   of   preventing   a   chronic  
inflammatory  response  –certain  mouse  lines  such  as  the  Balb-­c  strain,  are  more  skewed  




adipose   inflammation  even  under  obese  conditions  and  are  protected   from  developing  
insulin  resistance  and  diabetes.  Sex  differences  also  play  a  role   in   immune  response.  
Females   (up   to  a  certain  age)  appear   to  be  more   resistant   to  developing  chronic   low-­
grade  inflammation  in  adipose  tissue  and  IR.  This  has  been  attributed  to  the  protective  
role  of  estrogen  which  may  be  preventing  hypertrophy  of  adipose  tissue  even  on  a  high  
fat  diet  [59].      
Although  much  of  the  obesity  field  is  lagging  in  understanding  or  acceptance  of  the  
diversity   of   macrophage   phenotypes,   and   the   extent   to   which   these   various   cell  
phenotypes  contribute  to  energy  balance,  a  slow  change  in  perception  is  occurring.  For  
example,  a  new  source  of  crosstalk  between  BAT  and  WAT,  appears  to  be  mediated  by  
immune   cells.      Recently,   Cereijo   et   al.   [60]   discovered   a   BAT   secreted   chemokine,  
CXCL14,  which  triggers  macrophage  polarization  and  mediates  browning  in  WAT.  This  
batokine  is  secreted  by  BAT  in  response  to  thermogenic  stimulation,  which  we  know  is  a  
direct   result   of   sympathetic   activation,   and   provides   us   with   another   example   of   the  
layered   mechanisms   of   neural,   vascular,   and   immune   system   interplay   in   regulating  
adipose  tissue.    
  
Neuro-­immune  interactions    
It   is  well  appreciated   that   immune  cells,  especially  macrophages  play  a  critical   role   in  
energy   balance   and   metabolic   health.   The   study   of   neuro-­immune   interactions   is   a  
burgeoning   field   currently   gaining   much   traction.   Microglia   are   glial   cell   that   act   as  




cells  play  a  critical  role  in  immune  defense  and  maintain  homeostasis  trough  control  of  
cell  differentiation,  proliferation  and  formation  of  synaptic  connection,  in  the  CNS  [61-­65].  
As  is  the  case  with  all  macrophages,  microglia  actively  respond  to  traumatic  brain  injury  
and   initiate  a  healing/repair  program,  which  reestablishes  CNS  homeostasis.  Microglia  
also  play  a  role  in  learning-­associated  synaptic  plasticity  [66].    It  is  believed  that  synaptic  
plasticity  is  mediated  by  the  synthesis  and  release  of  brain  derived  neurotrophic  factor  
(BDNF)  by  microglia,  as  reviewed  by  [67].  On  the  other  hand,  microglia  can  play  a  role  in  
chronic  inflammation  of  the  CNS  [67],  similarity  to  how  tissue  resident  macrophages  are  
at  the  crux  of  chronic  inflammation  in  adipose  tissue  under  obese  conditions.      
   Neuroimmune  interactions  in  adipose  tissue  
Although  the  role  of  immune  cells,  especially  macrophages,  in  adipose  tissue  has  
been  and  continues  to  be  an  active  area  of  study,  neuroimmune  interactions  in  adipose  
tissue  remain  largely  obscure.  It  had  been  suggested  that  BAT  and  WAT  macrophages  
synthesize  catecholamines  in  response  to  cold  [68].  Although  Nguyen  et  al.  argued  that  
cold-­induced   adaptive   thermogenesis   requires   alternatively   activated   (M2,   anti-­
inflammatory)   macrophages   and   did   demonstrate   that   preventing   this   macrophage  
polarization   resulted   in   an   impaired   thermogenic   response,   these   findings   were   later  
challenged   to   suggest   a   different   explanation   for   the   observed   relationship   between  
macrophages   and   catecholamines.   In   2017,   Fischer  et   al.   used   a  mouse  model   with  
genetic   deletion   of   TH   (the   rate   limiting   enzyme   in   catecholamine   production)   in  
hematopoietic   cells   [69].      By   this   method,   they   refuted   the   findings   that   alternatively  
activated  macrophages  synthesize  catecholamines.  In  their  study,  not  only  did  deletion  




macrophages   from   various   adipose   tissues   revealed   that   no  macrophage   population  
tested  contained  transcripts  for  TH.  
The  debate  between  these  two  sets  of  findings  may  have  found  its  resolution  with  
some   recent   publications.   Studies   using   zebrafish   have   demonstrated   a   role   for  
macrophage   signaling   over   long   distances   between   non-­immune   cells   during   tissue  
developmental   remodeling,   whereby   macrophages   transported   airineme   vesicles  
between  two  different  cell   types   [70].  Furthermore,  buried   in   literature   from  the  1970s,  
was  evidence  that  mouse  peritoneal  macrophages  accumulated  NE  in  vitro  [71].  These  
studies  allow  for  the  possibility  of  macrophages  transporting  other  materials  such  as  NE  
within  adipose  tissues.    
Soon  after,  Pirzgalska,  et  al.  presented  data  that  supported  similar  macrophage  
behavior  but  pertinent  to  neuroimmune  interactions  in  adipose  tissue  [72].  They  recently  
described  a  distinct  macrophage  population  that  associates  in  a  specific  manner  with  SNS  
nerves   of   i-­scWAT.   The   appropriately   named   sympathetic   neuron-­associated  
macrophages  (SAMs),  can  be  found  interacting  with  SNS  fibers  within  WAT  and  are  not  
only   morphologically   distinct   from   adipose   tissue   resident   macrophages   (ATMs),   but  
exhibit  a  gene  expression  pattern  distinct  from  adipose  and  other   tissue  macrophages  
[72],  including  expression  of  genes  related  to  synaptic  signaling,  cell-­cell  adhesion,  and  
neuron  development.  Unlike  the  circular  morphology  of  ATMs,  SAMs  wrap  around  SNS  
fibers   and   exhibit   an   extended   shape   with   long   dendritic   like   projections.   Like  
observations  made  by  Nguyen,  et  al.  SAMs  contained  significant  amounts  of  intracellular  
NE,   but   lacked   the   requisite   enzymes   for   NE   synthesis,   as   previously   reported   for  




pro-­inflammatory  state  more  similar  to  classically  activated  than  M2  type  macrophages,  
however,  their  most  distinguishing  feature  was  the  expression  of  solute  carrier  family  6  
member  2  (Slc6a2;;  a  known  NE  transporter),  as  well  as  monoamine  oxidase  A  (MAOA),  
an  enzyme  that  degrades  NE.  Although  other  macrophages  have  been  shown  to  express  
MAOA   [72],   only   SNS   fiber   associating   SAMs   expressed   Slc6a2   [72].   The   authors  
proposed,  quite  believably,  that  SAMs  were  acting  as  an  NE  sink,  taking  up  excess  NE  
after  SNS  stimulation  and  degrading  it.  The  transport  of  NE  by  SAMs  was  not  explored.    
They  also   showed   that  SAMs  are   recruited   to  WAT   in   obesity   (both   diet   induced  and  
genetic  models)   and  may   be   contributing   to   the   adipocyte   hypertrophy   through   over-­
degradation  of  NE.  They  went  on  to  show  that  ablation  of  Slc6a2  from  SAMs  in  obese  
mice   lead   to   an   obesity   rescue,   through   reestablishment   of   NE   levels   that   served   to  
increase   lipolysis   and  energy   expending  processes   such  as  browning  of  WAT.  SAMs  
(with  analogous  molecular  machinery)  were  also  identified  in  the  SNS  tissue  of  humans  
[72].  SAMs  have  been  shown  to  associate  with  other  neuronal  tissues,  such  as  the  SCG  
and  thoracic  chains,  and  are  also  present  in  BAT  [72].  However,  their  abundance  in  BAT  
is  much  lower  than  WAT,  and  their  role  in  BAT  may  not  be  as  metabolically  relevant  as  in  
is  in  WAT,  but  this  remains  to  be  seen.    
In  a  parallel   study,  Camell  et  al.  presented   findings  of  ATMs   in  aged  mice   that  
degrade  NE  and  contribute  to  age-­related  lipolysis  impairment  in  visceral  adipose  tissue  
(VAT)  [74].    ATMs  from  24-­month-­old  mice  showed  increased  expression  of  MAOA  and  
other  catecholamine  degrading  enzymes  in  a  NOD-­,  LRR-­  and  pyrin  domain-­containing  
(NLRP)3  inflammasome  dependent  manner,  compared  to  young  3  month  old  mice  [74].  




with   TH+   nerves   in   VAT   [74];;   providing   the   likelihood   that   what   they   called   nerve  
associated  macrophages  (NAMs)  may  be  the  same  cells  as  SAMs.  Although  Camell,  et  
al.  used  a  LysM-­Cre:mTmG  reporter  mouse  model   to  visualize   their  ATMs,  which   is  a  
broader  myeloid  marker   than   the  Cx3cr1+  model   Pirzgalska  et   al.   used,   they   did   not  
investigate  whether  NAMs  expressed  Slc6a2  (SAM  marker)  even  though  the  morphology  
of  their  NAMs  is  consistent  with  that  of  SAMs.    
Mutations  in  another  type  of  Cx3cr1+  macrophage  that  do  not  appear  to  be  SAMs  
have   been   linked   to   decreased   BAT   innervation   and   subsequent   loss   of   homeostatic  
energy  expenditure  [75].  Mice  with  Mecp2  (methyl-­CpG-­binding  protein  2)  deficiency  in  a  
subset  of  BAT  resident  Cx3cr1+  macrophages,  exhibited   lower  expression  of  UCP1,  a  
paucity  of  BAT  tissue,  and  developed  obesity  after  3-­4  months  of  age  [75].  Interestingly  
these  findings  were  BAT-­specific  and  no  changes  were  observed  in  WAT.    Furthermore,  
tamoxifen   inducible  Cx3cr1cre:Mecp2fl/y  mice  were  created   to  restrict  Mecp2  deficiency  
from  macrophage  precursor  cells  (including  brain  microglia)  and  allowed  for  the  mutation  
to  be  induced  at  a  stage  when  tissue  macrophages  were  mature.  These  animals  were  
shown  to  respond  to  acute  cold  challenge,  which  appeared  to  rescue  the  BAT  impairment  
[75].   Mecp2   is   an   ubiquitously   expressed   nuclear   transcription   regulator   [76]   that  
maintains  mature  neurons  and  synaptic  connectivity  [77].  Mecp2  deficient  macrophages  
showed  an  up-­regulation  of  PlexinA4,  which  is  known  to  signal  through  semaphorins  to  
guide  axonal  growth  [78,  79].  Wolf  et  al.  thus  argued  that  overexpression  of  PlexinA4  in  
Mecp2   deficient   macrophages   inhibits   axonal   outgrowth   in   BAT,   thus   diminishing   its  
function   and   ability   to   maintain   homeostatic   thermogenesis.   They   did   confirm   the  




PlexinA4  reverse-­signals  through  Sema6a  to  inhibit  axonal  outgrowth  [79].  However,  the  
question  remains  as  to  what  overcomes  this  axonal  inhibition  with  cold  exposure,  since  
acute   cold   exposure   appeared   to   rescue   the   impaired   phenotype.   Cold   exposure  
increases  NE   content   in   adipose   tissue.  Macrophages   along  with   other   immune   cells  
express   adrenergic   receptors   that   bind   NE   [80],   and   have   been   shown   to   produce  
neurotrophic  factors  such  as  NGF  [81]  and  brain  derived  neurotrophic  factor  (BDNF)  [82]  
in   human   peripheral   blood   and   the   human   brain   [82]   suggesting   another   possible  
mechanism  in  regulation  of  axonal  plasticity  may  exist  in  adipose  tissue  whereby  immune  
cells  are  synaptically  wired  and  release  neurotrophic  factor  to  nearby  nerves.  
In  most  studies  mentioned  above,  except  Nguyen,  et  al.,  it  was  clear  that  Cx3cr1+  
immune   cells   are   implicated   in   neuro-­immune   interaction   in   adipose   tissue.   These  
findings   suggest   that   multiple   subsets   of   Cx3cr1+   macrophages   work   in   concert   to  
maintain  energy  homeostasis  though  interactions  with  the  neural  innervation  of  adipose  
depots.  There  are  many  more  studies  necessary  to  fully  understand  the  diversity  of  these  
immune  cells,  and  what  neuroimmune  role  Cx3cr1-­  macrophages  may  play  in  adipose  
tissue,  if  any.  One  issue  that  may  have  been  addressed  by  the  data  described  above  is  
that  definitions  such  as   ‘classically  activated’  or   ‘alternatively  activated’   (ie:  M1  or  M2)  
macrophages   are   not   sufficient   labels   when   describing   the   diverse   populations   of  
macrophages   in   adipose   tissue.  This   has   been  well-­understood   by   immunologists   for  





Figure  2.  Tissue  architecture  and  neuroimmune  cell  types  in  white  (WAT)  and  
brown  adipose  tissue  (BAT)  in  the  basal  state.    Both  WAT  and  BAT  are  comprised  
of   lipid-­laden   mature   adipocytes,   where   white   adipocytes   have   one   large   (or  
unilocular)  lipid  droplet  and  brown  adipocytes  have  many  small  (or  multilocular)  lipid  
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droplets.    The  stromal  vascular  fraction  (SVF)  is  the  non-­adipocyte  cell  fraction  of  the  
tissue  and  contains  preadipocytes  (and  stem/progenitor  cells  that  will  undergo  white  
or   brown   adipogenesis),   and   a   milieu   of   immune   cells.      Immune   cell   populations  
include  innate  immune  cells  such  as:  several  subtypes  of  monocyte-­macrophages,  
dendritic  cells,  mast  cells,  neutrophils,  eosinophils,  and  innate  lymphatic  cells  (ILCs);;  
as  well  as  adaptive  immune  cells  such  as:  several  subsets  of  T  cells,  natural  killer  
cells,   and   B   cells.      Neurovasculature   of   WAT   and   BAT   includes   blood   vessels,  
lymphatic  vessels,  and  a  dense  nerve  supply  of  both  sensory  and  sympathetic  fiber  
types,  although  it  is  currently  unclear  if  one  tissue  has  a  greater  extent  of  innervation  
than  another,  or  if  their  nerve  plasticity  (such  as  with  cold  or  exercise)  differs  between  
tissues  or  depots.    Some  nerves  innervate  the  vasculature  itself,  while  other  nerves  
innervate   the  parenchyma  of   the   tissue.   It   is  currently  unclear  which  cell   types  are  
directly  innervated  and  receive  synaptic  input.  Some  nerve  fibers  are  myelinated  and  
others  are  unmyelinated  (it  has  been  suggested  that  the  majority  of  TH+  nerve  fibers  
in  BAT  are  thin  and  unmyelinated  [83]),  and  sensory  nerve  products  such  as  CGRP,  
Substance  P,  and  NPY  [38,  83-­85]  have  been  detected   in  both   tissues.     Although  
NPY  may  also  be  released  from  vasculature  associated  sympathetic  nerves  as  well  
[86],   and   should   not   be   considered   by   itself   a   marker   of   sensory   innervation.    
Sympathetic   nerves   release   NE.      Additional   neurotransmitters   and   neuropeptides  
may  also  be  active  in  WAT  and  BAT.    The  presence  of  Schwann  cells  in  both  BAT  
and  WAT  further  underscores  the  presence  of  myelinated  nerves  [87].  Interestingly,  
Schwann  cells,  as  a  myelinated  glial  cell   type,  can  behave  similarly   to  an   immune  
cell.    Other  immune  cells,  that  are  also  present  in  adipose  tissue,  are  well  documented  
for  neuroimmune  functions,  including  monocyte/macrophage  subtypes,  as  reviewed  
previously  [88,  89].    Monocytes,  as  well  as  T  and  B  cells  can  produce  BDNF  in  human  
peripheral  blood  and  in  human  inflammatory  brain  lesions  [82].  Human  CD4  +  T  cell  
clones  (from  peripheral  blood)  were  shown  to  produce  and  release  NGF  in  vitro  [81].  
In   addition,   eosinophils   from  human  peripheral   blood   can  produce  NGF,  NT3  and  
BDNF   neurotrophic   factors   upon   immunologic   stimulus   [90,   91],   and   mast   cells  
contain  mRNA  for  NGF  and  may  be  another  source  of  neurotrophic  factor  [92].    It  is  
currently  unclear  if  these  immune  cell  types  play  similar  roles  in  adipose  tissue,  or  if  
other   tissue-­resident   immune  cells  have  neuroimmune  roles.    Differences  between  
BAT   and  WAT   immune   cells   include:      more   SAMs   in   white   than   brown   [72],   the  
presence  of  BAT  specific  Cx3cr1+  macrophages  that  play  a  role  in  regulating  axonal  
outgrowth   [75]   and   the   presence   of   a   subset   of   Tregs      (CD4+)   that   exhibited   a  
differential  gene  expression  in  BAT  versus  visceral  adipose  tissue  [93].  There  is  very  
little  knowledge  about  the  lymphatic  system  in  BAT  compared  to  WAT,  and  changes  
with  obesity  or  cold   likely  differs  between  BAT  and  WAT  as  well,  but   this  warrants  
further  exploration.    In  total,  cellular  cross-­talk  in  the  adipose  organ  is  clearly  important  
for   immunometabolic   function   and   brain   adipose   communication,   but   our  







IV.  What  makes  a  healthy  nerve  
Schwann   cells   are   the   glial   cells   of   the   peripheral   nervous   system;;   they   are  
responsible   for   the   formation   of  myelin   sheaths   around   larger   axons  which   allows   for  
increased  conduction  velocity.  Schwann  cells  also  play  an   important   role   in  peripheral  
nerve  regeneration  as  they  secrete  neurotrophic  factors  (NTFs)  to  guide  axonal  regrowth.  
After   nerve   injury  Schwann   cells   phagocytose  damaged  axons,   guide  nerve   regrowth  
through   secretion   of   NTFs   and   other   growth   factors,   and   remyelinate   demyelinated  
nerves.   In   this   sense,   they   behave   similarly   to   macrophages   in   wound   response.  
Furthermore,   macrophage-­Schwann   cell   crosstalk   appears   to   be   essential   in   the  
regenerative  process  of  peripheral  nerves.  In  rodent  models  of  nerve  injury  (spinal  and  
sciatic),  [94]  showed  that  Cx3cr1+  macrophages  hone  in  to  the  injury  site  to  clear  debris  
and  persist  up  to  3  weeks  post  injury,  during  which  time  Schwann  cells  increase  in  number  
and  remyelinate  injured  axons.    Ablation  of  macrophages  prior  to  remyelination  resulted  
in  a  lack  of  Schwann  cell  maturation  (with  concomitant  increase  in  immature  Schwann  
cells),  a  reduction  in  remyelination,  and  overall  poorer  electrical  signal  propagation  [94].  
The  authors  went  on  the  demonstrate  that  a  macrophage  derived  ligand,  Gas6,  promotes  
Schwann   cell   differentiation,   thereby   aiding   in   remyelination   of   regenerating   nerves.  
Furthermore,  macrophages  persistently  aggregate  around  denervated  human  nerves  and  
express  Gas6,  suggesting  that  the  mechanism  may  translate  to  human  peripheral  nerve  
regeneration.   Macrophages   also   appear   to   induce   vascular   remodeling   to   provide   a  
“bridge”   by  which   Schwann   cells   can   guide   severed   nerves   to   regrow   [95].   Here   the  
authors  showed  that  macrophages  (along  with  lower  percentages  of  other  cells,  including  
neutrophils,  fibroblasts  and  endothelial  cells)  aggregate  between  severed  nerves  in  rats  




space  that  creates  a  bridge  which  Schwann  cells  can   infiltrate  and  guide  regenerating  
axons.    
Schwann  cells  are  present  at  nerve  fibers  in  adipose  tissue,  and  adipose  SVF  may  
serve  as  a  potential  Schwann  cell  reservoir  [87].  Schwann  cell-­like  cells  (SCLCs)  have  
been  isolated  from  mouse  i-­scWAT.  Adipose  derived  SCLCs  expressed  specific  Schwann  
cell  markers,  secreted  NTFs  (nerve  growth  factor  (NGF)  and  BDNF)   in  vitro,  and  were  
able  to  function  in  sciatic  nerve  regeneration  in  vivo  ,  albeit  not  as  effectively  as  sciatic  
nerve  derived  Schwann  cells  [87].  Overall,  adipose  derived  SCLCs  present  an  attractive  
source  of  peripheral  nerve  regenerating  cells  as  it  is  much  easier  to  obtain  them  than  it  is  
to  isolate  nerve  fiber  associated  Schwann  cells.  SCLCs  may  also  play  a  role  in  axonal  
plasticity  within  adipose  tissue.    
  
Neurotrophic  factors  in  maintaining  nerve  health  
As  the  name  suggests  neurotrophic  factors  are  involved  in  nerve  growth,  but  they  
are  also  necessary  for  nerve  maintenance,  survival  and  proliferation.  NTFs  are  essential  
during  development,  but   they  also  serve  an   important   role   in   the  mature  animal.  NGF  
belongs  to  the  neurotrophin  family  of  NTFs  is  perhaps  the  most  well  studied,  as  it  was  the  
first  NTF  to  be  described  in  the  late  1950s  by  Rita  Levi-­Montalcini  and  colleague  Stanley  
Cohen  [96].  Since  then,  its  role  has  been  studied  in  the  CNS,  PNS,  endocrine  and  immune  
systems,  as  reviewed  by  [97].  Other  NTFs  (i.e.  Neurotrophin-­3,  BDNF,  glial  cell  derived  
neurotrophin  (GDNF),  ciliary  neurotrophic  factor  (CNTF))  appear  to  be  less  broadly  active  




which   is   slowly   being   rectified.   Nonetheless,   global   loss   of   any   NT   results   in   severe  
neuronal  deficits  and  early  postnatal  death.    
The  neurotrophin  family  of  NTFs,  includes  Neurotrophin-­3  (NT-­3)  Neurotrophin-­4/5  
(NT-­4/5),   Neurotrophin-­6,   NT-­6,   Neurotrophin-­7,   NT-­7,   NGF,   and   BDNF,   they   signal  
through  two  classes  of  receptors,  the  tyrosine  kinase  family  tropomyosin-­related  kinase  
(Trk)   receptors,   and   pan-­neurotrophin   receptor   p75NTR,   which   belongs   to   the   TNF  
receptor  superfamily  [98].  Neurotrophins  are  selective  to  Trk  receptor  subtypes,  NGF  is  
specific  to  TrkA,  BDNF  and  NT-­4  bind  to  TrkB,  and  NT-­3  preferentially  binds  to  TrkC,  but  
can   bind   to   the   other   Trk   receptors   albeit   with   less   efficiency,   binding   affinity   to   Trk  
receptors   is   regulated   by   p75NTR   [98].   Trk   receptors   are   expressed   throughout   the  
nervous  system;;  neurotrophins  are  internalized  by  their  respective  Trk  receptors  at  nerve  
terminals  (via  receptor  mediate  endocytosis)  and  can  be  transported  long  distances  along  
the   axon   to   the   cell   soma   where   nerve   differentiation,   survival   and/or   outgrowth   is  
determined.  This  allows  for  long  relay  signaling  that  is  essential  for  nerve  maintenance  in  
the   PNS.   Although   NGF   is   inarguably   important   for   the   survival,   differentiation,   and  
maintenance  of  the  PNS  during  development  and  in  the  adult,  BDNF  and  NT-­3  have  been  
shown  to  play  a  key  role  in  the  myelination  of  peripheral  nerves  in  developing  and  injured  
nerves   [99,   100].   While   the   presence   of   BDNF   was   necessary   for   myelination   and  
regeneration  to  occur,  NT-­3  appeared  to  modulate  BDNF  activity  by  inhibiting  myelination  
[99,  100].  
Although  neurons  and  glial  cells  are  predominant  sources  of  NTF  secretion,  other  
cells   types   have   been   shown   to   secrete   neurotrophins,   especially   after   nerve   injury,  




A   multitude   of   hematopoietic   cells   have   been   shown   to   release   NTFs.   Mast   cells  
synthesize,  store  and  release  NGF  during  nerve  injury  which  is  thought  to  play  a  role  in  
sensory   nociception   [92].  Monocytes,   as  well   as  T   and  B   cells   can  produce  BDNF   in  
human  peripheral  blood  and  in  human  inflammatory  brain  lesions  [82].  Human  CD4  +  T  
cell  clones  (from  peripheral  blood)  were  shown  to  produce  and  release  NGF  in  vitro  [81].  
In  addition,  eosinophils  from  human  peripheral  blood  can  produce  NGF,  NT3  and  BDNF  
neurotrophic  factors  upon  immunologic  stimulus  [90,  91].  
Recently,  some  attention  has  been  given  to  the  role  of  NTFs  in  adipose  tissue.    It  
has  been  suggested  that  NGF  is  secreted  from  adipocytes  and  plays  a  role  in  sympathetic  
nerve   plasticity   during   cold-­induced   browning   of   i-­scWAT   [102].   Adipose   immune-­cell  
derived  BDNF  has  been  demonstrated  to  be  necessary  for  proper  i-­scWAT  innervation,  
thermogenic   function,   and  energy   homeostasis   (and   is   the   focus  of  Chapter   4   of   this  
thesis).    
  
Peripheral  neuropathy  &  neural  plasticity  
When  nerves  in  the  periphery  become  damaged,  neuropathy  can  occur  and  lead  
to  loss  of  nerve  control  in  affected  tissues  resulting  in  organ/tissue  damage.  Peripheral  
neuropathy  (PN)  is  a  collective  term  for  disorders  that  result  in  the  progressive  dying  back  
of  nerves,  that  usually  begins  with  distal  axons  in  the  skin  of  hands  and  feet  and  moves  
inward.  PN  is  accompanied  by  weakness,  pain,  numbness,  and  in  severe  cases  can  lead  
to  limb  amputation.  Occurrence  of  PN  is  very  common,  varied  causes  can  be  hereditary,  




chemotherapy   treatment,   environmental   exposures,   metabolic   problems,   and   aging.  
Currently,  diabetes  is  the  greatest  contributing  factor  to  the  condition,  and  when  caused  
by  it  is  referred  to  as  diabetic  PN  (DPN).  Despite  its  common  occurrence  in  diabetic  and  
pre-­diabetic   individuals   the   pathophysiology  of  DPN   is   not   fully   understood,   treatment  
options  are  lacking  and  no  cure  exists,  and  the  condition  is  often  diagnosed  late  in  disease  
progression.  It  was  originally  argued  that  impaired  glucose  control  and  glucolipotoxicity  
resulted  in  DPN  [103],  however  this  relationship  is  not  very  direct  and  the  pathophysiology  
of  peripheral  neurodegeneration  is  much  more  complicated.  Diabetes  and  obesity  related  
microvascular  dysfunction  has  been  implicated  in  contributing  to  nerve  damage;;  impaired  
blood   flow   to   nerves   can   cause   hypoxia   and   nerve   death   [104,   105].   Systemic  
inflammation,   often   occurring   in   diabetes   and   obesity,   has   also   been   shown   to   be   a  
contributing  factor  in  DPN  development  and  progression  in  murine  and  human  models  
[106].  The  role  of  Schwann  cells  in  DNP  is  gaining  traction  as  a  research  focus  [107];;  and  
a   few  studies  have  examined  the  possibility  of  DNP  treatment  using  NTFs  with  mixed  
results  [108-­110].  An  NGF  based  treatment  even  reached  phase  III  clinical  trials,  but  was  
unfortunately   unable   to   replicate   efficacy   from   previous   phase   trials   which   were   also  
plagued  by  off-­target  effects.  The  full  story  has  been  reviewed  by  [109]  and  reveals  how  
much  more  we  still  need  to  understand  about  NTFs  and  their  potential  as  a  neuropathy  
treatment.  
   The  PNS  is  remarkable  in  its  ability  to  remodel,  and  axonal  growth  and  remodeling  
can  be  seen  through  the  nerve  injury/regenerative  process.  Loss  of  function  after  nerve  
injury  can  be  compensated  by  1)  the  regrowth  (and  remyelination)  of  damaged  axons,  2)  




Although  most  investigation  into  axonal  growth  revolves  around  peripheral  nerve  repair  
and   regeneration,   there   is   some   evidence   of   peripheral   nerve   remodeling   that   is   not  
prompted  by  insult  to  the  nerves.  The  term  plasticity  can  be  used  to  distinguish  axonal  
growth  in  response  to  environmental  stimuli  that  is  not  dependent  on  nerve  injury.  Another  
form  of  axonal  growth  is  sprouting,  which  can  be  induced  with  or  without  nerve  damage,  
and  is  often  associated  with  hypersensitivity  and  increased  pain  sensation.  Axonal  growth  
of  sensory  and  autonomic  nerves,  marked  by  an   increase   in  nerve  density  as  well  as  
nerve  size,  occurs  in  patients  with  pancreatic  cancer  and  pancreatitis,  and  is  not  caused  
by  direct  nerve  injury  [112].  The  NTF  neurturin,  has  been  implicated  in  contributing  to  the  
axonal  outgrowth  in  pancreatic  cancer,  through  its  production  by  pancreatic  cancer  cells  
[113].  However,  axonal  growth  under  these  disease  conditions  is  aberrant  and  often  the  
cause  of  neuropathic  pain  [112,  114].    
Evidence   for   adipose   neuropathy   and   plasticity   is   discussed   in   more   detail   in  
Chapter  3.    
Certain   environmental   factors   have   been   shown   to   affect   peripheral   nerve  
plasticity.  It  is  well  appreciated  that  exercise  produces  a  plethora  of  positive  physiological  
changes,  among  which   is  BDNF  mediated  neurogenesis  and  synaptic  plasticity   in   the  
hippocampus  of  rodents  [115,  116].  Neurogenesis  in  the  human  brain  is  a  bit  trickier  to  
study,   and  most   research   is   correlative,   however   BDNF   expression   does   increase   in  
humans  participating  in  moderate  exercise  [117]  and  is  linked  to  improved  cognition  in  
adults  [118].  Exercise  also  has  a  CNS  mediated  effect  on  peripheral  nerves,  by  rewiring  
CNS   neuronal   networks   to   improve   sympathetic   and   parasympathetic   control   of  




exercise   has  been   shown   to   enhance  axonal   regeneration   after   nerve   injury,   and   the  
process   is   dependent   on   neuron   secreted   BDNF   [121].   However,   this   treadmill   type  
exercise  may  only  be  effective  in  enhancing  axonal  regeneration  in  male  mice  and  not  
have  any  effect  on  axon  regeneration  in  females  [122].  
Cold-­induced   catecholamine   release   has   been   recently   proposed   as   another  
modulator  of  peripheral  nerve  plasticity.  Cao,  et  al   [102],  provided  evidence   that  cold-­
exposure   elicits   an   increase   in   synaptic   nerve   fiber   density,   and   that   NE   release  
stimulated  an  increase  in  NGF  within  i-­scWAT,  however,  adipocytes  as  the  source  of  NGF  
was  not  convincing  as  they  did  not  take  into  account  the  milieu  of  cells  that  reside  within  
the  adipose  depots.    
  
Lipids  and  peripheral  nerves  
Peripheral   nerve   bundles   consist   of   3   distinct   connective   tissue   layers:   the  
outermost  epineurium  which  contains   the  nerve  microvasculature  and  sheaths   fascicle  
bundles;;  the  perineurium,  thin  connective  tissue  than  surrounds  individual  fascicles;;  and  
endoneurium,   which   encapsulates   Schwann   cells,   fibroblasts,   and   individual   axons.  
Adipocytes  have  been  observed   in   the  epineurium   [123],  and  are  a  hypothesized   fuel  
storage  of   fatty   acids   for   the   endoneurium.  However,   considering   that   adipocytes   are  
endocrine  cells  they  may  be  communicating  in  a  paracrine  fashion  with  other  cells  within  
the  nerve  bundle.    The  myelin  sheath  itself  is  very  lipid  laden  (70-­85%  lipids),  and  although  
protein  types  of  CNS  and  PNS  myelin  can  vary,  lipid  composition  is  similar  in  both  [124].  




and   ethanolamine   plasmalogen   (a   phospholipid)   and   comprise   65%   of   total   lipid   dry  
weight  [125].  Myelin  lipid  composition  can  vary  and  has  been  shown  to  be  affected  by  diet  
[126],  but  de  novo  fatty  acid  synthesis  by  Schawnn  cell  also  appears  to  be  important  in  
peripheral   nerve   myelination   [127].   Schwann   cells   in   mature   peripheral   nerves,   also  
express  genes  for  fatty  acid  metabolism  and  extracellular  lipid  transport  [128].    
   Some  lipids  and/or  their  metabolites  serve  as  endogenous  sensitizers,   inhibitors  
or  activators  of  certain   transient   receptor  potential   (TRP)  channels.  TRP  channels  are  
Ca2+  permeable  non-­selective  cation  channels  found  on  sensory  neurons,  and  although  
they  have  been  predominantly  studied  in  relation  to  pain  sensation,  emerging  research  
has  shown  that   they  play  a  crucial   role   in  energy  homeostasis   [129,  130].  Agonism  of  
certain  sensory  nerve  TRP  channels  such  as  transient  receptor  potential  vanilloid  subtype  
1   (TRPV1)   has   been   shown   to   attenuate   diet   induced   obesity   through   increased  
sympathetic  tone  via  activation  of  the  central  nervous  system  thereby  increasing  browning  
of  WAT  (as  reviewed  by  [130]).  Multiple  lipid  species  have  been  identified  as  endogenous  
agonists  of  TRPV1,  including  certain  arachidonic  acid  metabolites  (i.e.  the  eicosanoids:  
5-­HETE,   12-­HETE)   and  phospholipid   derivatives   (i.e.   lysophosphatidic   acid),   amongst  
others   as   reviewed  by   [131].   Transient   receptor   potential   cation   channel   subfamily  M  
member  8  (TRPM8)  has  been  well  studied  as  the  primary  ion  channel  on  somatosensory  
nerves  responsible  for  cold  (and  menthol)  sensation.  Its  activation  on  both  sensory  nerves  
and  BAT  leads  to  thermogenesis  and  energy  expenditure  [132,  133].  TRPM8  can  also  be  
activated  by  membrane   lipids  such  as  phosphatidylinositol  4,5-­bisphosphate  (PIP2)  as  




lysophosphatidylserine  [129,  131].  The  amount  and  bodily  distribution  of  these  lipids  and  
their  metabolites  can  be  greatly  affected  by  diet,  and  is  the  focus  of  Chapter  2.    
     
V.  Sex  differences  to  consider  
Sex  dimorphisms  are  known  to  exist  with  respect  to  energy  homeostasis,  obesity  and  its  
complications,   although   they   have   been   historically   understudied.   Sexual   dimorphism  
also  present  in  the  nervous  system  and  extends  to  innervation  of  WAT.  The  physiological  
consequences  of  these  sex  differences  are  still  being  investigated.    
   Human  females,  of  reproductive  age,  have  a  greater  amount  of  energy  expending  
BAT  compared  to  males  or  postmenopausal  females  [134].  Women  also  have  a  higher  
percentage   of   body   fat   compared   to   males   and   yet   are   more   resistant   to   metabolic  
diseases  even  on  high  fat/high  sugar  diets,  a  characteristic  that  is  also  observed  in  female  
rats  and  mice  [135,  136].  Estrogens  emerged  as  the  most  likely  cause  of  this  protective  
effect  due  to  their  reduction  at  postmenopausal  age,  as  well  as  the  sexually  dimorphic  
expression   of   estrogen   receptors   in   the   hypothalamus   (the   CNS   regulatory   center   of  
energy  homeostasis)  [137,  138].  However,  studies  implicating  hormone  protective  effects  
are   problematic   since   rodents   do   not   experience   the   same   type   of   reproductive  
senescence   as   humans   do  and   ovariectomy   produces   a  more   violent   effect   than   the  
gradual  reduction  in  hormones  experienced  during  reproductive  senescence.    
   Immune  system  sex  differences  can  contribute   to   the  sexual  dimorphism   in  diet  
induced  obesity.  As  previously  discussed,  inflammation  plays  a  key  role  in  obesity  related  




have  been  documented  across  a  variety  of  species,  and  have  been  linked  to  hormonal  
as   well   as   genetic   mediators   (including   sex   chromosome)   [139].   Pro-­inflammatory  
cytokine   production   by   macrophages   is   higher   in   human   and   murine   males,   while  
macrophage  activation,  phagocytic  capacity,  and   IL-­10  production   is  higher   in   females  
[139,  140].  This  would  suggest  females  have  a  greater  capacity  to  clear  apoptotic  tissue  
(such   as   with   hypertrophic   obese   adipose)   without   entering   a   chronic   state   of   low  
inflammation.  Sex  differences  in  the  adaptive  immune  system  include  a  TH2  cell  bias  in  
females,  which   has  been   linked   to   increased  anti-­inflammatory   response,   and  obesity  
resistance.   CD   4+   T   cells,   T   cell   proliferation,   and   B   cell   numbers   are   also   higher   in  
females  [139],  all  these  cell  types  are  present  in  adipose  tissue  (Fig.  2),  and  have  been  
demonstrated  to  be  a  source  of  NTF  production  upon  immunological  simulation;;  they  may  
be   playing   a   role   in  male   versus   female   innervation   of   adipose   tissue   and   is   further  
discussed  in  Chapters  3  &  4.    
   Finally,  sexual  dimorphism  exists  in  the  human  brain  [141]  and  peripheral  nervous  
system  [142].  One  of  these  PNS  sexual  dimorphisms  may  explain  another  adipose  tissue  
sex  dimorphism.  gWAT  of  male  mice  does  not  readily  undergo  browning  the  way  i-­scWAT  
does,  however,  gWAT  of  female  mice  does.  Coincidentally,  NGF  and  BDNF  are  higher  in  
female  gWAT  as   is   the  amount  of  sympathetic   innervation   [143].     NGF  was  shown   to  
increase  in  gWAT  of  females  upon  adrenergic  stimulation,  while  presence  of  BDNF  and  
sympathetic  nerve  activation  appeared  to  be  estrogen  dependent   [143].  These  studies  
illustrate   the   physiologically   consequential   effects   sex   difference   can   have   and  






The  historical  and  contemporary  findings  reviewed  in  this  introduction,  helped  form  and  
guide  the  hypotheses  expounded  and  investigated  in  the  subsequent  chapters.  Although  
it  had  been  demonstrated  that  adipose  tissue  contained  nerves,  and  that  this  innervation  
is   critical   for  metabolic   health,   the   nerve  network   and   interaction   of   nerves  with   other  
adipose  resident  cells  was  still  unknown.  The  question  of  whether  adipose   innervation  
was   parenchymal   or   primarily   perivascular   was   still   a   point   of   debate,   and   questions  
regarding  the  presence  of  myelinated  nerves  in  adipose  still  remained.  All  assessment  of  
adipose  nerves  hitherto,  did  not  considered   the  distribution  of  nerves  within   the  whole  
adipose  depot,  and  where  synapses  were  forming.  Furthermore,  the  dynamics  of  adipose  
nerves  had  not  been  investigated  at  all;;  questions  regarding  adipose  nerve  remodeling  -­
neuropathy,  and  neurite  outgrowth,  and  what  factors  could  control  such  actions  remained  
open  for  exploration.    
   Since  diet  bears  weight  on  adipose  tissue  remodeling,  we  designed  experiments  
to  determine   if   various  dietary   lipids  and  changes   in   their  amount  has  any  bearing  on  
metabolic  parameters  including  energy  expenditure,  which  is  greatly  reliant  on  adipose  
innervation.  Lipidomic  analyses  of  adipose  tissues,  could  provide  insight  into  how  various  
dietary   fats   are   metabolized   and   sequestered   in   adipose   tissue,   allowing   for   further  
investigation  regarding  lipid  nerve  interactions  in  the  adipose  organ.  These  questions  are  
explored  in  Chapter  2.  
   Loss  of  brain-­adipose  communication  had  been  shown  to  …through  surgical  and  




communication   through   pathophysiological   means   had   not   been   explored.   We   know  
obesity  leads  to  dysfunction  of  adipose  tissue  and  overall  metabolic  distress,  but  could  
this  dysfunction  be  related  to  an  obesity  related  loss  of  adipose  innervation?  We  know  
incidence  of  obesity  and  type  2  diabetes   increases  with  age,  but   it  remained  unknown  
whether   ordinary   aging   affects   adipose   innervation.   Cold-­induced   noradrenergic  
stimulation  had  been  shown  to  induce  lipolysis  and  browning  of  adipose  tissue,  thereby  
increasing  energy  expenditure.  Could  this  stimulation  have  any  effect  on  the  distribution  
of  adipose  nerves  within  a  depot?  Therefore,  hypotheses  regarding  adipose  innervation  
under  basal,  pathophysiological,  or  stimulated  conditions  are  surveyed  in  Chapter  3.    
   Nerves   require   continuous   signals   from  NFs   in   order   to   survive.  NFs,   can  also  
regulated   neurite   remodeling   and   outgrowth.   Various   NFs   exist   and   can   come   from  
various  cellular  sources.  However,  which  NFs  and  what  their  cellular  source  is  in  adipose  
tissue  had  not  been  interrogated.  Based  on  the  support  role  of  immune  cells  in  adipose  
tissue,   and   the   fact   that   microglia   mediate   neural   and   synaptic   plasticly   through   the  
release  of  BDNF  in  the  brain,  we  aimed  to  inspect  if  a  similar  mechanism  may  be  in  effect  
in  adipose  tissue.  This  hypothesis  is  probed  in  Chapter  4.    
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  A  PEROXIDIZED  OMEGA-­3-­ENRICHED  POLYUNSATURATED  DIET  LEADS  TO  




Consumption  of  diets  that  differ  in  fat  type  and  amount,  and  sequestration  of  various  fatty  
acids   to   tissues   and   organs,   likely   have   effects   on   overall   physiology   and  metabolic  
health.    However,  the  contributions  of  dietary  lipids  to  brain-­adipose  communication  and  
adipose  tissue  function  are  poorly  understood.    We  designed  6  custom  diets  that  differed  
only   in  amount  and   type  of  dietary   fat,  with  high  or   low   levels  of  saturated   fatty  acids  
(SFA),  omega-­6  polyunsaturated  fatty  acids  (n-­6  PUFA),  or  omega-­3  (n-­3)  PUFA.    Mice  
fed   the   n-­3   PUFA   diet   for   16   weeks   displayed   a   striking   reduction   in   weight   gain,  
accompanied   by   smaller   adipose   depots   and   improved  glucose   sensitivity.      Reduced  
body   weight   occurred   despite   lowered   energy   expenditure   and   no   difference   in   food  
intake.      Despite   the   apparent   beneficial   effects   to   whole   body   physiology,   we   have  
demonstrated  for  the  first  time  that  a  peroxidized  n-­3  enriched  diet   led  to  lipotoxicity  of  
white   adipose   tissue,   as   evidenced   by   increased   fibrosis,   lipofuscin,   reduced   anti-­
inflammatory  markers,  and  loss  of  proper  nerve  supply.  While  healthful,  n-­3  fats  are  prone  
to  peroxidation,  and  we  observed  peroxidated  lipid  metabolites  in  the  adipose  tissue  of  
mice  on  these  diets.    Furthermore,  using  a  lipidomics  approach  we  have  observed  that  
brain,   white   adipose   tissue,   and   brown   adipose   tissue   accumulate   lipid   metabolites  




amount,   but   differences   in   adipose   lipid  metabolites   across   these   six   diets  may  have  
affected  metabolic  function  and  brain-­adipose  communication,  as  observed  in  this  study.  
Introduction  
Dietary  Fatty  Acids,  Lipid  Biochemistry  and  Metabolic  Health    
Dietary  fats,  one  of  the  3  macromolecules  in  our  food,  are  important  for  adding  flavor  to  
what  we  eat,  for  providing  fuel  for  metabolism,  and  for  enhancing  the  absorption  of  lipid-­
soluble   vitamins   such   as   A,   D,   E   and   K.   Dietary   fat-­derived   cellular   lipids   are   also  
important  as  structural  components  for  cellular  membranes,  which  in  turn  affect  cellular  
activities  such  as  the  function  of  transmembrane  receptors.  Additionally,  fatty  acids  also  
play  an  important  role  as  signaling  molecules  in  the  body,  thereby  affecting  other  cellular  
tasks.  There  are  two  main  types  of  dietary  fats:  saturated,  meaning  all  the  carbons  are  
bound  with  hydrogen  atoms,  and  unsaturated,  meaning  some  carbons  lack  hydrogen  and  
are  double-­bonded  to  each  other.  Within  unsaturated  fats,  there  can  be  a  single  point  of  
‘unsaturation’   (or   double-­bond),   termed   monounsaturated,   or   multiple   points,   termed  
polyunsaturated.   Omega-­9   (n-­9)   fats   are   monounsaturated   while   Omega-­3   (n-­3)   and  
Omega-­6  (n-­6)  are  polyunsaturated.  While  mammals  are  able  to  form  the  double-­bonds  
necessary  for  the  synthesis  of  n-­9  fatty  acids,  they  lack  the  necessary  enzymes  (i.e.  Δ15-­
desaturase)   that   form   the  cis  double-­bonds  which  define  n-­3  and  n-­6  PUFAs   [1].  This  
inability  to  synthesize  these  fatty-­acids  implies  that  they  must  be  derived  from  diet  and  
are  therefore  ‘essential’.  The  essential  n-­6  PUFA  is  linoleic  acid  (LA,  18:2n-­6)),  which  can  
be  converted  to  the  longer  chain  arachadonic  acid  (AA,  20:4n-­6).  The  parent  fatty  acid  of  




acid  (EPA,  20:5n-­3)  and  docosahexaenoic  acid  (DHA,  22:6n-­3).  Although  conversion  of  
LA  to  AA,  as  well  as  conversion  of  ALA  to  EPA  and  DHA,  occurs  in  vivo,  this  process  is  
extremely   limited.     Both  LA  and  ALA  compete   for   the  same  elongase  and  desaturase  
enzymes  (i.e.  Δ5-­desaturase,  Δ6-­desaturase,  elongase,  etc.)   in  the  synthesis  of   longer  
PUFAs  such  as  AA  and  EPA  [1].    Conversion  rates  in  humans  of  ALA  to  EPA  or  DHA  are  
reported  between  5-­10%  and  less  than  1%,  respectively  [2].  Therefore,  consumption  of  
EPA  and  DHA  is  also  considered  essential  in  our  diet,  but  humans  often  do  not  take  in  
sufficient   amounts   of   these   lipids.   Biologically   important   fatty   acids   also   include  
eicosanoids  (such  as  prostaglandins,  leukotrienes,  and  thromboxanes  –  derived  from  AA  
or  EPA),  DHA,  fatty  esters,  and  fatty  amides,  which  include  endocannabinoid  lipid  ligands.  
Most,  if  not  all,  of  these  fatty  acids  have  been  implicated  in  metabolic  physiology.  
Over   time,   the  Western   diet   has   reduced   intake   of   n-­3   PUFAs,   and   increased  
intake  of  n-­6  PUFAs  and  saturated  fats  [3].  Correlational  studies  have  indicated  that  diets  
higher   in   n-­3   PUFAs   (such   as   Inuit   diets   enriched   for   whale   or   seal   meats,   or   the  
Mediterranean  diet  which  is  high  in  fish,  olives,  nuts,  whole  grains,  and  produce)  result  in  
lower  risk  for  cardiovascular  diseases  [4].  Thus,  the  Western  diet  as  it  looks  today  with  
lower  n-­3  and  higher  n-­6  PUFAs,  may  be  predisposing  us  to  cardiovascular  complications  
and  other  metabolic  diseases.  n-­3  PUFAs  are  important  for  cell  membrane  fluidity  and  
function,  hormone  production,  regulating  inflammation,  and  binding  nuclear  receptors  –  
all   of   which   are   implicated   in   cardiometabolic   function.      The   brain   is   second   only   to  
adipose  tissues  in  terms  of  its  lipid  content,  and  thus  understanding  how  dietary  fats  affect  
both   brain   and   adipose   lipid   metabolites   and   their   cellular   functions   is   an   important  




The  complete  repertoire  of  physiological  and  metabolic  effects  of  differing  fatty  acid  
composition  in  the  diet  is  also  not  well  understood.  For  example,  we  do  know  that  certain  
essential   fatty  acids  (such  as  DHA  and  EPA)  are   important   for  brain  development  and  
neural  plasticity   (reviewed   in   [5]),  but  we  do  not  yet  know  how  these  fatty  acids  affect  
other  cellular  and  molecular  mechanisms  in  discrete  brain  regions,  or  if  peripheral  nerve  
function  is  also  affected.  In  addition,  effects  on  cardiovascular  risk  or  health  may  also  be  
secondary   to   how   these  diets   impact   neural   function,  whole-­body  metabolism,  energy  
balance,  or   adiposity  –   but   these  have  not   been  delineated   in   the   research   literature.    
Finally,   consumption   of   low   n-­3   PUFA   diets   that   may   or   may   not   be   comprised   of  
peroxidized  n-­3s  also  confounds  the  nutritional  literature.  
Therefore,  the  goal  of  this  study  was  to  investigate  how  differing  dietary  fat  type  
and  amount  resulted  in  changes  to  brain  and  adipose  lipid  composition,  as  well  as  brain-­
adipose  communication  (by  investigating  adipose  innervation  status).    We  hypothesized  
that  diets  enriched  for  saturated  vs  n-­6  or  n-­3  PUFAs  would  result  in  different  fatty  acid  
profiles  in  adipose  vs.  brain,  and  that  the  diets  would  also  differentially  affect  metabolic  
function   and   energy   balance   regulation.   An   unexpected,   but   nonetheless   insightful,  
outcome   of   this   work   was   the   discovery   that   peroxidized   n-­3   PUFA   diets   have   a  
detrimental  effect  on  white  adipose  tissue  (WAT)  health,  which  may  negatively  impact  the  
peripheral  nerves   that  are  resident   in   this   tissue,  and  thereby  result   in   impaired  brain-­






Materials  and  Methods    
Mice,  Metabolic  Phenotyping,  and  in  vivo  Analyses  
   Dietary  fat  interventions  and  food  intake  
Adult  (10  week  old)  C57BL/6J  male  mice  were  fed  custom  diets  (designed  with  Research  
Diets  (New  Brunswick,  NJ);;  as  described  in  Table  1-­2),  for  16  weeks.  All  groups  had  N=6  
mice,  except  for  high  n-­3  PUFA  which  had  8  animals.  Mice  were  housed  2-­3  per  cage,  at  
room  temperature.  Body  weight  was  measured  weekly.  Food  intake  was  measured  daily  
for  7  days,  then  weekly  until  28  days.  Adiposity  was  assessed  at  the  end  of  the  study,  
and  hypothalamus,  subcutaneous  white  adipose  tissue  (scWAT)  and  intrascapular  brown  
adipose  tissue  (iBAT)  depots  were  harvested  and  sent  for  lipidomics  analysis  with  Berg,  
which  included  a  measure  of  non-­enzymatic  (peroxidized)  lipids.    
CLAMS  
Metabolic   cage   analyses   were   conducted   in   a   Comprehensive   Laboratory   Animal  
Monitoring  System  (CLAMS;;  Columbus  Instruments,  Columbus,  OH),  for  measurement  
of  oxygen  consumption   (VO2)  and  carbon  dioxide  production  (VCO2),   from  which  both  
respiratory   exchange   ratio   (RER),   and   energy   expenditure   (heat)   were   calculated:  
RER=VCO2/VO2;;  Energy  expenditure  (heat)  =  CV  *  VO2    cal/hr,  where  CV  is  the  “caloric  
value”  as  given  by  CV  =  (3.815  +  1.232)  *  RER.  Animal  were  single  housed  in  a  bedding  
free  cage,  at  room  temperature  on  a  12hr  light/dark  cycle.    Mice  were  acclimated  for  24-­
48hrs,  after  which  VO2,  VCO2,  RER,  and  Heat  were  measured  every  15min  for  3  days  
(72hrs).  Waveform  analysis  of  CLAMS  data  was  performed  by  matching  every   15min  




variance  (RM,  ANOVA)  was  performed  for  average  VO2,  VCO2,  RER,  and  Heat  per  group.  
An  uncorrected  Fisher’s  Least  Significance  Difference  test  was  performed  for  each  time  
point  between  dietary  groups  as  a  post-­hoc  test.  Interaction  P  values  are  reported,  which  
represent  differences  in  24hr  data  between  groups,  as  well  as  multiple  comparison  results  
for  differences  which  were  only  day/night  phase  specific.  
Lipidomics  analysis  of  peroxidized  lipid  content  in  adipose  
Mass-­spectrometry  lipidomic  analysis  of  scWAT  was  performed  by  Berg  (Boston,  MA).  
After  dietary  intervention,  tissues  were  harvested,  frozen  on  liquid  nitrogen  and  shipped  
to  Berg,  where  structural  and  signaling  lipids  within  tissues  were  identified  using  the  LC-­
MS/MS  platforms,  as  previously  described  [6-­8].  Only  structural   lipidomics  across  all  3  
tissues  was  used  as  a  dataset  for  comparison  across  tissue  and  diet.  
Thiobarbituric  Acid  Reactive  Substances  (TBARS)  Assay  
To   independently   determine   peroxidation   of   our   n-­3   PUFA   diets,   a   malondialdehyde  
(MDA,  a  common  by-­product  of  lipid  peroxidation)  production  assay  was  performed  using  
a  Cayman  Chemical  (Ann  Arbor,  MI)  TBARS  Assay  Kit,  per  manufacturer’s  instructions.    
Western  Blot  
Protein  lysates  were  prepared  by  homogenizing  frozen  tissue  in  RIPA  buffer  using  a  Bullet  
Blender  (Next  Advance,  Averill  Park,  NY).  Primary  antibodies,  including  anti-­TH  (Millipore  
Cat.  #  AB152;;  Merck  Millipore,  Burlington,  MA)  and  anti-­β-­actin  (Abcam  Cat.  #  ab8227),  
were   both   used   at   1:1000   dilution.   Secondary   antibody   was   anti-­rabbit   HRP   (Cell  




chemiluminescence   (ECL;;  Pierce)  on  a  Syngene  G:BOX.     TH  protein  expression  was  
normalized  to  β-­actin  and  quantified  in  Image  J.  
Gene  Expression  (qPCR)  
RNA  was  isolated  from  whole  tissue  depots  using  Trizol  reagent,  and  total  RNA  extracted  
using  a  Zymo   (Irvine,  CA)   kit.  RNA  yield  was  determined  on  a  Nanodrop;;   cDNA  was  
synthesized  using  a  High  Capacity  Synthesis  Kit  (Applied  Biosystems,  Foster  City,  CA).  
Real-­time  quantitative  (q)PCR  was  performed  with  SYBR  Green  (Bio-­Rad,  Hercules,  CA)  
on   a   CFX96   instrument   (Bio-­Rad,   Hercules,   CA).   Primer   sequences   are   listed   in  
Supplemental  Table  S1.  
Statistical  Analysis  
   Statistical   calculations   were   carried   out   in   Excel   (Micosoft,   Redmond,   WA)   or  
GraphPad   Prism   (La   Jolla,   CA)   programs,   utilizing   ANOVA   or   Student’s   T-­test   as  
indications  of  significance.  For  effects  of  diet  and  tissue  type,  non-­metric  multidimensional  
scaling  (NMDS)  ordination  to  summarize  structure  of  lipid  species  was  performed.  Bray-­
curtis   dissimilarity   indices,   to   reflect   differences   in   abundances   of   lipid   species,   were  
calculated  on  loge(+1)-­transformed  data.  Differences  in  lipid  species  structure  between  
diet,  tissue  type,  and  their  interaction  was  tested  using  permutational  multivariate  analysis  
of   variance   (PERMANOVA)   with   9999   permutations   using   the   adonis   function   in   the  
vegan  package   [9]   in  R   [10].     Other   statistical   analyses  are   described   in   the   relevant  
Methods  section  above  and  Supplemental  Materials.    Error  bars  are  SEMs.  For  all  figures,  





Further   detailed   Methods   can   be   found   in   APPENDIX   A:   Chapter   2   Supplemental  
Materials  
Results  
Improved  glucose  tolerance  and  reduced  weight  gain  in  mice  fed  an  n-­3  PUFA  diet,  
despite  lower  energy  expenditure.  
In  order  to  test  the  effects  on  energy  balance  when  differing  dietary  fat  type  and  
amount,  we  designed  6  custom  diets  that  contained  either  high  or  low  levels  of  saturated  
(SFA),  n-­6  or  n-­3  PUFAs,  without  differing  sucrose  or  protein  content  (Table  1).     Male  
C57BL/6  mice  at  10  weeks  old  were   fed   the  6  diets   for  16  weeks.     By   the  end  of   the  
feeding  period,  mice  on  the  high  SFA  and  n-­6  PUFA  diets  had  gained  significantly  more  
weight   compared   to   their   low-­fat   counterparts,   but   mice   on   the   high   n-­3   PUFA   diet  
weighed  less  than  animals  on  the  5  other  diets  (Fig.  1A).    This  difference  in  weight  gain  
can  also  be  seen  across  the  entire  time-­course  of  the  study,  in  terms  of  percent  change  
in  body  weight  each  week  and  average  body  weight  each  week  (Suppl.  Fig.  S1A-­B).      
The  differences  in  body  weight  at  the  conclusion  of  the  study  were  mirrored  by  the  
weights  of  subcutaneous  WAT  (scWAT)  as  well  as  perigonadal  WAT  (pgWAT)  depots,  
both  of  which  were  higher  in  the  high-­SFA  and  high  n-­6  PUFA  mice  versus  their  low-­fat  
diet  counterparts,  but  did  not  differ  between  the  high  n-­3  PUFA  and  low  n-­3  PUFA  mice  
(Fig.   1B-­C).      Consistent   with   reduced   weight   gain,   the   high   n-­3   PUFA   mice   had   a  
significantly  improved  glucose  tolerance  test  (GTT)  at  week  4  of  the  diet,  versus  mice  on  
the  high-­SFA  or  high  n-­6  PUFA  diets  (Fig.  1D),  but  at  this  time-­point  the  body  weights  




end  of  the  16wk  feeding  period,  the  high  n-­3  PUFA  mice  did  not  eat  fewer  calories  over  
the  first  4  weeks  of  the  diets  (cumulative  food  intake;;  Fig.  1E).  
When  comparing  metabolic  cage  measurements  between  the  high  n-­3  PUFA  and  
high  n-­6  PUFA  mice  at  week  7  of  the  diets,  it  was  apparent  that  the  high  n-­3  PUFA  mice  
had  lower  energy  expenditure,  as  indicated  by  a  lower  VO2  (Fig.  2A),  VCO2  (Fig.  2B),  and  
heat  production  (Fig.  2C).  These  differences  were  not  apparent  in  low  n-­3  PUFA  vs  low  
n-­6  PUFA  mice  (at  week  8  of  the  diets,  Suppl,  Fig.  S2  A-­D),   indicating   that   this  was  a  
function  of  dietary  fat  amount,  as  well  as  dietary  fat  type.    Interestingly,  the  respiratory  
exchange   ratio   (RER)  measurement,   an   indication   of   fuel   utilization,   demonstrated   a  
significant  interaction  difference  across  the  24-­hour  period  for  the  high  and  low  n-­6  vs  n-­
3  PUFA  diets  (Fig.  2D  and  Suppl.  Fig.  S2D),  with  a  lower  RER  observed  overall  during  
the  dark  phase  for  the  low  n-­3  PUFA  animals  only  (Supply.  Fig.  S2D).    These  findings  
indicated  greater  utilization  of  lipids  as  fuel  by  the  n-­3  PUFA  mice,  since  RER  was  closer  
to  0.7  than  to  1.0,  which  supports  the  finding  that  n-­3  PUFA  fed  mice  had  smaller  WAT  
depots  and  likely  had  higher  rates  of  lipolysis.    
Adipose  tissue  effects  of  the  PUFA-­enriched  diets  
Hematoxylin  staining  and  histological  analysis  of  scWAT  depots  indicated  that  the  
high-­SFA  and  high  n-­6  PUFA  tissues  were  indistinguishable  in  terms  of  cell  size,  crown-­
like   structures,   and   browning   pattern   (Fig.   3A).      However,   the   high   n-­3   PUFA   mice  
displayed   more   browning   (or,   development   of   inducible   and   multilocular   beige/brite  
adipocytes),  smaller  cell  size,  and  marked  inclusions  of  lipofuscin  stain  (arrows,  Fig.  3A),  




stain  was  observed  more  strongly  in  some  areas  of  the  n-­3  PUFA  tissue  than  others,  as  
demonstrated  by   the  multiple  representative  images  (Fig.  3A).     Lipofuscin   is  known  to  
accumulate  with  tissue  damage  and  with  age,  and  represents  a  type  of  lysosome  storage  
disease   [11-­13]   that   is   often   considered   a   sign   of   aging,   inflammation,   and   tissue  
degeneration.  In  both  scWAT  and  perirenal  white  adipose  tissues  (prWAT)  from  mice  fed  
the  n-­3  PUFA  diet,  large  areas  of  lipofuscin  accumulation  can  be  seen  through  bright  field  
microscopy  as  iridescent  ‘oil  slicks’  between  adipocytes  (Fig.  3A  and  5B).  Lipofuscin  is  
also   known   to   be   autofluorescent   [11],   and   fluorescent   microscopy   revealed   highly  
intense  autofluorescent  signals  only  in  WAT  of  the  n-­3  PUFA  animals,  and  not  those  on  
an  SFA  diet  (Fig.  3C).    
In  addition,  trichrome  stain  revealed  that  the  high  n-­3  PUFA  mice  had  significantly  
more   collagen   (bluish-­purple;;   Fig.   3B),   indicating   more   tissue   fibrosis,   an   accepted  
indicator  of  dysregulated  adipose  tissue.    Trichrome  stain  also  revealed  more  crown-­like  
structures   around   the   adipocytes   of   n-­3   PUFA   mice,   indicating   greater   immune   cell  
infiltration  in  the  stromovascular  fraction  for  this  diet.      Crown-­like  structures  are  a  common  
occurrence   in   adipose   under   high   fat   feeding,   and   are   formed   from   macrophage  
efferocytosis  of  dying  cells,  which  increases  in  obesity  due  to  increased  inflammation  and  
hypoxia.  It  is  not  surprising  to  see  crown-­like  structures  surrounding  large  adipocytes  (ie:  
with   the   hypertrophy   observed   in   mice   fed   an   obesogenic   diet),   however,   we   were  
surprised   at   the   higher   extent   of   crown-­like   structures   that   accompanied   the   small  





Peroxidation  of  an  n-­3  enriched  diet    
Despite   the   fact   that  animals   fed  a  high  n-­3  PUFA  diet  appeared   to  exhibit   the  
reported  beneficial  metabolic  effects,  such  as  decreased  body  and  adipose  weight,  as  
well  as  better  glucose  tolerance  compared  to  animals  fed  a  high  SFA  diet  (Fig.  1),  after  
closer  inspection  of  the  tissues,  we  observed  that  adipose  tissue  damage  and  dysfunction  
had  occurred  (Fig.  3)  and  that  the  n-­3  PUFA  diet  had  become  peroxidized.    Specifically,  
two  independent  approaches  confirmed  that  the  n-­3  PUFA  diets  themselves,  as  well  as  
the  tissues  from  mice  fed  this  diet,  exhibited  signs  of  peroxidized  lipid  species.    A  mass-­
spectroscopy   lipidomics   approach   revealed  a   greater   concentration   of   lipid  metabolite  
species  that  had  been  produced  through  non-­enzymatic  oxidation  in  scWAT  of  mice  fed  
the  high-­  and  low  n-­3  PUFA  diets  (Fig.  4A).      
In  support  of  this,  a  TBARS  assay  measuring  malondialdehyde  (MDA),  a  common  
byproduct  of  peroxidation,  demonstrated  peroxidation  of  the  n-­3  PUFA  diet  itself,  as  well  
as  the  menhaden  fish  oil  that  was  used  as  the  n-­3  source  in  the  diet  (Fig.  4B).  A  threshold  
of  50uM  MDA  was  set  based  on  previously  published  data  indicating  this  amount  of  MDA  
accumulation  is  sufficient  to  cause  intercellular  oxidative  stress  [14,  15].  Interestingly,  a  
high   level  of  peroxidation  was  similarly  observed   in  common   fish  oil   supplements  and  
food   items  that  are  high   in  n-­3  PUFAs  (tinned  sardines  and  salmon),  but   this  was  not  
observed  in  the  n-­6  PUFA  or  SFA  diets  (Fig.  4B),  nor  other  canned  fish  such  as  tuna  in  






Metabolic  dysregulation  after  a  peroxidized  n-­3  PUFA  diet  
To  observe  the  effects  of  consuming  a  peroxidized  n-­3  PUFA  diet,  we  measured  
gene  expression  in  the  perigonadal  WAT  (pgWAT),  a  depot  more  likely  to  exhibit  insulin  
resistance  and  inflammation,  and  found  significantly  reduced  anti-­inflammatory  cytokines  
il4,  il10,  and  il13  in  animals  fed  our  n-­3  PUFA  diet  compared  to  the  other  two  high-­fat  diets  
(Fig.   5A).   These   similarly   fit   with   the   prevailing   narrative   that   n-­3   PUFA   diets   are  
metabolically  healthy.    By  contrast,  we  observed  a  decrease  in  the  Schwann  cell  marker  
sox10  with  the  high  n-­3  PUFA  diet,  indicating  a  negative  impact  on  myelination  and  nerve  
health  (Fig.  5A).  This  was   further  substantiated  by  a  decrease   in   tissue   levels  of  brain  
derived  neurotrophic  factor  (bdnf),  as  well  as  decreased  expression  of  synaptic  markers  
(synapsin   I  &   II,   synaptophysin,  psd95;;   Fig.  5A).   Together   these   indicate   harm   to   the  
peripheral  nerves  innervating  adipose  tissue.  
Since   sympathetic   nerve   stimulation   is   necessary   for   activation   of   uncoupling  
protein   1   (ucp1)   and   thermogenesis   in   brown   or   beige   adipocytes,   we   analyzed  
expression   of   genes   related   to   ‘browning’   and   thermogenic   function   in   WAT.   Not  
surprisingly,  ucp1  expression  was  reduced  in  WAT  from  animals  fed  high  n-­3  PUFA  diet;;  
as   was   the   enzyme   elongation   of  very  long   chain   fatty   acid   (elovl3),   an   important  
component  in  early  lipid  recruitment  during  ‘browning’  [16]  (Fig.  5A).    Surprisingly,  we  saw  
an  increase  in  pgc1α,  indicating  that  the  ‘browning’  processes  may  be  triggered  by  the  n-­
3  PUFA  diet,  but  in  the  absence  of  proper  sympathetic  stimulation,  thermogenesis  could  




The   browning   pattern   (defined   by   presence   of   multilocular   cells,   distinct   from  
lipofuscin  and  crown-­like  structures)  in  perirenal  WAT  (prWAT;;  Fig.  5B)  was  distinct  from  
scWAT  (Fig.  3A).    These  data  are  summarized  in  Table  3.      
While  we  did  not  run  lipidomics  analysis  on  prWAT,  there  remains  the  possibility  
that  diet-­derived  lipids  accumulate  differently  in  the  two  WAT  depots  and  are  responsible  
for  the  differences  in  browning  patterns  that  were  observed.      
Consistent  with  our  hypothesis  that  a  peroxidized  diet  damages  nerve  health,  we  
observed  a  decrease   in  protein  expression  of   the  sympathetic  activity  marker   tyrosine  
hydroxylase  (TH)  in  the  interscapular  WAT  (iWAT)  depot  of  high  n-­3  PUFA  animals,  when  
compared  to  those  on  a  high  SFA  diet  (Fig.  5C).  This  may  reflect  impaired  communication  
between  brain  and  adipose,  or  a  compensatory  reduction  in  sympathetic  outflow  given  
the  dysregulated  lipolysis  observed  in  the  WAT  of  mice  fed  the  n-­3  PUFA  diet.    In  addition,  
despite  displaying  an  increase  in  circulating  levels  of  insulin-­sensitizing  adiponectin  in  the  
low  n-­3  PUFA  diet,  there  was  no  increase  maintained  with  the  high  n-­3  PUFA  diet  (Fig.  
5D),   which   was   mirrored   by   a   trend   for   a   decrease   in   circulating   levels   of   the   anti-­
inflammatory  cytokine  IL10  in  the  high  n-­3  PUFA  fed  mice  (Fig.  5E).  Gene  expression  of  
il10  in  WAT  was  significantly  decreased  in  the  n-­3  PUFA  mice  (Fig.  5A).  
Tissue  distribution  of  dietary  fats  and  TRP-­activating  lipids  
Mass-­spectroscopy   structural   lipidomics   data   were   compared   by   non-­metric  
multidimensional  scaling  (NMDS),  across  all  3  high-­fat  diets  for  all  3  tissues  tested  (WAT,  
BAT,  and  hypothalamus).     These  data   indicated   that  hypothalamus  was   least   likely   to  




due  to  diet  (Fig.  6A).    The  concentration  of  anti-­inflammatory  lipid  metabolite  species  was  
increased  the  most  in  scWAT  by  the  n-­6  PUFA  diet,  followed  by  the  n-­3  PUFA  diet,  but  
interestingly  the  pro-­inflammatory  lipids  were  also  increased  the  most  by  an  n-­6  PUFA  
diet  (Fig.  6B).    A  subset  of  the  anti-­inflammatory  lipids,  including  TRP-­channel  inhibitors  
such  as  maresin  1  and  the  resolvins  RvD1  and  RvD2,  were  increased  the  most  by  the  n-­
3   PUFA   diet   (Fig.   6C).      In   addition,   TRPM8-­activating   lipids,   including  
lysophosphatidylcholine  (LPC),  lysophosphatidylinositol  (LPI)  and  lysophosphatidylserine  
(LPS)  were  increased  in  n-­6  and  n-­3  PUFA  diets.    However,  since  TRP  calcium  channels  
are  largely  found  on  sensory  nerves,  it  is  likely  that  some  of  the  response  we  observed  in  
scWAT  could  be  due  to  increased  TRPM8  activation  of  WAT-­resident  sensory  nerves  by  
the  high  PUFA  diets.    Despite  the  potential  for  increased  sensory  nerve  feedback  of  lipid  
stores  to  brain,  the  n-­6  PUFA  mice  were  not  protected  from  weight  gain  and  increased  
adipocyte  cell  size  (Fig.  1  and  Fig.  3),  but  they  were  protected  from  the  changes  in  gene  
expression   that   were   observed   in   scWAT   of   n-­3   PUFA   mice   and   did   not   display   a  
reduction  in  peripheral  nerve  markers  (Fig.  5A).    This  is  likely  because  the  n-­6  PUFA  diet  
was  not  peroxidized.  
Discussion	  
Diet  peroxidation  and  metabolic  health  
Very  little  is  currently  known  about  how  varying  dietary  fat  type  and  amount  affects  
tissue  distribution  of  lipids  and  lipid  metabolites,  and  how  tissue  lipid  composition  affects  
brain-­adipose  communication  and  metabolic  control.    We  have  demonstrated  that  a  high  




weight   gain   and   improved  glucose   tolerance,   and   that   this   occurs  without   consuming  
fewer  calories  and  despite  a  decrease   in  energy  expenditure.     Given  that   there  was  a  
demonstrable  negative  impact  on  scWAT  tissue  integrity  due  to  the  peroxidized  n-­3  PUFA  
diet,  we  believe  that  altered  WAT  lipolysis  underlies  the  weight  reduction  in  these  mice  
and  not  a  shift  in  energy  balance  to  alter  appetite  or  overall  metabolic  rate.    This  fits  with  
the  smaller  depot  size  and  increased  expression  of  lipolytic  genes  (atgl,  hsl,  Fig.  5A)  in  
WAT,   and   the   fact   that   increased   lipid   utilization   and   reduction   in   fat   pad   size   are  
hallmarks  of  certain  illnesses  [17,18].  In  addition,  the  peroxidation  of  the  n-­3  PUFA  diet  
led   to   signs   of   peripheral   nerve   damage   in   the  WAT   and   lipofuscin   stain.      Thus,   the  
beneficial  effects  of  this  diet  may  have  been  outweighed  by  the  negative  consequences  
of  the  peroxidation.  
Most  surprising  was  the  observation  that  despite  numerous  attempts  to  mitigate  it  
(see   details   Suppl.   Methods),   the   n-­3   PUFA   diets   readily   undergo   peroxidation,   a  
detrimental  non-­enzymatic  degradation  pathway  that  has  been  described  only  sparingly  
in   the   literature   [15,   19]   but   is   well-­known   to   labs   studying   n-­3   fats.      Despite   careful  
procedures  undertaken  by  the  menhaden  fish  oil  processor,  as  well  as  the  mouse  diet  
manufacturer  to  reduce  or  eliminate  this  peroxidation  process,  we  measured  peroxidized  
lipid  byproducts  in  both  the  fresh  fish  oil  (from  a  new,  sealed  vial)  and  the  fresh  n-­3  PUFA  
diet   (from   a   new,   sealed   bag).   By   determining   that   the   fish   oil   source  was  minimally  
peroxidized,   we   were   able   to   conclude   that   the   majority   of   peroxidation   must   have  
occurred   during   the   diet   manufacturing   process,   since   peroxidation   creates   a   chain  
reaction  leading  to  more  peroxidation,  and  diet  manufacturing  does  put  the  food  under  




temperatures   and   avoiding   heat.      We   also   observed   peroxidized   lipid   metabolites   in  
scWAT  of  mice  fed  the  n-­3  PUFA  diet.    This  tenacious  process  of  peroxidation  takes  an  
otherwise  healthy  polyunsaturated  fatty  acid  and  turns  it   into  a  lipotoxic  product,  which  
we  have  demonstrated  to  correlate  with  WAT  lipofuscin  stain,  inflammation,  and  signs  of  
tissue  denervation  (including  a  reduction  in  neurotrophic  and  synaptic  markers  in  WAT).    
To  date,  several  studies  have  reported  that  a  hyperglycemic  state  can  lead  to  glucotoxicity  
of  nerves  [20]  and  now  our  data  support  the  notion  of  lipotoxicity  to  nerves  as  another  
likely  cause  of  neuropathy.  
Given  the  observation  that  only  n-­3  PUFA  diets  undergo  peroxidation  (ie:  not  SFA  
or  n-­6  PUFA),  and  the  finding  that  fish  oil  in  many  processed  forms  exhibits  high  levels  of  
peroxidized  lipids  (as  we  have  measured  in  human  fish  food  products),  our  new  findings  
regarding   lipotoxicity   and   neuropathy   in   WAT   hold   potentially   striking   importance   for  
human  nutrition   and  dietary   health.      This   could   especially   be   true   for   pets,  who  on  a  
regular  basis  eat  fish-­based  foods  that  may  have  become  peroxidized.    In  addition,  since  
so  many  people  take  fish  oil  supplements  for  the  vitamin-­D  and  healthy  fat  components,  
the  high  level  of  peroxidation  in  the  supplements  we  measured  indicate  that  the  health  
benefits   may   be   outweighed   by   the   risks.   Furthermore,   although   the   World   Health  
Organization  has  set  levels  of  acceptable  total  oxidation  in  fish  oil  supplements,  and  the  
European   Pharmacopoeia   Standards   specify   both   peroxidation   and   total   oxidation  
standards,  there  are  currently  no  set  standards  for  peroxidation  or  total  oxidation  levels  
in  fish  oil  supplements  for  the  U.S.,  resulting  in  no  market  control  of  products  available  for  
public  consumption.  In  one  study  in  New  Zealand,  it  was  found  that  fish  oil  supplements  




average),   they  also  were  peroxidized  at  a   rate  of  83%,  with  some  at   toxic   levels   [21].    
Another  study  from  Norway  determined  that  most  fish  oil  supplements  tested  were  above  
the  recommended  limit  of  2meq/kg  of  peroxide  values  (29  out  of  33  samples  tested  [19].  
Dietary  fat  type  &  brain-­adipose  communication    
Adipose  tissue  is  able  to  sequester  toxins,  store  fat-­soluble  vitamins,  and  maintain  
triglyceride   stores   in   lipid   droplets   that   structurally   resemble   lipoproteins,   as   they   are  
studded  with  biologically  important  proteins  (reviewed  in  [16]).  The  intake  of  excess  diet  
results   in   neutral   lipid   storage   as   cholesterol   esters,   triglycerides,   and   fatty   acids   in  
adipose   lipid   droplets.   However,   with   obesity   comes   mitochondrial   dysfunction,   a  
decrease  in  fatty  acid  oxidation,  and  defects  in  degradation  of  triglycerides  by  lipolysis.  
Thus,  the  tissue  lipid  stores  swell  and  lipid  droplets  grow  in  size,  as  do  the  adipocyte  cells  
themselves,  thus  leading  to  eventual  metabolic  dysregulation.  
While  adipose  tissue  is  the  most  lipid-­laden  tissue  in  the  body,  the  brain  contains  
the  second-­most  amount  of  lipid.    The  dry  weight  of  the  brain  has  around  50-­80%  lipid,  
with   essential   fatty   acids   comprising   about   15-­30%   of   that   total.   Dietary   fat   type   and  
amount   is   known   to   be   very   important   for   brain   health,   including   proper   brain  
development,  and  also   impacts  neurodegenerative  conditions  such  as  with  aging   [22].  
Thus,  unsurprisingly,  parallel  to  the  decrease  of  n-­3  PUFAs  in  western  diets,  there  has  
also  been  an  increase  in  neurological  disorders  [23].    Diets  high  in  n-­3  or  supplemented  
with  n-­3  appear  to  result  in  improved  cognition  (reviewed  in  [24]),  but  it  is  not  known  how  




Neuronal   membranes   are   made   from   a   choline-­phosphocoline-­
phosphatidylcholine  mixture  requiring  synthesis  from  the  long-­chain  PUFAs  DHA,  EPA,  
and  AA  (reviewed  in  [24]).    Membranes  making  up  synapses,  dendrites,  mitochondria  and  
vesicles  are  also  rich  in  n-­3  and  n-­6  PUFAs.  In  the  absence  of  these  essential  fats  in  our  
diet,  other  fatty  acids  fill  in  the  structural  role  in  neurons,  thus  changing  cellular  behavior  
[23].  Non-­membrane  lipids  in  the  brain  include  steroid  hormones  and  eicosanoids,  which  
act  as  biomessengers.  Long-­chain  PUFAs  are  required   for  neural  plasticity  and  neural  
protection,  whereas  lipids  like  ceramides  may  be  lipotoxic  [25].  On  a  high-­fat  diet  there  is  
increased  hypothalamic  fatty  acid  uptake  but  very  low  beta-­oxidation,  resulting  in  excess  
fatty  acid  storage  and  potential  lipotoxicity  [25],  whereas  adipose  tissue  can  take  up  and  
store  lipids  in  a  more  efficient  manner,  as  well  as  oxidize  them  as  needed  for  fuel.  Adipose  
tissue   lipids   also   likely   have   an   effect   on   the   structure   and   function   of   the   peripheral  
nerves  that  innervate  them,  but  this  has  not  been  explored.  
Signaling  lipids  and  sensory  nerve  TRP  channels  
   Sensory   nerves,   including   those   innervating   adipose   depots   and   mediating  
adipose  to  brain  communication,  contain  specialized  calcium  channels  of   the   transient  
receptor   potential   family   (TRPs).      Sensory   nerves   contain   the   following   TRP   family  
members:   TRPV1-­4,   TRPA1,   TRPM8,  TRPC1/C3/C6   (reviewed   in   [26]).      These   TRP  
channels  are  important  for  metabolic  processes  like  thermogenesis  (TRPM8)  and  adipose  
tissue  function  (TRPV1-­3;;  reviewed  in  [27]).    Some  of  these  TRPs  respond  to  lipid  ligands,  
and  may  also  play  a  role  in  synaptic/neural  plasticity  (reviewed  in  [28]).  We  have  found  
that  n-­3  PUFA  diets,  perhaps  exacerbated  by  peroxidation,  produce  signaling  lipids  in  the  




TRP  channels.     These   lipids  would  also  normally  exhibit  a  beneficial  anti-­inflammatory  
role,   but   the   peroxidation   of   the   n-­3   diet   may   be   masking   that   beneficial   effect.      By  
contrast,   n-­6   PUFA   diets   display   the   opposite   and   are   enriched   for   HODE-­family  
metabolites  that  are  known  to  activate  sensory  nerve  TRP  channels  [26].  Maresin  1,  a  
macrophage-­derived  mediator  of   inflammation  resolution   [29]  can  act  to   inhibit  TRPV1  
[30].  Maresins  are  produced  by  macrophages  in  response  to  the  oxygenation  of  DHA  with  
14-­HDHA  serving  as  an  intermediate  step  and  precursor  to  maresin1  biogenesis  [29,  31]  
and  14-­HDHA  is  significantly  increased  in  n-­3  PUFA  groups.      
In  addition,  we  observed  that  PUFA  diets  lead  to  increased  LPC,  LPI  and  LPS  in  
WAT.    These  lipids  serve  as  TRPM8  activators  [32].  TRPM8  is  a  cold-­activated  channel  
[33]   expressed   in   WAT,   and   when   activated   can   induce   browning   of   WAT,   thereby  
increasing  energy  expenditure.    
Conclusions  
Taken  together,  our  data  indicate  that  differing  dietary  fat  type  and  amount  results  
in  a  distinct  pattern  of  lipid  distribution  between  brain,  white,  and  brown  adipose  tissues,  
as  well  as  differences  in  metabolic  function.    This  may  be  due  to  altered  brain-­adipose  
communication,   as   peripheral   nerves   in   adipose   depots   appear   to   be   affected   by   the  
dietary   fat   components.      Finally,   the   unexpected   finding   that   n-­3   PUFA   diets   were  
peroxidized,  leading  to  accumulation  of  peroxidized  lipid  species  in  adipose,  fibrosis,  and  
lipofuscin,   likely   explains   the   blunted   metabolic   benefit   (such   as   lower   energy  
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Figure  1:  Effects  of  differing  dietary  fat  type  and  amount  on  body  weight,  adiposity,  
glucose  tolerance  and  food  intake.  (A)  Percent  change  of  body  weight  across  16wks  
of  dietary  fat  feeding.  No  difference  in  percent  change  of  body  weight  was  observed  within  
low  fat  groups  (denoted  by  A);;  percent  change  in  body  weight  was  comparable  for  mice  
on  high  SFA  and  high  n-­6  PUFA  diets  (denoted  by  B);;  percent  change  in  body  weight  for  
mice  on  high  n-­3  PUFA  diet  was  significantly  lower  than  any  other  diet  (denoted  by  C,  
with  p=<0.0001  when  compared  to  either  high  SFA  or  high  n-­6  PUFA).  Data  was  analyzed  
by   one-­way   ANOVA   with   Tukey’s   post   hoc   test.      (B-­C)   Adipose   depot   weight   as   a  
percentage  of  body  weight:  subcutaneous  (scWAT)  and  perigonadal  (pgWAT)  adiposity  
was  comparable  across  all  low  fat  diets  and  high  n-­3  PUFA  (denoted  by  A),  while  similar  
between  mice   on   high   SFA   and   high   n-­6   PUFA   diets   (denoted   by   B,   p<0.001   when  
analyzed  by  one-­way  ANOVA  with  Tukey’s  post  hoc  test).  (D)  Glucose  tolerance  test  after  
4   weeks   of   dietary   intervention,   high   SFA   and   high   n-­6   PUFA   displayed   significantly  
slower  glucose  clearance  at  30  and  70min.  Data  was  analyzed  by  two-­way  ANOVA  with  
uncorrected  Fisher’s  LSD  post  hoc.  (E)  Cumulative  food  intake  was  calculated  as  average  
kcal  consumed  by  each  mouse  over  a  28-­day  period.  There  was  no  difference  in  food  
intake  within  low  or  high  fat  diets.  Data  was  analyzed  by  one-­way  ANOVA  with  Tukey’s  
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Figure   2:   Metabolic   Cage   Measurements   Waveform   analysis   of   metabolic   cage  
measurements  (CLAMS)  taken  at  15min  increments  for  3  days.    Time  of  day  is  indicated  
on  the  x-­axis,  and  animals  were  maintained  on  a  12  hr  light/dark  cycle  (black  bars  indicate  
dark  cycle).  (A)  Volume  of  oxygen  (VO2)  consumption  was  higher  for  n-­6  PUFA  mice  at  
multiple   time  points   throughout   the  24  hr  cycle.   (B)  Volume  of  carbon  dioxide   (VCO2)  
produced  was  greater  for  animals  on  a  high  n-­6  PUFA  diet  compared  to  those  on  high  n-­
3  PUFA,  predominately  during  the  light  phase.  (C)  Energy  expenditure  as  measured  by  
heat  was  higher  at  various   time  points,  but  especially  during   the  day,   for   the  high  n-­6  
PUFA   animals.      (D)   A   strong   interaction   for   the   whole   24hr   cycle   was   observed   for  
respiratory  exchange  as  a  ratio  (RER)  between  the  two  groups,  indicating  greater  use  of  
carbohydrates  for  fuel  by  the  high  n-­3  PUFA  animals  compared  to  high  n-­6  PUFA.    Data  
analyzed  by  two-­way  repeated  measures  ANOVA  with  Fisher’s  LSD  test;;  N=4  per  group.    
Error  bars  are  SEMs.  *p  <  0.05,  **p  <  0.01,  ***p  <  0.001,  ****p  <  0.0001.  
  
  








































































Figure  3:  Adipose  tissue  effects  of  differing  dietary  fat  amounts  
(A)  Hematoxylin  staining  of  subcutaneous  adipose   tissue  showed  no  difference   in  cell  
size  or  browning  between  high  SFA  and  high  n-­6  PUFA  groups.  Despite  greater  variation  
within  the  high  n-­3  PUFA,  cell  size  is  smaller  overall  and  lipofuscin  (arrows)  is  noticeable.  
Inset   is   a   digital   zoom   of   10x   magnification   showing   representative   lipofuscin.   (B)  
Trichrome   staining   of   scWAT   revealed   fibrosis   and  higher   concentration   of   crown-­like  
structures  in  tissue  of  high  n-­3  PUFA  fed  animals  compared  to  those  on  a  high  SFA  diet.  
Inset   is   a   20x   magnification   of   a   representative   crown-­like   structure.   (C).   Green  
autofluorescence  in  high  n-­3  PUFA  diet  animals  indicative  of  increased  lipofuscin  content  
relative  to  high  SFA  diet.  For  all  experiments,  N=6-­8  mice  per  group.  
  




Figure  4.  Peroxidation  of  the  n-­3  diet.  (A)  Lipidomics  analysis  revealed  an  increase  in  
non-­enzymatic  oxidized  (peroxidized)  lipids  in  scWAT  of  mice  fed  n-­3  PUFA  enriched  
diets  only  (groups  labeled  B  are  significantly  different  than  groups  labeled  A).  These  
lipids  included:  11-­HEPE,  9-­HEPE,  11-­HETE,  9-­HETE,  8-­HETE,  11-­HDHA,  8-­iso  
PGF2a,  and  5-­iPF2a-­VI.  Lipidomics  data  of  non-­enzymatic  oxidized  lipids  were  
analyzed  by  ANOVA,  with  Tukey’s  post  hoc  test,  N=6-­8  per  group.  (B)  Peroxidation  was  
confirmed  by  a  TBARs  assay,  which  compared  the  mouse  diets  themselves  to  both  fish  
oil  supplements  and  canned  fish  products.  50uM  MDA  was  used  as  a  threshold  above  
which  oxidative  stress  is  exhibited  in  certain  tissues.  All  data  were  run  in  technical  
replicates  of  n=3.      
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Figure  5:  Adipose  dysregulation  in  other  depots  due  to  peroxidized  n-­3  diet  
(A)   Gene   expression   analysis   of   pgWAT.   Anti-­inflammatory   cytokines   (il4,   il10,   il13),  
inflammatory  markers  (il6,  tnfa),  macrophage  marker  (f4/80),  lipolysis  markers  (atgl,  hsl),  
nerve  related  genes  (sox10,  bdnf,  synapsin   I,  synapsin   II,  synaptophysin,  psd95),  and  
browning  markers  (ucp1,  elovl3,  pgc1a)  were  measured  by  qPCR  and  analyzed  by  two-­
tailed  Student’s  t-­test,  using  Welch’s  correction  when  variance  was  unequal,  N=6-­7  per  
group.  Error   bars   are  SEMs.   *p  <   0.05,   **p   <   0.01,   ***p  <   0.001,   ****p   <   0.0001.   (B)  
Hematoxylin   staining   of   perirenal   adipose   tissue;;   signs   of   lipofuscin   (arrows).   (C)   A  
decrease  in  sympathetic  activation  (TH  protein  levels)  in  the  scWAT  of  n-­3  PUFA  mice,  
as  measured  by  western  blot.  TH   levels  were  normalized   to  β-­actin  housekeeper,  and  
band  densities  were  quantified   in   Image  J  and  analyzed  by   two-­tailed  Student’s   t-­test.    
Error   bars   are  SEMs.   *p  <   0.05,   **p  <   0.01,   ***p  <   0.001,   ****p  <   0.0001.   (D)  ELISA  
measurements  of  circulating  HMW  adiponectin  revealed  higher   levels   in   the   lower  n-­3  
PUFA  mice  only.  (E)  ELISA  measurements  of  circulating  anti-­inflammatory  IL10,  with  a  
trend  for  reduced  IL10  in  the  high  n-­3  PUFA  mice.  
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Figure  6:  Tissue  Distribution  of  Lipids  
(A)  A  total  of  2106  structural   lipid  species  measured  by  lipidomics  from  hypothalamus,  
BAT  and  WAT  across  all  3  high-­fat  diets  were  compared  using  NMDS  in  R,  revealing  non-­
overlapping  differences  in  lipid  species  composition  among  the  three  tissues.    In  addition,  
hypothalamus  had  little  difference  in  lipid  composition  regardless  of  diet,  whereas  WAT  
had  the  most  diversity  in  lipid  composition  depending  on  diet.    (B)  Total  concentration  of  
anti-­   and   pro-­inflammatory   lipid   species   as   measured   in   scWAT.   (C)   Levels   of   anti-­
inflammatory  TRP   inhibiting   lipids   in   scWAT.   (D)   Levels   of  TRPM8  activating   lipids   in  








Table  1:  Composition  of  Custom  Diets  
Research   Diets  
Cat.#  
D06061301   D06061303  
    
      D02062102   D06061302   D06061304   D06061305  
Diet  Type   High  fat  77%  
SFA  
Low  fat  77%  
SFA  
High  fat  77%  n-­‐
6  PUFA  
Low  fat  77%  n-­‐6  
PUFA  
High  fat  77%    
n-­‐3  PUFA  
Low  fat  77%          
n-­‐3  PUFA  
%   gm   kcal   gm   kcal   gm   kcal   gm   kcal   gm   kcal   gm   kcal  
Protein   23.7   20   19.2   20   23.7   20   19.2   20   23.7   20   19.2   20  
Carbohydrate   41.4   35   67.3   70   41.4   35   67.3   70   41.4   35   67.3   70  
Fat   23.6   45   4.3   10   23.6   45   4.3   10   23.6   45   4.3   10  
Total   88.7   100   90.8   100   88.7   100   90.8   100   88.7   100   90.8   100  
Kcal/gm   4.73        3.85        4.73        3.85        4.73        3.85       
Ingredient     gm   kcal   gm   kcal   gm   kcal   gm   kcal   gm   kcal   gm   kcal  
Casein,  80  
Mesh  
200   800   200   800   200   800   200   800   200   800   200   800  
L-­‐  Cystine   3   12   3   12   3   12   3   12   3   12   3   12  
Corn  Starch   72.8   291   492.2   1969   72.8   291   492.2   1969   72.8   291   492.2   1969  
Maltodextrin  10   100   400   35     140   100   400   35     140   100   400   35     140  
Sucrose   172.8   691   172.8   691   172.8   691   172.8   691   172.8   691   172.8   691  
Cellulose,  
BW200  
50   0   50   0   50   0   50   0   50   0   50   0  
Soybean  Oil   25   225   6   54   25   225   6   54   25   225   6   54  
Lard   0   0   0   0   0   0   0   0   0   0   0   0  
Coconut  Oil,  
Hydrogenated  
151   1359   33.5   302   0   0   0   0   0   0   0   0  
Safflower  Oil   0   0   0   0   177.5   1598   39   351   0   0   0   0  
ProOmega  Oil   0   0   0   0   0   0   0   0   177.5   1598   39   351  
High  Oleic  
Safflower  Oil  
26.5   239   5.5   50   0   0   0   0   0   0   0   0  
Mineral  Mix  
S10026  
10   0   10   0   10   0   10   0   10   0   10   0  
Dicalcium  
Phosphate  
13   0   13   0   13   0   13   0   13   0   13   0  
Calcium  
Carbonate  
5.5   0   5.5   0   5.5   0   5.5   0   5.5   0   5.5   0  
Potassium  
Citrate,  1  H2O  
16.5   0   16.5   0   16.5   0   16.5   0   16.5   0   16.5   0  
Vitamin  Mix  
V10001  
10   40   10   40   10   40   10   40   10   40   10   40  
Choline  
Bitartrate  
2   0   2   0   2   0   2   0   2   0   2   0  
FD&C  Yellow  
Dye  #5  
0   0   0   0   0.025   0   0.025   0   0   0   0.05   0  
FD&C  Red  Dye  
#40  
0   0   0.05   0   0   0   0.025   0   0.025   0   0   0  
FD&C_Blue  Dye  
#1  
0.05   0   0   0   0.025   0   0   0   0.025   0   0   0  
Total   858.15   4057   1055.05   4057   858.15   4057   1055.05   4057   858.15   4057   1055.05   4057  
  




Table  2:  Typical  fatty  Acid  Profile  of  Diets  Based  on  Data  from  the  Manufacturers  
of  the  Fat  Sources  
  





High fat,             
77%  n-6 
PUFA
Low fat       
77% n-6 
PUFA
High fat            
77%  n-3 
PUFA




Coconut Oil, 101 151 33.5
Lard
Menhaden Oil, ARBP-F
ProOmega (Omega-3 Oil) 177.5 39
Safflower Oil, USP 177.5 39
Safflower Oil, High Oleic 26.5 5.5
Soybean Oil 25 6 25 6 25 6
Total 202.5 45 202.5 45 202.5 45
C2, Acetic 0.0 0.0 0.0 0.0 0.0 0.0
C4, Butyric 0.0 0.0 0.0 0.0 0.0 0.0
C6, Caproic 0.9 0.2 0.0 0.0 0.0 0.0
C8, Caprylic 11.6 2.6 0.0 0.0 0.0 0.0
C10, Capric 8.9 2.0 0.0 0.0 0.0 0.0
C12, Lauric 71.9 15.9 0.0 0.0 0.0 0.0
C14, Myristic 27.2 6.0 0.0 0.0 0.8 0.2
C14:1, Myristoleic 0.0 0.0 0.0 0.0 0.0 0.0
C15 0.0 0.0 0.0 0.0 0.1 0.0
C15:1 0.0 0.0 0.0 0.0 0.0 0.0
C16, Palmitic 17.3 3.9 13.9 3.1 7.5 1.7
C16:1, Palmitoleic 0.0 0.0 0.0 0.0 2.1 0.5
C16:2 0.0 0.0 0.0 0.0 0.0 0.0
C16:3 0.0 0.0 0.0 0.0 0.0 0.0
C16:4 0.0 0.0 0.0 0.0 0.0 0.0
C17 0.0 0.0 0.0 0.0 0.0 0.0
C17:1
C18, Stearic 17.5 3.9 5.0 1.1 6.1 1.4
C18:1, Oleic 27.8 6.0 27.1 6.1 19.4 4.4
C18:2, Linoleic 16.4 3.8 152.1 33.7 14.6 3.5
C18:3, Linolenic 1.9 0.5 2.1 0.5 2.9 0.7
C18:4, Stearidonic 0.0 0.0 0.0 0.0 2.9 0.6
C20, Arachidic 0.1 0.0 0.1 0.0 0.7 0.2
C20:1, 0.1 0.0 0.1 0.0 4.7 1.0
C20:2 0.0 0.0 0.0 0.0 0.6 0.1
C20:3 0.0 0.0 0.0 0.0 0.5 0.1
C20:4, Arachidonic 0.0 0.0 0.0 0.0 0.4 0.1
C20:5, Eicosapentaenoic 0.0 0.0 0.0 0.0 52.1 11.4
C21:5 0.0 0.0 0.0 0.0 0.0 0.0
C22, Behenic 0.1 0.0 0.1 0.0 0.4 0.1
C22:1, Erucic 0.0 0.0 0.0 0.0 4.2 0.9
C22:4, Clupanodonic 0.0 0.0 0.0 0.0 0.0 0.0
C22:5, Docosapentaenoic 0.0 0.0 0.0 0.0 6.9 1.5
C22:6, Docosahexaenoic 0.0 0.0 0.0 0.0 35.4 7.8
C24, Lignoceric 0.0 0.0 0.0 0.0 0.0 0.0
C24:1 0.0 0.0 0.0 0.0 1.1 0.2
Total 201.8 44.8 200.5 44.6 163.6 36.4
Saturated (g) 155.5 34.5 19.2 4.3 15.8 3.6
Monounsaturated (g) 27.9 6.0 27.1 6.1 31.6 7.1
Polyunsaturated (g) 18.4 4.3 154.2 34.2 116.2 25.8
Saturated (%) 77.1 77.0 9.6 9.6 9.7 9.7
Monounsaturated (%) 13.8 13.4 13.5 13.6 19.3 19.4
Polyunsaturated (%) 9.1 9.6 76.9 76.7 71.0 70.9
Linoleic Acid (%) 8.1 8.5 75.8 75.6 8.9 9.5
Oleic Acid (%) 13.8 13.3 13.5 13.6 11.8 12.0
Alpha-linolenic acid (%) 1.0 1.0 1.0 1.1 1.8 1.9
Eicosapentaenoic Acid (%) 0.0 0.0 0.0 0.0 31.8 31.4
Docosahexaenoic Acid (%) 0.0 0.0 0.0 0.0 21.6 21.3
Total Omega-3 (%) 1.0 1.0 1.0 1.1 61.2 60.5





Table  3:  Browning  patterns  across  WAT  depots  by  diet,  as  indicated  by  multilocular  
histology  
Diet   scWAT  Browning  Pattern   prWAT  Browning  Pattern  
Low  SFA   3/6  mice  exhibit  browning   3/6  mice  exhibit  browning;;  
large  patches  
High  SFA   No  browning  observed   Some  smaller  patches  of  
browning  in  a  couple  of  
animals  
Low  n-­6  PUFA   All  mice  exhibit  some  extent  
of  browning,  but  only  small  
patches  
1/6  mice  exhibited  
browning;;  large  patches  
High  n-­6  PUFA   Little  to  no  browning  
observed  
5/6  mice  exhibited  browning  
Low  n-­3  PUFA   No  browning  observed   All  tissues  exhibited  some  
browning;;  2/6  had  large  
patches  
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NEUROPATHY  AND  NEURAL  PLASTICITY  IN  THE  SUBCUTANEOUS  WHITE  




The  difficulty  in  obtaining  as  well  as  maintaining  weight  loss,  together  with  the  impairment  
of  metabolic  control  in  conditions  like  diabetes  and  cardiovascular  disease,  may  represent  
pathological   situations   of   inadequate   neural   communication   between   the   brain   and  
peripheral   organs   and   tissues.      Innervation   of   adipose   tissues   by   peripheral   nerves  
provides  a  means  of  communication  between  the  master  metabolic  regulator  in  the  brain  
(chiefly  the  hypothalamus),  and  energy-­expending  and  energy-­storing  cells  in  the  body  
(primarily  adipocytes).  Although  chemical  and  surgical  denervation  studies  have  clearly  
demonstrated   how   crucial   adipose   tissue   neural   innervation   is   for   maintaining   proper  
metabolic  health,  we  have  uncovered  that  adipose  tissue  becomes  neuropathic  in  various  
conditions   of  metabolic   dysregulation.  Here,  utilizing   both   human  and  mouse  adipose  
tissues,  we  present  evidence  of  adipose  tissue  neuropathy,  or  loss  of  innervation,  under  
pathophysiological   conditions   such   as   obesity,   diabetes,   and   aging,   all   of   which   are  
concomitant  with  insult  to  the  adipose  organ  and  metabolic  dysfunction.  Neuropathy  is  
indicated  by   loss  of  nerve   fiber  protein  expression,   reduction   in  synaptic  markers,  and  
lower  neurotrophic  factor  expression  in  adipose  tissue.    Aging-­related  adipose  neuropathy  
particularly  results  in  loss  of  innervation  around  the  tissue  vasculature.    These  findings  
underscore  that  peripheral  neuropathy  is  not  restricted  to  classic  tissues  like  the  skin  of  




metabolic   diseases.      In   addition,  we  have  demonstrated   stimulation  of   adipose   tissue  
neural  plasticity  with  exercise,  cold  exposure  or  local  AAV-­mediated  neurotrophic  factor  
treatment,   which   may   ameliorate   adipose   neuropathy   and   be   a   potential   therapeutic  
option  to  re-­innervate  adipose  and  restore  metabolic  health.      
Introduction  
Since  body  weight  regulation  involves  a  precise  balance  between  energy  intake  
and  energy  expenditure,  and  requires  coordination  and  control  stemming  from  the  central  
nervous   system   (CNS),   the   brain   needs   to   adequately   communicate   with   peripheral  
organs  and  tissues  via  peripheral  nerves  in  order  to  maintain  metabolic  health.  The  CNS  
is  able  to  control  energy  expenditure  by  signaling  motivation  to  exercise  or  seek  certain  
foods,   driving   sympathetic   nervous   system   (SNS)   activation   of   energy   expending  
processes   in   the   peripheral   tissues  of   the   body,   and   through   receiving   feedback   from  
tissue  sensory  nerves,  like  those  from  adipose1.  Sensory  nerves  in  white  adipose  tissue  
(WAT)  are  thought  to  communicate  the  status  of  energy  stores  to  the  brain,  in  order  to  
help   regulate   energy   intake   versus   expenditure.      In   WAT,   SNS   activation   serves   to  
increase   lipolysis,   de   novo   adipogenesis,   and   a   process   termed   ‘browning’,   whereby  
uncoupling   protein   1   (UCP1)-­positive   brown   adipocytes   appear   in   WAT   depots   and  
contribute  to  energy  expenditure  via  thermogenesis2.  In  brown  adipose  tissue  (BAT),  SNS  
activation  also  drives  non-­shivering  thermogenesis  via  activation  of  mitochondrial  UCP1,  
which  is  a  brown  adipocyte-­specific  gene  and  required  for  this  energy  expending  process  
in   both   classical   and   inducible/recruitable   brown   adipocytes3,4.   During   thermogenesis,  




brown  adipocytes  and  are  also  obtained  via  circulating  lipids  that  are  released  from  WAT  
through  lipolysis5,6.    
Surgical  and  chemical  denervation  studies  have  demonstrated  the  importance  of  
adipose  tissue  nerves,  and  denervation  leads  to  a  loss  of  proper  metabolic  control3,7,8.    
Denervation  of  WAT  also  leads  to  an  increase  in  tissue  mass  and  adipocyte  cell  number9-­
11.  Therefore,   the  regulation  of   lipid  stores   in  both  BAT  and  WAT  and  the  activation  of  
energy   expenditure   through   CNS-­SNS   communication   are   essential   for   proper   body  
weight  maintenance  and  metabolic  health.  It  is  not  yet  understood  what  other  aspects  of  
adipose   tissue   function   are   under   neural   control,   and  whether   or   not   the   nerves   that  
innervate   adipose   tissue   can   modify   their   connections   under   physiological   or  
pathophysiological   conditions.      Therefore,   these   questions   regarding   adipose   nerve  
remodeling  warrant  further  investigation.    
The   nerves   that   innervate   white   adipose   tissues   include   numerous   peripheral  
nerve  subtypes,  such  as  sensory,  parasympathetic  and  sympathetic  nerves12-­14.  Although  
the   number   of   studies   assessing   adipose   innervation   are   increasing,   further  
demonstrating  the  importance  of  brain-­adipose  communication15-­17,  it  is  still  unclear  which  
neurotransmitters   and   neuropeptides,   aside   from   the  well-­studied   norepinephrine,   are  
synaptically  released  in  adipose  tissue  and  onto  which  receptor-­expressing  cell  types.  A  
better   understanding   of   how   the   peripheral   nerves   in   adipose   tissue   are   regulated   is  
important  for  the  field,  including  differences  in  nerve  plasticity  between  innervation  of  BAT  
and  WAT,  as  well  as  sex  differences  in  innervation  density.      
In   other   tissues,   and   in  many  organisms,  peripheral   nerves  are   appreciated  as  




or  neuropathic   (dying-­back   in  pathophysiological  conditions).     For  example,  with  distal  
peripheral  neuropathy  nerves   in   the  skin  of  distal  extremities  can  die  back   through  an  
unclear  process,  resulting  in  pain,  loss  of  sensation,  and  severe  discomfort.    The  process  
begins  in  the  skin  and  moves  inward.    Neuropathy  can  be  caused  by  aging,  certain  drugs  
(such  as  antibiotics  and  chemotherapy  agents),  or  diabetes  18-­20.  Diabetic  neuropathy  is  
especially  prominent,  affecting  over  50%  of  diabetic  individuals,  and  often  leads  to  limb  
amputation  21,22.  Aging  is  associated  with  a  loss  of  metabolic  regulation  and  an  increased  
propensity   for   diabetes23-­25,   and   is   independently   associated   with   peripheral  
neuropathy26.     The  debilitating  aspects  of  peripheral  neuropathy  are   largely  due  to   the  
inability   to   prevent   or   treat   these   conditions,   and   the   inability   to   halt   and   reverse   the  
neurodegeneration.  Standard  clinical  approaches  include  pain  management  or  glucose  
regulation  (with  diabetic  neuropathy),  but  no  therapies  are  currently  approved  to  mitigate  
nerve  death  or  to  stimulate  peripheral  nerve  re-­growth  or  re-­myelination.    It  is  important  
to   understand   whether   or   not   neuropathy   can   extend   below   the   skin   into   underlying  
adipose  tissue,  which  may  exacerbate  metabolic  disease.  
Given  the  close  association  between  situations  of  metabolic  dysregulation  (aging,  
obesity,  diabetes)  and  peripheral  neuropathy,  and  the  clear  importance  of  adipose  tissue  
innervation  for  metabolic  homeostasis,  we  sought  to  determine  if  adipose  tissue  nerves  
also  undergo  neuropathy  with  these  conditions.    To  do  this,  we  assessed  human  adipose  
tissue  samples  across  a  range  of  ages  and  body  mass  indices  (BMIs),  and  also  utilized  
mouse   models   of   aging   and   obesity/diabetes.   We   hypothesized   that   age   and  
obesity/diabetes   would   be   positively   correlated   with   a   loss   of   proper   innervation   of  




innervation  of  adipose  tissue  in  situations  of  adipose  neuropathy,  through  a  beneficial  and  
physiological  process  of  nerve  plasticity.  
  
Methods    
Mice,  Metabolic  Phenotyping,  and  in  vivo  Analyses  
Young/Aged  Sedentary/Exercised  mice  
  Age-­matched  C57BL/6J  male  mice  (Jackson  Laboratory,  Bar  Harbor,  ME;;  stock  number  
000664  Black  6)  were  aged  to  16  months.  Body  weight  and  adiposity  were  compared  to  
age-­matched  C57BL/6J  male  mice  at  10-­12  weeks  old.    
   Young  Sedentary/Exercised  mice  
Young   (12-­15  week   old)   C57BL/6J  male  mice   (Jackson  Laboratory,   Bar   Harbor,  ME;;  
stock  number  000664  Black  6)  were  age  and  body  weight  matched  before  randomized  
assignation  to  either  sedentary  or  exercised  groups.    
Voluntary  running-­wheel  exercise  
Young  and  aged  animals  were  single-­housed   in   running  wheel  cages   that  allowed  ad  
libitum  access  to  running,  for  a  period  of  7  days.  Control  (sedentary)  animals  were  either  
single-­caged  with  locked  running  wheels,  or  caged  in  pairs  without  a  running  wheel.    
   BTBR  ob/ob  
Male  BTBR  +/+   (WT)  and  ob/ob  mutant   (MUT)  mice   (Jackson  Laboratory,  Bar  Harbor,  




aged  to  a  minimum  of  12  weeks  of  age,  when  they  exhibit  a  robust  phenotype  including  
obesity,  diabetes,  and  hyperglycemia  27.  These  animals  (aged  12-­28  weeks)  were  then  
euthanized  after  Von  Frey  Analysis  of  tactile  allodynia  (see  details  in  Supplement).    
For  tissue  harvesting  all  animals  were  CO2  euthanized  followed  by  cervical  dislocation.         
Human  adipose  tissue  analyses  
Human  adipose  samples   (subcutaneous  and  omental)  were  obtained   from   the  Boston  
Nutrition  Obesity  Research  Center  (BNORC)  adipose  tissue  core.  Biopsies  of  scWAT  and  
omental  adipose  were  taken  from  patients  during  elective  surgery.  All  patients  were  either  
non-­diabetic  or  pre-­diabetic,  with   the  exception  of   four  diabetic   individuals,  2  of  whom  
were  in  the  BMI  cohort  and  2  in  the  aged  cohort  (indicated  by  asterisks  in  data  plots;;  see  
Suppl.  Tables  S1-­3  for  relevant  patient  data).    Frozen  and  fixed  tissue  (from  only  a  subset  
of  patients)  samples  were  obtained  for  analyses,  including  histology  and  western  blotting.  
Whole  depot  imaging  and  analysis  
Mouse  inguinal  subcutaneous  adipose  depots  were  removed  intact  and  immunostained  
as  described  in  Supplemental  Materials.  Entire  depots  were  imaged  for  Fig.  4  with  a  10x  
objective  on  a  Leica  TCS  SP8  or  DMI6000  confocal  microscope   (Leica  Microsystems,  
Wetzlar,   Germany),   by   tiling   z-­stacks   of   the   entire   depth   of   tissue.   Images   ranged  
between  542-­3464  tiles  per  depot,  the  average  lied  at  approximately  1000  tiles  per  depot.  
Tiles   were   individually   Z-­projected   and   background   subtracted   (using   the   rolling   ball  
method).    Processed  tiles  were  then  thresholded  into  binary  images  and  skeletonized.  To  
analyze   arborization   of   adipose   nerves,   skeletons   were   assessed   for   the   following  




tortuosity.  Branches  less  than  4μm  in  length  were  excluded  from  the  analysis.  All  analyses  
were   performed   in   FIJI   image   analysis   software.   Arborization   parameters   were  
normalized   to   tissue   weight.      Additional   analyses   of   whole   depots   are   described   in  
Supplement.  
Statistical  Analysis  
   For  all  animal  experiments,  mice  were  randomized  to  treatment  groups  to  ensure  
no   difference   in   starting   body   weight.      All   plots   represent   mean   +/-­SEM.      Statistical  
calculations  were  carried  out  in  Excel  or  GraphPad  Prism  software  (La  Jolla,  CA,  USA),  
utilizing   ANOVA,   Linear   Regression,   or   Student’s   T-­test   as   indications   of   significance  
(specified   in  Figure   legends).  Gene  and  protein  expression  data  were  normalized   to  a  
housekeeper   and   analyzed   by   either   ANOVA   or   by   Student’s   t-­test,   two-­tailed,   using  
Welch’s  correction  when  variance  was  unequal.  Error  bars  are  SEMs.  For  all  figures,  *p  
<  0.05,  **p  <  0.01,  ***p  <  0.001,  ****p  <  0.0001.    
Ethical  Statement  
All  procedures  and  handling  of  animals  were  performed  in  accordance  with  the  University  
of  Maine’s   Institutional  Animal  Care   and  Use  Committee   (IACUC),   to   comply  with   the  
guidelines  of  the  PHS  Policy  on  Humane  Care  and  Use  of  Laboratory  Animals,  and  Guide  
for  the  Care  and  Use  of  Laboratory  Animals.    This  study  was  approved  by  the  University  
of  Maine’s  IACUC,  under  protocol  A2017-­09-­04.  Human  tissue  samples  were  obtained  
from  the  Boston  Nutrition  and  Obesity  Research  Center  (BNORC)  and  were  de-­identified  







The  datasets  generated  and/or  analyzed  during  the  current  study  are  available  from  the  
laboratory’s  DataVerse  site  or  by  emailing  the  corresponding  author.      
  
Additional  Methods  can  be  found  in  APPENDIX  B:  Chapter  3  Supplemental  Material.  
  
Results  
Obese   and   diabetic   mice   display   subcutaneous   white   adipose   tissue   (scWAT)  
neuropathy  
   In   order   to   investigate   whether   obesity/diabetes   leads   to   adipose   tissue  
neuropathy,  we  used  BTBR  mice  with  the  ob/ob  leptin-­deficient  mutation  (MUT).  These  
animals   develop   severe   obesity,   type   2   diabetes,   hypercholersterolemia,   and   insulin  
resistance,  with  significantly  increased  body  weight  and  blood  glucose  by  8  weeks  of  age  
27.    Although  disease  progression  is  slower  in  females  when  compared  to  males28,  both  
sexes  eventually  develop  diabetes  and  peripheral  neuropathy,  with  nerve  conductance  
deficits  and  intraepidermal  nerve  fiber  loss  evident  by  9  and  13  weeks,  respectively  27.  
While  this  diabetic  neuropathy  has  been  well  described  in  skin  and  paw,  the  effects  on  




By  12  weeks  of  age,  male  BTBR  MUT  mice  exhibited   the  expected   increase   in  
body  weight   when   compared   to   BTBR   +/+  wild   type   (WT)  mice   (Fig.   1a),   which  was  
concurrent   with   increased   adiposity   (Fig.   1b).   In   a   pilot   cohort   that   also   included  
heterozygous  (+/-­  HET)  BTBR  mice,  only  MUT  animals  displayed  a  trend  for  increased  
body  weight  and  inguinal  scWAT  weight,  for  both  males  and  females  (Suppl.  Fig.  S1a).  
Thus,  HET  mice  were   not   included   in   subsequent   analyses.  Consistent  with   previous  
reporting,  neuropathy  was  detectable  in  BTBR  MUT  mice  around  12  weeks  of  age  via  a  
Von  Frey  mechanical  nociceptive  assay  (male  mice,  Fig.  1c;;  female  mice,  Suppl.  Fig.  1b).    
This  test  determines  tactile  sensitivity  in  the  skin  of  the  hind  paw,  as  an  indirect  measure  
of  small   fiber  peripheral  neuropathy.    These  data  revealed  that  male  mice  displayed  a  
stronger  phenotype  of  peripheral  neuropathy  of  extremities  (Fig.  1c  compared  to  Suppl.  
Fig.  1b),  consistent  with  previous  reports  28.  
The   pan-­neuronal   marker   protein   gene   product   9.5   (PGP9.5,   also   known   as  
ubiquitin  C-­terminal  hydrolase  L1  (UCHL-­1)),  was  also  greatly  reduced  in  inguinal  scWAT  
of  MUT  mice  (Fig.  1d;;  Suppl.  Fig.  S1c),  indicating  a  loss  of  total  nerve  supply.  BTBR  MUT  
mice  also  displayed  a  marked  reduction  in  sympathetic  activation  in  inguinal  scWAT  as  
evidenced  by  a  substantial  decrease  in  tyrosine  hydroxylase  (TH)  protein  levels  (Fig.  1e,  
Suppl.  Fig.  S1d).  TH  is  the  rate-­limiting  enzyme  in  catecholamine  biosynthesis,  including  
norepinephrine,  the  main  sympathetic  nerve  neurotransmitter  in  WAT,  and  an  indicator  of  
SNS   activation.   After   12   weeks   of   age,   the   loss   in   total   inguinal   scWAT   innervation  
remained  consistent  in  MUT  mice  (Fig.  1f),  but  TH  continued  to  decrease  in  MUT  mice  
aged  to  24  weeks  (Fig.  1g).  As  loss  of  synaptic  connections  is  another  important  factor  in  




postsynaptic  density  95   (PSD95),  and  observed  a   reduction   in  PSD95   in  12-­week-­old  
MUT  mice  when   compared   to  WT   (Fig.   1h).      PSD95   protein   levels   were   also   further  
decreased  in  24-­week-­old  MUT  animals  (Fig.  1h).    
Because   the   energy   expending   interscapular   brown   adipose   tissue   (iBAT)   is  
known  to  be  highly   innervated  29,30,  we  examined   iBAT   innervation   in   the  BTBR  mice.    
Protein  expression  of  PGP9.5  revealed  a  significant  decrease  in  total  innervation  of  iBAT  
in  BTBR  MUT  animals  when  compared  to  littermate  controls  (Fig.  1i).  These  finding  were  
concurrent  with  a  decrease  in  protein  expression  of  TH  in  the  iBAT  of  BTBR  MUT  mice  
indicating   decreased   sympathetic   activation   (Fig.   1j).   iBAT   gross   morphology   also  
revealed  a  marked  increase  in  lipid  accumulation,  also  called  “whitening”,   in  both  male  
and   female  mutant  BTBR  mice,   but  most  prominently   in  male  mice   that   exhibited   the  
stronger   neuropathy   phenotype   (Suppl.   Fig.   S1f).   For   BTBR   MUT   mice,   iBAT   gene  
expression   showed   a   significant   decrease   in   Ucp1,   whose   activation   by   the   SNS   is  
necessary   for   thermogenesis   to   occur,   along   with   reductions   in   the   brown   adipocyte  
markers  Cidea  and  Dio2,  despite  no  decrease  in  synaptic  markers  (Synapsin  I,  Synapsin  
II,  Synaptophysin,  Psd95),  or  other  indicators  of  nerve  health  such  as  the  Schwann  cell  
marker  Sox10  and  neurotrophic   factor  brain  derived  neurotrophic   factor   (Bdnf)   (Suppl.  
Fig.  S1g).  The  gene  expression  pattern  in  inguinal  scWAT  of  BTBR  MUT  was  opposite  of  
what  we  observed  in  iBAT  and  included  a  coordinated  trend  for  reduced  expression  of  
neural  markers  in  MUT  animals  (Suppl.  Fig.  S1h).    In  peri-­renal  (pr)  WAT,  another  WAT  
depot  that  readily  undergoes  browning,  the  gene  expression  pattern  was  similar  to  that  of  
iBAT  (Suppl.  Fig.  S1i),  which  is  perhaps  not  surprising  considering  the  higher  similarity  of  




differences  related  to  innervation,  and  suggest  that  different  mechanisms  may  be  involved  
in  maintaining  nerve  health  in  different  adipose  depots.  
To  determine  whether  peripheral  neuropathy  extended  beyond  adipose  in  BTBR  
MUT  mice,  we  examined  the  neuromuscular  junctions  (NMJ).  Immunofluorescent  staining  
of  NMJs  revealed  that  BTBR  MUT  mice  had  fewer  fully  occupied  NMJs  in  both  the  medial  
gastrocnemius   (MG)   and   soleus   (SOL)   muscles   when   compared   to   WT   littermates,  
accompanied  by  an  increase  in  partially  occupied  junctions  (Suppl.  Fig.  S2a-­b).  As  there  
was  no  difference  in  unoccupied  NMJs,  neurodegeneration  at  the  NMJ  may  be  a  slower  
neurodegenerative   process   with   obesity   and   diabetes   than   in   skin   and   underlying  
adipose.    
White  adipose  tissue  from  obese  humans  exhibits  neuropathy  
   Based   on   our   findings   in   the   BTBR   mouse   model   we   sought   to   determine   if  
neuropathy   exists   in   adipose   tissue   of   obese   humans.   We   investigated   degree   of  
innervation   in   human   scWAT   (and   omental   WAT)   obtained   from   individuals   who  
underwent   elective   surgery.   Protein   expression   of   the   pan-­neuronal   marker   PGP9.5  
revealed  a  decreasing  trend  with  increasing  BMI  in  human  scWAT  adipose  tissue  (Fig.  
1k),  despite  no  difference  in  adipocyte  diameter  (Suppl.  Fig.  S3a,  left  panel),  indicating  
that  adipose  neuropathy  also  exists  in  human  tissues.    Since  we  were  unable  to  obtain  
an   entire   WAT   depot   from   humans,   in   order   to   determine   if   innervation   status   was  
confounded  by  cell  size,  adipocyte  diameter  was  quantified  for  the  human  samples  and  
revealed  no  differences  that  may  confound  these  analyses.    In  addition,  for  all  innervation  




and  normalization  to  a  housekeeping  protein.    For  mouse,  entire  inguinal  scWAT  depots  
were  homogenized  to  analyze  the  total  level  of  innervation,  however,  this  was  not  possible  
for  human  samples  as  we  could  only  obtain  a  small  biopsy.  Therefore,  normalized  protein  
expression  was  plotted  against  average  cell  size  for  each  corresponding  sample,  which  
showed  no  correlation  (Suppl.  Fig.  S3b).  Interestingly,  post-­translational  modification  of  
PGP9.5  appears  to  be  restricted  to  scWAT  of  humans  (Fig.  1k-­l)  since  we  did  not  observe  
multiple  band  sizes  in  any  of  our  mouse  models.      
We  also  assessed  degree  of   innervation   in  human  omental  adipose  tissue,  and  
found   no   significant   difference   in   innervation   with   increasing   BMI   (Suppl.   Fig.   S3c),  
suggesting  that  adipose  neuropathy  may  be  restricted  to  scWAT  depots.    This  fits  with  
our  data   from  mouse  as  well.  However,  due  to   the   limited  number  of  omental  adipose  
samples   available,   along  with   the   narrow   range   in   BMI,   further   assessments  may   be  
warranted  to  confirm  this  observation.  Nevertheless,  these  data  show  that  human  adipose  
tissue  undergoes  neuropathy  with  obesity  similar  to  the  mouse  model.  
Aging  leads  to  white  adipose  tissue  neuropathy  in  humans  and  mice  
   Since  adiposity  increases  with  age  concordant  to  increased  risk  of  developing  type  
2  diabetes,  we  sought  to  determine   if   there   is  a   link  between  adipose  neuropathy  and  
aging.   When   investigating   the   relationship   between   adipose   innervation   and   age   in  
humans,  linear  regression  analysis  revealed  a  significant  decrease  in  protein  levels  of  the  
pan-­neuronal  marker  PGP9.5  with  increasing  age  in  inguinal  scWAT  (Fig.  1l)  despite  no  




expression  (Suppl.  Fig.  S3a-­b,  right  panels).    Again  this  finding  did  not  extend  to  omental  
WAT  (Suppl.  Fig.  S3d).    
To   further  explore   this   relationship,  we  employed  an  aged  mouse  model.  Male  
C57BL/6J  mice  were  aged  to  16  months,  and  the  state  of  their  adipose  innervation  was  
compared  to  young  mice  at  10-­12  weeks  old.  Protein  expression  of  PGP9.5  in  inguinal  
scWAT  was  decreased  in  16  month  old  aged  mice  when  compared  to  young  mice  at  10-­
12   weeks   of   age   (Fig.   2a),   together   with   a   trend   for   decreased   TH   levels   (Fig.   2b).  
Consistent  with  the  metabolic  consequences  of  aging,  total  body  mass  of  aged  mice  was  
significantly   greater   than   that   of   young   animals,   however,   there   was   no   significant  
difference  in  quadriceps  muscle  weight  or  adipose  depot  weight,  although  inguinal  scWAT  
and  perigonadal  (pg)WAT  depot  weight  did  display  a  trend  to  be  higher  at  this  age  (Suppl.  
Fig.  S4a).    
Since  a  state  of  chronic  inflammation  increases  tissue  dysfunction  and  is  known  to  
damage  nerves  33,  we  measured  levels  of  anti-­inflammatory  cytokines  which  are  involved  
in   inflammatory   resolution   34   in   young   and   aged   sedentary   mice.   A   non-­significant  
reduction  in  the  anti-­inflammatory  cytokines  Interleukin  13  (Il13),  Interleukin  4  (Il4),  but  
not   Interleukin   10   (Il10),   was   observed   in   the   16  month   old  mice  when   compared   to  
younger   mice   in   the   sedentary   state   (Fig.   2c),   suggesting   an   altered   inflammatory  
homeostasis  in  aged  adipose  tissue.  Gene  expression  for  presynaptic  proteins  (Synapsin  
I  and  II),  the  neurotrophic  factor  Bdnf,  which  supports  growth  and  survival  of  nerves,  as  
well  as  the  Schwann  cell  marker  Sox10,  showed  a  coordinated  trend  for  reduction  in  aged  




Considering   that   nerves   and   vasculature   are   often   linked,   we   measured   gene  
expression  of  vascular  markers  (Cd31,  Vegfa)   in  young  and  aged  sedentary  mice  and  
saw   no   difference   with   respect   to   age   (Fig.   2c).      We   took   advantage   of   vascular  
autofluorescence35   to   visualize   adipose   blood   vessels   in   combination   with  
immunofluorescent  staining  of  nerves  with  a  new  whole-­depot  3D  microscopy  technique  
developed   in  our   lab  (see  Supplemental  Methods  Section).  This   imaging  revealed   that  
aged  mice  exhibit  an  overall  decrease   in   innervation  with  a  striking   loss  of   innervation  
around  vasculature  within  their  inguinal  scWAT  (Fig.  2d).  In  young  mice,  autofluorescent  
blood   vessels   (red/orange)   are   clearly   shrouded   by   fine   PGP9.5-­expressing   nerves  
(green,  Fig.  2d,  left  panels),  but  by  16  months  of  age,  the  adipose  vasculature  shows  a  
striking  loss  of  this  neuronal  sheathing  (Fig.  2d,  right  panels).  Taken  together,  these  data  
reveal   that   loss   of   proper   adipose   innervation  may  precipitate   aging-­related  metabolic  
dysfunction.  
Exercise  attenuates  age-­related  adipose  neuropathy    
   Exercise  has  been  shown  to  increase  circulating  levels  of  the  nerve  survival  factor  
BDNF  36.    We  therefore  exposed  young  and  aged  mice  to  voluntary  wheel  running  for  7  
days  and  assessed  the  status  of  their  adipose  innervation.  Two-­way  ANOVA  analysis  of  
gene  expression  revealed  an  interaction  of  exercise  and  age  only  for  Synaptophysin,  with  
exercise  (p<0.0001)  having  a  stronger  effect  than  age  (p=0.0213)  (Fig.  2c).    Exercise  had  
an  overall  effect  on  the  expression  of  Bdnf  (p=0.0008),  Synapsin  II  (p=0.0008),  and  Psd95  
(p=0.0003)   in  axillary  scWAT,  and  resulted   in   increased  expression   in  both  young  and  
aged  animals,  suggesting  an  improvement  in  innervation  (Fig.  2c).  This  occurred  despite  




(Suppl.  Fig.  S4a).  No  difference  in  anti-­inflammatory  cytokines  Il4,  and  Il13  was  seen  after  
exercise   in   either   young   or   aged   animals   (Fig.   2c).   Exercise   also   increased   gene  
expression  of  vasculature  markers  Cd31  and  Vegfa,  but  only  in  young  animals  (Fig.  2c),  
indicating  that  physical  activity  can  increase  both  vascular  and  nerve  supply  to  adipose,  
but  perhaps  is  blunted  with  advancing  age.    
Protein  levels  of  both  PGP9.5  and  TH  in  inguinal  scWAT  of  young  exercised  mice  
were   significantly   increased   when   compared   to   young   sedentary   mice   (Fig.   3a-­b),  
indicating   that  neurite   outgrowth   has   likely   taken  place,   as  well   as   sympathetic   nerve  
activation.  Exercise  also  resulted  in  a  trend  for  increased  protein  expression  of  PGP9.5  
and   TH   in   aged   animals   (Fig.   3c-­d),   although   this   did   not   reach   significance,   further  
supporting   a   blunted   effect   with   age.   Direct   comparison   of   the   effect   of   exercise   on  
inguinal   scWAT   innervation   of   young   versus   aged   animals   revealed   no   significant  
difference   in  response  based  on  age,  as  both  young  and  aged  mice  showed  relatively  
similar  levels  of  PGP9.5  and  TH  expression  (Suppl.  Fig.  S4b-­c).  The  effects  of  exercise  
on  adipose  tissue  did  not  extend  to  BAT.  Protein  expression  of  PGP9.5,  TH,  and  PSD95  
in  BAT  did  not  differ  between  young  sedentary  and  exercised  groups  (Suppl.  Fig.  S4d-­f),  
nor  did  gene  expression  of  nerve  and  synaptic  markers  (Suppl.  Fig.  S4g).    
Exercise  did  not  appear  to  have  a  specific  effect  on  the  vasculature  innervation,  
but  the  levels  of  PGP9.5  around  vasculature  had  high  intra-­individual  variability  (Fig.  3e).  
To  further  probe  the  effects  of  exercise  on  vascular  innervation,  a  separate  cohort  with  
only  young  animals  was  subjected   to  7  days  of  voluntary  wheel   running  as  described  
above.  As  observed  previously  (Suppl.  Fig.  S4a),  there  was  no  change  observed  in  body  




Consistent  with  other  reports  37,38  there  was  also  no  difference  in  skeletal  muscle  mass  
for  either  sedentary  or  exercised  animals  after  1  week  of  voluntary  wheel  running  (Suppl.  
Fig.  S5a).  There  was  a   trend   for   increased  protein   expression  of   the   synaptic  marker  
PSD95  in  axillary  scWAT  (Suppl.  Fig.  S5b),  consistent  with  the  previously  observed  (Fig.  
2c)  increased  gene  expression  of  Psd95  in  this  depot  in  response  to  exercise.  Although  
gene  expression  of  innervation  markers  in  inguinal  scWAT  was  not  as  pronounced  as  in  
the  axillary  depot  (Fig.  2c),  there  was  an  increased  trend  for  Schwann  cell  marker  Sox10,  
neurotrophic  factor  Bdnf,  and  post-­synaptic  marker  Psd95  (Suppl.  Fig.  S5c).  Innervation  
of   blood   vessels   was   assessed   by   immunostaining   of   PGP9.5   was   combined   with  
isolectin   staining   of   vasculature   in   inguinal   scWAT.   Innervation   of   blood   vessels   that  
measured  50  µm  or  more  in  diameter  was  evaluated  (Suppl.  Fig.  S5d-­e).  We  found  no  
difference  in  either  percentage  of  blood  vessels  innervated  (Suppl.  Fig.  S5a,  left  panel)  
or  number  of  nerves  per  blood  vessel  (Suppl.  Fig.  S5a,  right  panel),  between  sedentary  
and  exercised  groups.    
In  order  to  determine  changes  to  sensory  nerves  innervating  WAT,  we  assessed  
gene  expression  in  the  T13-­L1  dorsal  root  ganglion  (DRG),  which  is  known  to  innervate  
inguinal  scWAT39,40  (Fig.  3f).  The  following  neuropeptides  were  measured  with  or  without  
exercise   intervention:   calcitonin   gene-­related   peptide   (CGRP),   neuropeptide   Y   (NPY),  
pituitary   adenylate   cyclase-­activating   polypeptide   (PACAP),   pro-­opiomelanocortin  
(POMC),  proenkephalin  (PENK),  substance  p  (Tac1),  and  vasoactive  intestinal  peptide  
(Vip).  We  found  that  mRNA  expression  of  Npy  was  decreased  in  exercised  mice  (Fig.  3f).  
The   effect   of   exercise   on  Cgrp   expression  was   highly   variable,   but   linear   regression  




performed  (Fig.  3g),  which  fits  with  reports  of   increased  Cgrp  expression  in  neurons  of  
the  T13/L1  ganglia  upon  inguinal  scWAT  cold  induced  ‘browning’  40.      
Adipose  tissue  undergoes  remodeling  with  cold  exposure  
In  addition  to  exercise  as  a  means  to  promote  adipose  tissue  neural  plasticity,  cold  
exposure  has  been  demonstrated  to  increase  TH+  nerve  fibers  in  murine  adipose  tissue.  
31,41   Similarly,   we   also   found   that   cold   stimulation   also   increased   adipose   tissue  
innervation,   as   protein   levels   of   PGP9.5  went   up   in   scWAT   after   only   3   days   of   cold  
exposure  compared  to  tissues  from  mice  housed  at  room  temperature  or  thermoneutrality  
(Fig.   4a).      To   examine   the   adipose   nerve   network   under   this   innervation   promoting  
condition,  adult  mice  maintained  at  room  temperature  (RT)  were  compared  to  littermates  
that  were  either  cold  exposed  for  10  days  or  cold  exposed  for  10  days  and  rewarmed  for  
1  week.  Inguinal  scWAT  depots  were  immunostained  with  the  pan-­neuronal  marker  β-­3-­
tubulin.    At  room  temperature,  a  diffuse  pattern  of  innervation  can  be  discerned  (Fig.  4b,  
left  panel),  with  larger  nerve  bundles  converging  around  the  subiliac  lymph  node  (white  
arrow),  similar  to  the  staining  pattern  we  observed  with  the  other  pan-­neuronal  marker,  
PGP9.5.  The  posterior  end  (right  of  subiliac  lymph  node  in  image)  of  the  tissue  did  not  
appear  to  have  as  much  innervation  as  the  anterior  portion  (left  of  subiliac  lymph  node  in  
image)  or  as  the  area  surrounding  the  subiliac  lymph  node.    
After   cold   exposure,   a   distinct   change   in   the   neural   arborization   pattern   was  
observed  (Fig.  4b,  middle  panel),  particularly  an  increase  in  intensity  around  the  lymph  
node.  Since   these  2D   representations  of  3D  data  do  not  convey  accurate  changes   in  




as  total  axon  length  normalized  to  tissue  weight)  and  this  revealed  a  trend  for  increased  
innervation  density   in   the  10  day  cold  exposed  group  compared   to  RT  and   rewarmed  
groups  (Fig.  4b,  right  panel).  However,  taking  an  average  of  the  entire  tissue  (as  we  did  
in  Fig.  4b  quantifications)  blunts  regional  anatomical  differences  in  innervation  density,  
which  we  can  observe  when  qualitatively  assessing  the  tissues.    This  can  also  be  seen  
when   looking   at   the   2D   representations   in   Fig.   4b,   where   the   anterior   and   posterior  
portions  display  differences  in  innervation  status  after  cold.      
Of  note,  average  innervation  density  per  inguinal  scWAT  depot  totaled  up  to  25  
meters  per  tissue  depot,  underscoring  the  great  density  of  nerve  fibers  contained  in  WAT  
depots.   Furthermore,   the   inguinal   scWAT  depot   can  be   considered   to   have  3   distinct  
anatomical  regions,  as  illustrated  in  Fig.  4c.  Region  1  is  the  anterior  side  of  the  depot  and  
contains  major  branches  of  the  thoracoepigastric  vein  (TEV)  (Fig.  4c,  blue  lines/arrows);;  
the   subiliac   drainage   lymph   node,   often   used   as   an   orientation   landmark   in   inguinal  
scWAT,  is  located  in  Region  2,  as  is  the  superficial  caudal  epigastric  artery  (SCEA,  red  
lines/arrow);;  Region  3  is  the  posterior  end  of  the  tissue  with  smaller  vasculature  including  
branches  of  the  common  iliac  vein.  From  the  anterior  to  the  posterior  side  of  the  tissue  
and   travelling   through   the  subiliac   lymph  node   is  a   large  branching  network  of  nerves  
which  we  have  called  the  subiliac  transverse  nerves  (SiTN)  (Fig.  4c,  green  lines/arrows).  
These   nerves   were   present   in   the   inguinal   scWAT   regardless   of   age,   exercise  
intervention,   or   cold   exposure,   and   travelled   in   parallel   to   the  main   vasculature   in   the  
depot.  It  is  important  to  note  that  these  subiliac  transverse  nerves  are  not  the  only  nerves  
found  within  the  inguinal  adipose  depot.  Similar  to  previous  observations  in  BAT42-­44  and  




been  observed  running  along  vasculature,  extending  throughout  the  parenchymal  space  
and   wrapping   around   individual   adipocytes,   and   sympathetic   nerve   synapsing   on  
adipocytes  has  been  recently  proposed  as  the  means  of  leptin  driven  lipolysis  in  scWAT15  
In   separate   experiments,   we  mimicked   cold   exposure   by   delivering   the   beta-­3  
adrenergic  agonist  CL  316,243  (‘CL’)  to  wild  type  mice,  and  measured  secretion  of  the  
neurotrophic   factor   BDNF   from   scWAT   tissue   explants.      This   approach   revealed   a  
significant   increase   in   BDNF   secretion   after   10-­14   days   of   CL   treatments   (Fig.   4d),  
supporting  the  notion  that  cold  stimulation  increases  BDNF  secretion  from  adipose,  while  
neuropathic  states  reduce  BDNF  expression  in  adipose.  Increased  hypothalamic  BDNF  
expression  was  previously  shown  to  affect  energy  expenditure  by  increasing  sympathetic  
drive  to  scWAT,  inducing  browning  of  the  depot  and  decreasing  depot  mass45.      To  test  
whether   BDNF   was   capable   of   promoting   these   effects   directly   in   the   periphery   by  
increasing  scWAT  innervation,  we  used  adeno-­associated  virus  (AAV)  to  deliver  BDNF  
directly  to  the  inguinal  scWAT  of  BTBR  MUT  male  mice  at  16  weeks  of  age,  when  adipose  
neuropathy   is  prominent.  The  AS/Rec2  dual  cassette  vector  used  to  deliver   the  BDNF  
transgene,  transduces  adipose  tissue  efficiently  while  restricting  off-­target  transduction  in  
liver46.     Animals   received  a   bolus   injection   of   1x1010  vg   of  AAV-­BDNF   in   one   inguinal  
scWAT  depot  and  a  vehicle  injection  in  the  other  inguinal  scWAT.  After  two  weeks,  protein  
expression   of   PGP9.5   was   significantly   increased   in   the   fat   pads   that   received   virus  
compared   to   the   vehicle   treated   depots   (Fig.   4e).   No   difference   was   seen   in   protein  
expression  of  TH  or  PSD95   following  AAV-­BDNF   treatment   (Suppl.  Fig.  6a-­b)   for   this  
dose  and  duration.    Taken  together,  these  data  suggest  a  role  for  BDNF  in  promoting  total  




Extent  of  adipose  innervation  is  depot,  but  not  sex,  specific  
   To   determine  whether   a   difference   in   adipose   innervation   between  depots   and  
sexes  exists   in  healthy  animals,  16  week  old  male  and  female  control  mice  were  cold  
exposed   for   3   days.   No   difference   between   sexes   was   observed   for   sympathetic  
activation  (TH)  or  synapses  (PSD95)   in   inguinal  scWAT  and   iBAT  (Suppl.  Fig.  S7a-­b),  
however,  both  TH  and  PSD95  protein  expression  were  much  greater  in  iBAT  than  inguinal  
scWAT.  Similarly,  protein  expression  of  PGP9.5  and  TH  in  axillary  and  inguinal  scWAT  
depots   was   comparable   between   sexes   (Suppl.   Fig.   S7c-­d).   However,   while   PGP9.5  
expression   remained   the  same  between   the  depots   (Suppl.  Fig.  S7c),  axillary  scWAT  
exhibited  significantly  more  protein  expression  of  TH  than  inguinal  scWAT  (Suppl.  Fig.  
S7d),   which   correlates   to   the   ‘browning’   potential   of   this   particular   WAT   depot   in  
comparison  to  inguinal  WAT.31    
   Since  we  had  seen  decreases  in  BDNF  in  both  obesity  and  age-­related  inguinal  
scWAT   neuropathy   (Fig.   2c,   Suppl.   Fig.   S1h),   an   increase   in   BDNF   in   response   to  
noradrenergic  stimulation  (Fig.  4d),  and  observed  the  ability  of  BDNF  to   increase  total  
innervation  as  evidenced  by  AAV-­BDNF  delivery  to  inguinal  scWAT  (Fig.  4e),  we  decided  
to  investigate  whether  there  were  sex  differences  in  BDNF  expression  in  inguinal  scWAT.  
After   a   3-­day   cold   exposure,   adult   (16  weeks  old)   female  mice   (C57BL/6J)   showed  a  
much  greater  level  of  BDNF  expression  in  inguinal  scWAT  than  male  mice,  as  measured  
by   multiplex   ELISA   (Suppl.   Fig.   S7e).   This   fits   with   the   apparent   protection   from  
neuropathy  in  female  BTBR  ob/ob  mice  (Suppl.  Fig.  S1b  and  28),  despite  females  having  




that   females   have   more   adipose-­secreted   BDNF   that   maintains   nerve   integrity   in  
neuropathic  conditions.    
  
Discussion  
Our   data   have   demonstrated   that   under   certain   pathophysiological   conditions,  
including  aging,  obesity  and  diabetes,  WAT  from  humans  and  mice  does  not  maintain  
proper   innervation   and   undergoes   a   process   of   nerve   death   that   we   call   ‘adipose  
neuropathy.’   While   the   exact   neuropathy   phenotypes   differed   slightly   between   these  
metabolic  conditions,  the  underlying  theme  was  decreased  adipose  tissue  health.    In  all  
cases,  the  neuropathy  was  accompanied  by  a  loss  of  synaptic  markers  and  a  reduction  
in  the  local  expression  of  the  neurotrophic  and  nerve  survival  factor  BDNF.    These  new  
findings  have  implications  for  the  treatment  of  metabolic  diseases,  in  that  re-­innervating  
adipose   tissue   may   be   required   to   properly   regain   metabolic   control.   Therapeutic  
interventions  that  act  to  support  neurite  outgrowth  and  synapse  formation  on  adipocytes  
and  stromovascular  cells  may  assist  with  the  efficacy  of  glucose-­lowering  drugs  or  diet  
and  exercise  interventions.    In  this  study,  we  have  found  a  promising  novel  treatment  by  
locally  delivering  scWAT  with  AAV-­BDNF,  which  appeared  to  succeed  in  re-­innervating  
the   tissues   of   diabetic   mice.      How   this   increase   in   innervation   improves   metabolic  
parameters  in  obesity  is  the  focus  of  ongoing  research.    
Interestingly,   while   diet   and   exercise   are   often   prescribed   in   concert,   despite  
exercise  not  being  a  very  effective  means  to  reduce  appetite,  the  myriad  health  benefits  




mediating  increased  peripheral  nerve  plasticity,  including  in  adipose  depots,  as  we  have  
demonstrated   here.      Furthermore,   we   have   also   demonstrated   that   cold   exposure  
similarly   boosts   peripheral   nerve   plasticity   in   adipose,   and  may   also   be  a   strategy   to  
enhance   diet   and   exercise-­based  weight   loss   interventions,   and   help   prevent   obesity  
related  adipose  tissue  neuropathy.  
We  have  demonstrated  that  both  mouse  and  human  scWAT  undergo  neuropathy  
with   aging   and   diabetes/obesity,   and   these   data   provide   evidence   that   peripheral  
neuropathy   is   not   restricted   to   classical   tissues   such   as   epidermis   and   distal   limbs.  
Adipose  tissue  nerves  are  known  to  be  essential  for  energy-­expending  processes  such  
as   lipolysis   and   thermogenesis,   and   loss   of   a   proper   nerve   supply   can   have   serious  
detrimental   effects   on   metabolic   control,   which   may   exacerbate   or   initiate   an   insulin  
resistant   state.   Additionally,   as   recently   demonstrated,   leptin   stimulated   lipolysis   is  
mediated  at   least   in  part  by  sympathetic   innervation  of  scWAT,15   further  underscoring  
how  adipose  neuropathy  can  contribute  to  metabolic  dysfunction  through  obesity-­induced  
leptin  resistance.    
In   all   pathophysiological   states   we   studied,   lack   of   adipose   innervation   was  
associated  with  one  or  more  of  the  following:  an  increase  in  adipose  depot  size,  loss  of  
proper  adipose   tissue   function  and  metabolic  control,  or  altered  cytokine   inflammatory  
markers.   These   changes   in   WAT   may   be   due   to   loss   of   synapses   on   adipocytes  
themselves,  or  on  stromovascular  cells  resident  in  WAT,  including  the  macrophages  and  
other  immune  cells  that  are  important  for  proper  tissue  function.    Indeed,  macrophages  
are   known   to   express   adrenergic   receptors47,   and   may   also   become   denervated  




the  obese  and  diabetic  BTBR  ob/ob  mice,  which  displayed  additional   lack  of  synaptic  
integrity  in  the  neuromuscular  junction  and  BAT,  as  well  as  in  skin  and  underlying  adipose.    
In   the  aged  mouse  model,  most  striking  was  the   loss  of   innervation  around  the  
vasculature  of  WAT,  without  any  apparent  deficits   to   the  vasculature  morphology  or   to  
vascular  markers  such  as  CD31  and  VEGFa  (at  least  at  the  mRNA  level).  However,  these  
markers  cannot  attest  to  the  functionality  of  adipose  vasculature,  which  was  not  assessed  
here.    Aging  is  known  to  cause  alterations  in  the  structure  and  function  of  vasculature48  
and   leads   to   decreased  basal   limb  blood   flow49,  which  may   result   from   loss   of   nerve  
supply   to   the  blood  vessels,  but   to  our  knowledge   this  has  not  yet  been   investigated.  
Exercise   was   able   to   at   least   partially   restore   the   innervation   around   the   adipose  
vasculature  in  the  aged  mice.  Thus,  exercise  may  be  important  for  prevention  of  aging-­
related  diabetes  by  maintaining  adipose  innervation  and  metabolic  health,  similarly  to  how  
exercise  induces  neural  plasticity  in  the  brain50.  
Beyond  vasoregulation,   it   is  still  unclear  exactly  how  nerves  and  blood  vessels  
interact   and   whether   their   plasticity   is   functionally   linked,   and   this   warrants   further  
investigation.   Vasculature   within   the   adipose   tissue   promotes   metabolic   health   by  
preventing  adipose  tissue  hypoxia  and  subsequent  inflammation,  and  provides  endocrine  
communication  between  adipose   tissue  and  the   rest  of   the  body.  Nerves  also   rely  on  
vasculature  for  sustained  health,  since  they  become  damaged  in  a  hypoxic  state,  while  
vasculature  relies  on  innervation  for  constriction  and  vasodilation  of  blood  vessels.  Since  
nerves,  such  as  those  in  the  sympathetic  nervous  system,  regulate  vascular  control  (ie:  
vasoconstriction)  and  may  also  be   involved   in  angiogenesis,  adipose  neuropathy  may  




may   lead   to  adipose  hypoxia  due  to   lack  of  proper  vascular  supply51.  The  association  
here  could  also  go  in  the  other  direction,  with  circulating  factors  affecting  nerve  supply  (ie:  
glucose,  lipids,  hormones)  –  but  these  hypotheses  require  closer  investigation.    
Synaptic  markers  and  the  neurotrophic  factor  BDNF  were  reduced  with  adipose  
neuropathy,  fitting  with  the  loss  of  pan-­neuronal  protein  expression  in  neuropathic  WAT  
depots.  Neurotrophic  factors,  such  as  BDNF,  are  important  mediators  of  neural  plasticity,  
essential   for   nerve   survival   and   growth,   neurite   outgrowth   and   branching,   and  
synaptogenesis.   Loss   of   neurotrophic   signaling   can   prompt   neurite   retraction,   axonal  
degeneration,  and  nerve  death.  It  is  well  known  that  exercise  often  leads  to  an  increase  
of  BDNF  in  the  brain  52,53  and  in  the  peripheral  circulation,36  and  that  this  improves  health  
outcomes  in  patients  with  neurodegenerative  diseases  such  as  Parkinson’s  54.  It  has  been  
shown  that  BDNF  is  expressed  in  adipose  tissue,  but  it’s  role  there  is  vastly  understudied  
55.  Nerve  growth  factor  (NGF)  has  also  been  reported  as  a  neurotrophic  factor  expressed  
in  adipose  tissue56  but  until  recently  its  role  in  adipose  tissue  had  been  unclear.  Cao  et  
al.  recently  argued  that  cold  induced  synaptic  plasticity  in  scWAT  is  dependent  on  adipose  
derived  NGF.17  Other   neurotrophic   factors   are   expressed   in   adipose   depots   but   their  
functional  significance  is  not  currently  known.    Here  we  present  a  case  for  a  potential  role  
of  BDNF  in  maintaining  WAT  peripheral  nerve  innervation.  This  idea  is  strengthened  by  
the   efficacy   of   AAV-­BDNF   treatments   to   scWAT   and   the   striking   increase   in   adipose  
BDNF  in  response  to  exercise,  a  known  neurogenic  intervention  in  the  brain  as  well50.  
We  and  well  as  others17,31,41  have  shown  that  noradrenergic  stimulation  via  cold  
exposure   increased   nerve   density   in   scWAT.   Previously   reported   increases   in  




areas   of   increased   browning   within   the   adipose   tissue.31,41   Catecholamines   elicit  
differential  effects  when  signaling  through  α-­  or  β-­adrenergic  receptors  (AR)  in  adipose.  
ARs  belong  to  the  family  of  G-­protein  coupled  receptors  (GPCRs);;  the  five  ARs  active  in  
white  and  brown  adipose  are  α-­1  AR  (ADRA1),  α-­2  AR  (ADRA2),  and  β1-­,  β-­2,  β-­3,  AR  
(ADRB1/2/3)57.  ADRB3  is  the  predominate  βAR  present  in  rodent  adipose,  through  which  
sympathetic   nerve   released   neurotransmitter,   NE   acts.58      βAR   mediated   signaling  
activates   lipolysis   through   stimulating   activity   of   adenylyl   cyclase,   thus   increasing  
intracellular   cyclic   adenosine  monophosphate   (cAMP),  which   in   turn   stimulates   cAMP  
dependent   protein   kinase   activity   that   activates   hormone   sensitive   lipase   (HSL)   by  
phosphorylation.      By   contrast,   ADRA2  mediated   signaling   promotes   adenylyl   cyclase  
inhibition  leading  to  antilipolytic  effects58.    
Although  catecholamines  have  a  higher  affinity  for  αARs  than  βARs,  physiological  
effects   of   catecholamine   signaling   through   ARs   is   largely   determined   by   receptor  
abundance57   which   varies   between   adipose   depots59.   Catecholamine   residence   in  
peripheral   tissues   has   been   observed   under   certain   disease   states,   although   the  
mechanisms  behind   its  occurrence  have  not   been   fully   understood.   In   obese  adipose  
tissue  lipolytic  catecholamine  resistance  has  been  associated  with  a  decrease  in  βARs  in  
adipose  of  human  females,60  and  has  been  attributed  to  decreased  expression  of  βARs  
on  fat  cells,61,62  as  well  as  increased  sensitivity  to  ADRA2  signaling63.  There  may  be  a  
similarity   between   lipolytic   catecholamine   resistance   and   insulin   or   leptin   resistance,  
where  receptors  are  no  longer  properly  transducing  the  ligand  signals.    
A   recently   discovered   subset   of  macrophages  present   in   scWAT   interacts  with  




macrophages  or  “SAMs”  increase  in  abundance  in  obesity64  and  their  increased  activity  
of  NE  degradation  can  be  seen  as  a  type  of  AR  ligand  sequestration,  possibly  contributing  
to   lipolytic  catecholamine  resistance   in  obesity.  NE  degrading  macrophages  have  also  
been  reported  to  increase  in  aging,65  and  aging  is  associated  with  decreased  lipolysis  in  
adipose   tissue.   These   reports,   combined   with   our   findings   presented   here,   all   likely  
contribute   to   reduced   lipolysis   under   the   obese   state.   It   is   unknown   whether   loss   of  
innervation  leads  to  decreased  βARs  in  increased  NE  degrading  macrophages  in  adipose  
tissue,  or  visa  verse,  and  this  requires  further  investigation.  However,  lipolysis  can  also  
be  affected  by  non-­adrenergic  signaling  as  recently  reviewed66  and  should  be  considered.  
Purinergic   (via   adenosine   and   ATP)   signaling   in   adipose   produces   similarly   diverse  
effects   as  NE   signaling   and   is   dependent   on   specific   receptor   activation.      Adenosine  
appears   to  be  a  negative  modulator  of   lipolysis   in  WAT,  yet  has  pro-­lipolytic  activity   in  
BAT.66     Other  neurotransmitters  and  neuropeptides  are  expressed   in  adipose   tissues,  
such  as,  NPY,  Substance  P,  CGRP  and  others51.      It   is  currently  unknown  what  role,   if  
any,  these  play  in  lipolysis.  
Finally,   we   have   revealed   that   iBAT   and   scWAT   differ   in   their   patterns   of  
innervation  and  response  to  neuropathic  stimuli,  and  that  male  and  female  mice  differ  in  
scWAT  innervation  with  a  blunted  response  to  neuropathy  and  higher   levels  of  BDNF.  
Using  a  new   technique   for  whole-­depot   imaging  of  adipose   innervation,  we  have  also  
revealed  a  consistent  pattern  of  nerves   in   inguinal  WAT  (traversing   the  subiliac   lymph  
node),  which  changes  regionally  in  response  to  cold  stimulation.  
Taken  together,  we  have  demonstrated  for  the  first  time  that  adipose  tissue  nerves  




neural  plasticity  in  response  to  exercise  or  cold  exposure.    We  have  also  identified  BDNF  
as  a  locally  produced  peripheral  nerve  survival  factor  in  WAT,  which  can  therapeutically  
improve  adipose  neuropathy  of  diabetes.    Changes  in  adipose  innervation  status  were  
correlated   with   altered   metabolic   control   and   underscore   the   importance   of   adipose  
nerves  for  proper  metabolic  health.    
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Figure  1.  Obesity  and  diabetes  led  to  white  adipose  tissue  neuropathy.  The  BTBR  
ob/ob  (MUT)  model  of  obesity  and  diabetes  was  compared  to  BTBR  +/+  wild-­type  (WT)  
for  body  weight  measurements  (a),  and  adiposity  (b).  Body  and  tissue  weight  data  were  
analyzed   by   two-­tailed   Student’s   T-­Test.   Von   Frey   tactile   allodynia   analysis   was  
performed  on  MUT  and  WT  animals  to  determine  onset  of  peripheral  neuropathy  (c).  Von  
Frey  data  was  analyzed  by  ANOVA  with  Sidak’s  post  hoc  test.  For  (a-­c),  all  males;;  WT  
N=8,  12-­20  weeks  old;;  MUT  N=6,  12-­24  weeks  old.    Protein  levels  of  PGP9.5  (d),  as  well  
as  TH  (e)  in  inguinal  scWAT  of  the  MUT  and  WT  mice  were  measured  by  western  blotting.  
For  (e),  lane  5  was  excluded  from  analyses  due  to  uneven  resolution  of  housekeeper.  For  
(d-­e),   all  males;;  WT  N=5,   12-­20  weeks   old   and  MUT  N=4,   12-­20  weeks   old.   Protein  
expression  of  PGP9.5  (f),  TH  (g)  and  PSD95  (h)  in  inguinal  scWAT  of  12-­25  weeks  old  
WT,  12  week  old  MUT  and  24-­28  week  old  MUT  was  measured  by  western  blotting.  All  
males,  N=3  per  group.  Protein  expression  of  PGP9.5  (i)  and  TH  (j)  in  iBAT  was  measured  
in  MUT  mice  and  compared  to  WT  littermate  controls;;  for  (i-­j)  all  12  week  old  males,  N=3  
WT/MUT.  For  all  western  blots,  data  were  normalized  to  housekeeper  proteins  b-­tubulin  
or  cyclophilin  B,  band  intensities  were  quantified  in  Image  J,  and  analyzed  using  a  two-­
tailed  Student’s  T-­Test.  Error  bars  are  SEMs.   In  human  scWAT,  protein   levels  of  pan-­
neuronal  marker  PGP9.5  were  measured  by  western  blotting;;  linear  regression  analysis  
was  performed  for  assessment  of  normalized  protein  levels  compared  to  body  mass  index  
(BMI)  (k)  or  age  (25-­38  years  old)  (l).  For  (k-­l)  N=9  BMI  cohort,  N=9  Age  cohort.  For  (k-­l)  
*   indicates   individuals  with  diagnosed  diabetes.     The  majority  of  human  samples  were  
females,  see  Suppl.  Table  S1-­S3  for  clinical  details.  Western  blot  data  were  normalized  
to  b-­actin,  band  intensity  were  quantified  in  Image  J,  and  analyzed  by  two-­tailed  Student’s  
T-­Test.    Error  bars  are  SEMs,  *p  <  0.05,  **p  <  0.01,  ***p  <  0.001,  ****p  <  0.0001.    
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Figure  2.  Aging  is  associated  with  adipose  tissue  neuropathy.  In  young  (10-­12  weeks  
old)  and  aged  (16  months  old)  sedentary  male  C57BL/6J  mice,  western  blotting  was  used  
to  measure   protein   expression   of   PGP9.5   in   inguinal   scWAT   for   assessment   of   total  
innervation   (a),   while   TH   was   used   to   measure   sympathetic   activation   (b).   Protein  
expression  was  normalized  to  either  b-­actin  or  cycophilin  b,  band  intensity  was  quantified  
in  Image  J  and  analyzed  by  two-­tailed  Student’s  T-­Test;;  N=4  for  young  and  aged  groups.  
Gene  expression  of  anti-­inflammatory  markers  Il4  and  Il13,  Il10,  neurotrophic  factor  Bdnf,  
synaptic  markers  (Synapsin  I  and  II,  Synaptophysin,  Psd95),  as  well  as  vascular  markers  
(Cd31,  Vegfa)  was  measured  by  qPCR  in  axillary  scWAT  of  young  and  aged  mice  (c).  
For  young  and  aged  sedentary  animals  N=4,  for  young  and  aged  exercised  (run)  mice,  
N=5   per   group.      Gene   expression   data   expressed   as   fold   change   normalized   to   the  
housekeeping   gene  Cyclophilin,   was   analyzed   by   two-­way   ANOVA,  with  Uncorrected  
Fisher’s  LSD  post  hoc  test,  and  significance  denoted  with  *  for  young  sedentary  versus  
aged  sedentary;;  #   for  aged  sedentary  versus  aged   run;;  ¥   for  young  sedentary  versus  
young  run;;  and  $  for  young  run  versus  aged  run.  Whole  depot  immunofluorescent  imaging  
of   inguinal  scWAT  from  sedentary  animals   for   total   innervation  (PGP9.5   in  green)  and  
vasculature  (red/orange;;  autofluorescence)  was  performed  (d).  Images  captured  at  10x  
and  are  representative  of  N=4  mice  analyzed  per  group.  Error  bars  are  SEMs,  *p  <  0.05,  
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Figure  3.  Exercise   increases  adipose   innervation   in   young  mice  and  attenuated  
loss   of   age-­related   adipose   innervation.      Young   (10-­12   weeks   old)   and   aged   (16  
months  old)  male  C57BL/6J  mice  were  placed   in  running-­wheel  cages   for  7  days  with  
continuous   access   to   a   running   wheel   (run).   To   assess   exercise   effects   on   adipose  
innervation   in   young   mice,   protein   expression   in   inguinal   scWAT   was   measured   by  
western  blotting  with  PGP9.5  as  a  marker  of  total  innervation  (a),  and  TH  as  an  indicator  
of  sympathetic  activation   (b).  Protein  expression  was  normalized   to  either  b-­tubulin  or  
cyclophilin   b,   band   intensity   was   quantified   in   Image   J   and   analyzed   by   two-­tailed  
Student’s   T-­Test;;   N=4   for   young   sedentary   and   N=5-­6   for   exercised   groups.   Protein  
expression  of  PGP9.5  (c)  and  TH  (d)  in  inguinal  scWAT  of  aged  sedentary  and  exercised  
mice  was  also  determined  by  western  blotting.  Protein  expression  was  normalized  to  b-­
Actin,  band  intensity  was  quantified  in  Image  J  and  analyzed  by  two-­tailed  Student’s  T-­
Test;;   N=4   for   aged   sedentary   animals,   N=5   for   aged  exercised   (run)   animals.  Whole  
depot  nerve  and  vasculature  imaging  of  inguinal  scWAT  from  exercise  (run)  animals  was  
performed  by   combining   immunostaining   for  PGP9.5   (green)  with   autofluorescence  of  
vasculature  (red/orange);;  images  were  captured  at  10x  (e).  Images  are  representative  of  
N=5   mice   analyzed   per   group.   Young   (12-­15   weeks   old)   male   C57BL/6J  mice   were  
placed  in  running-­wheel  cages  for  7  days  with  continuous  access  to  a  running  wheel  (run),  
control  (sed)  animals  were  placed  in  cages  with  a  locked  running  wheel.  Gene  expression  
of  neuropeptides  in  the  T13-­L1  DRGs  was  measured  by  qPCR,  expressed  as  fold  change  
normalized  to  the  housekeeping  gene  Cyclophilin,  and  analyzed  by  Student’s  T-­test  (f).  
Linear   regression  analysis  was  performed   for  Cgrp   to  assess   the  effect  of   running  on  
changes  in  gene  expression  (g).  Error  bars  are  SEMs,  *p  <  0.05,  **p  <  0.01,  ***p  <  0.001,  
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Figure  4.  Cold  exposure  induces  adipose  nerve  remodeling.  
Adult   (8  week  old)  wild-­type  C57BL/6J  male  mice  were   either   cold   exposed   (at   5°C),  
maintained  at  room  temperature,  or  at  thermoneutrality  (30°C)  for  3  days.    Changes  in  
innervation  were  assessed  by  measuring  protein  expression  of  a  pan-­neuronal  marker  
(PGP9.5)  in  inguinal  scWAT  via  western  blotting  (a).  Protein  expression  was  normalized  
to  b-­actin,  band  intensity  was  quantified  in  Image  J  and  analyzed  by  two-­tailed  Student’s  
T-­Test;;  N=4  per  group.  In  a  separate  experiment,  adult   (18-­22  week  old)  male  control  
male  mice  on  a  mixed  genetic  background  were  maintained  either  at  room  temperature  
(RT),   at   5°C   for   10   days,   or   at   5°C   for   10   days   and   then   returned   to  RT   for   1  week  
(rewarmed).  Entire  depots  were  immunostained  with  β3-­Tubuilin  and  imaged  on  a  Leica  
TCS  SP8  or  DMI6000  confocal  microscope  by  tiling  z-­stacks  through  the  entire  depth  of  
tissue   (b).   For   quantification   of   arborization   (b,   right   panel),   tiles   were   individually   Z-­
projected,   background   subtracted,   thresholded   into   binary   images,   and   skeletonized.  
Branches  less  than  4μm  in  length  were  excluded  from  the  analysis.  White  arrows  point  to  
subiliac  lymph  node,  red  arrows  indicate  branches  of  the  thoracoepigastric  vein  (TEV);;  
anterior  side  (A)  is  left  of  subiliac  lymph  node,  posterior  side  (P)  is  right  of  subiliac  lymph  
node.  Images  are  representative  of  N=3  per  group,  error  bars  are  SEMs.  Schematic  of  
inguinal   scWAT   (c)   divided   into   three   anatomically   distinct   areas:   1.   area   anterior   to  
subiliac  lymph  node  (LN),  2.  LN  area,  3.  area  posterior  to  LN.    Major  vasculature  is  shown  
with  the  TEV67  illustrated  as  blue  line  and  the  superficial  caudal  epigastric  artery  (SCEA)68  
and  other  vasculature  illustrated  as  red  lines.  Branches  of  the  subiliac  transverse  nerves  
(SiTN)   are   illustrated   as   green   lines.   Adult   (12-­13   weeks   old)   male   C57BL/6J   mice  
received  either  daily  i.p.   injections  of  ADRβ3  agonist  CL316,243  (at  1.0  mg/kg  BW),  or  
vehicle  (Veh)  for  10-­14  days;;  ex  vivo  secretions  (collected  at  1hr  and  2hr)  from  inguinal  
scWAT  explants  were  measured  for  BDNF  by  ELISA,  analyzed  by  two-­tailed  Student’s  T-­
Test,  and  presented  as  fold  change  in  picograms  (pg)/mL  (d).  Data  is  representative  of  
multiple  cohorts,  N=5  (Veh),  N=7  (CL316,243).  Error  bars  are  SEMs.  16  week  old  male  
BTBR  MUT  mice  (N=3)  received  single  injection  of  AAV-­BDNF  (1x1010  vg)  into  their  left  
inguinal  scWAT  and  an  equal  volume  of  vehicle  into  their  right  inguinal  scWAT;;  protein  
expression  of  PGP9.5  in  inguinal  scWAT  was  measured  by  western  blotting  after  2  weeks  
(e).   Protein   expression   was   normalized   to   b-­tubulin,   band   intensity   was   quantified   in  
Image  J  and  analyzed  by  two-­tailed  Student’s  T-­Test;;  error  bars  are  SEMs.  
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MYELOID-­SECRETED  BDNF  MAINTAINS  INNERVATION  OF  INGUINAL  ADIPOSE  





Innervation  of  adipose  tissue  is  essential  for  the  proper  function  of  this  critical  metabolic  
organ.   Numerous   surgical   and   chemical   denervation   studies   have   demonstrated   how  
maintenance   of   brain-­adipose   communication   through   both   sympathetic   efferent   and  
sensory   afferent   nerves   helps   regulate   adipocyte   size,   cell   number,   lipolysis,   and  
LysMcre:BDNF-/-










‘browning’  of  white  adipose  tissue.  Neurotrophic  factors  are  growth  factors  that  promote  
neuron  survival,  regeneration  and  outgrowth  of  neurites  on  adult  nerves.  Peripheral  blood  
immune  cells  have  been  shown  to  be  a  source  of  neurotrophic   factors   in  humans  and  
mice.  Although  a  number  of  these  cells  also  reside  in  the  adipose  stromal  vascular  fraction  
(SVF)  it  has  remained  unclear  what  role,  if  any,  they  play  in  adipose  innervation.  We  have  
demonstrated  that  adipose  resident  myeloid  lineage  immune  cells  secrete  brain  derived  
neurotrophic  factor  (BDNF)  and  that  deletion  of  this  neurotrophic  factor  from  myeloid  cells  
led  to  a  ‘genetic  denervation’  of  inguinal  subcutaneous  adipose  tissue,  thereby  causing  
decreased   energy   expenditure   and   increased   adipose   mass.      We   and   others   have  
previously   shown   that   noradrenergic   stimulation   via   cold   exposure   increases   adipose  
innervation  in  the  inguinal  depot.  Here  we  have  identified  a  subset  of  myeloid  cells  that  
are  Cx3cr1+  monocytes/macrophages  expressing  adrenergic  receptors.    The  quantity  of  
these  mobile  immune  cells  increased  in  adipose  tissue  upon  cold  stimulation,  fitting  with  
their  function  to  hone  to  sites  of  tissue  injury,  and  these  cells  also  expressed  BDNF.  We  
propose   that   these   cold   induced   neuroimmune   cells   (CINCs)   are   key   players   in  
maintaining  adipose   innervation  as  well  as  promoting  adipose  nerve  remodeling  under  
adrenergic  stimuli  such  as  cold  exposure.    
  
Introduction  
In  order  for  the  central  nervous  system  (CNS)  to  regulate  functions  of  distal  organs,  
peripheral   innervation   of   tissues   needs   to   be   maintained.   It   has   been   demonstrated  




tissue   and   disrupts   energy   homeostasis.   Denervation   of   brown   adipose   tissue   (BAT)  
greatly   impairs   the   energy   expending   process   of   adaptive   thermogenesis   [1-­4],   while  
denervation   of   white   adipose   tissue   (WAT)   results   in   fat   mass   accumulation   via  
hyperplasia   and   impaired   lipolysis   [5-­7].   Furthermore,   we   have   previously   shown   that  
nerves   in   subcutaneous   adipose   tissue   (scWAT)   undergo   remodeling   in   response   to  
pathophysiological  and  environment  stimuli  [8].  While  obesity  and  aging  can  lead  to  dying  
back  (neuropathy)  of  adipose  nerves,  exercise  and  cold  exposure  served  to     enhance  
nerve  growth  and  branching  within  the  scWAT  depot  [8].  
Nerve  remodeling  is  facilitated  by  neurotrophic  factors  (NFs)  both  in  the  CNS  [9]  
and   in  peripheral  nerves  [10].  NFs  are  nerve  growth   factors   that  support  nerve  health,  
survival,  and  plasticity.  Brain  derived  neurotrophic  factor  (BDNF),  is  one  member  of  the  
neurotrophin  family  of  NFs  which  in  mammals  also  includes  nerve  growth  factor  (NGF),  
Neurotrophin-­3   (NT-­3),   and   Neurotrophin-­4/5   (NT-­4/5).   Neurotrophins   signal  
predominantly  through  Trk  receptors  on  nerves,  through  which  they  are  endocytosed  and,  
in  peripheral  nerves,  transported  in  a  retrograde  manner  to  the  nerve  cell  body.  BDNF  
has  been  well  studied  for  its  role  in  hippocampal  synaptic  plasticity  in  the  adult  brain  [11-­
13],  as  well  as  learning  and  exercise  related  neurogenesis  [14].  BDNF  is  also  an  important  
modulator  of  energy  balance  through  its  actions  in  the  hypothalamus  [14].  In  rats,  deletion  
of  Bdnf  in  the  ventromedial  and  dorsomedial  regions  of  the  hypothalamus  resulted  in  an  
obesity  phenotype  due   to  hyperphagic  behavior   [15].  Obesity   is  associated  with   lower  
serum   levels   of   BDNF   in   humans,   and   animal   studies   have   shown   that   central   and  
peripheral  administration  of  BDNF  reduced  food  intake  and  hyperglycemia,  and  increased  




2016,  (genetic  mutations   in  human  BDNF  and   its  receptor  TrkB  result   in  morbid  early-­
onset  obesity  [19];;  furthermore  genome  wide  associated  studies  (GWAS)  have  identified  
single  nucleotide  polymorphisms  (SNPs)  in  or  near  BDNF  to  be  associated  with  increased  
BMI   [19].  Despite   these  strong  correlations  between  BDNF  and   its   receptor  TrkB  and  
obesity  it  is  predominately  studied  in  CNS.    However,  a  few  studies  have  shown  that  NFs,  
including  BDNF  are  present  in  adipose  tissue  [20-­22]  but  the  cellular  source  of  BDNF  in  
adipose  has  not  been  determined.  An  adipose  specific  (Adipoq-­Cre)  knock-­out  of  BDNF  
and  TrkB,  only  reduced  TrkB  expression  in  adipose,  suggesting  that  mature  adipocytes  
are  not  the  celluar  source  of  BDNF  [23].  NFs  are  secreted  by  glial  cells  in  the  brain  [24]  
and  Schwann  cells   in  peripheral  nerves   [25].  However,  other  cell   types,  predominantly  
immune  cells,  are  also  known  sources  of  NFs  [26-­30].  
As  part  of  the  immune  response  to  injury  immune  cells  are  critical  players  in  wound  
healing,   regeneration,   and   remodeling   of   various   tissues.   They   are   an   important  
component  of  the  adipose  organ  where  they  modulate  the  inflammatory  response,  clear  
tissue  of  apoptotic  cells,  and  mediate  adipose  tissue  remodeling  during  obesity  through  
an  influx  of  monocytes  (undifferentiated  macrophages),  neutrophils,  T  cells,  B  cells  and  
mast   cells   [31-­36].  Macrophages   and   their  monocyte   precursors   are   myeloid   lineage  
immune  cells  and  comprise  the  highest  fraction  of  immune  cells  present  in  adipose  tissue  
[37].  They  are  highly  heterogenous  cells   that  are  polarized  by  environmental  stimuli  to  
evoke  differential  responses  within  a  tissue.  In  a  simplistic  paradigm,  classically  activated  
macrophages   (M1)   act   in   a   pro-­inflammatory   manner,   while   alternatively   activated  
macrophages  (M2)  produce  an  anti-­inflammatory  response  and  initiate  tissue  remodeling  




tissue  macrophages  (ATMs)  greatly   increase   in  number   thus  contributing   to  a  chronic  
state  of  tissue  inflammation  [38];;  and  inflamed,  insulin-­resistant  adipose  tissue  histology  
is  characterized  by  macrophage  crown-­like  structures  surrounding  hypertrophic,  hypoxic  
and   dying   adipocytes.   On   the   other   hand,   it   has   been   suggested   that   cold-­induced  
browning  of  adipose  promotes  an  M2  phenotype  in  ATMs  [38]  possibly  promoting  tissue  
remodeling  and  may  be  a  source  of  NFs  in  adipose  tissue.      
Although  myeloid  cells,   including  monocytes  and  macrophages,   from  peripheral  
blood  have  been  shown  to  store  and  release  NFs  [39]  it   is  still  unclear  what  role  these  
immune  cells  play   in  peripheral  nerve   innervation,  and   it   remains  unknown  how  and   if  
adipose-­resident  immune  cells  are  stimulated  to  release  NFs  that  act  locally.  Microglia,  
or  the  CNS  resident  myeloid  cells  that  are  most  similar  to  macrophages,  are  an  accepted  
source   of   BDNF   in   the   brain   [40]   and   increase   secretion   of   BDNF   in   response   to  
neuroinflammation   [41].   Microglial   derived   BDNF   in   the   CNS   promotes   hippocampal    
synaptic  plasticity   [40]  and  neurogenesis   [42].     We  hypothesized   that  myeloid   lineage  
cells  may  play  a  similar  role  in  adipose  tissue,  and  generated  a  myeloid  specific  BDNF  
knock-­out  mouse  model,  by  crossing  LysMcre/-­  and  BDNFfl/fl  mice.    Here  we  report  a  role  
for  myeloid  derived  BDNF  in  the  specific  maintenance  of  adipose  innervation,  and  identify  
a  subpopulation  of  macrophages  (Cx3cr1+)  that  infiltrate  adipose  tissue  in  response  to  







Materials  and  Methods    
Mice,  Metabolic  Phenotyping,  and  in  vivo  Analyses  
   Animals  
The   following  mouse   strains   were   obtained   from   The   Jackson   Laboratory:   C57BL/6J  
(Stock  #  000664);;  LysMcre/-­   (B6.129P2-­Lyz2/J,  Stock  #  004781);;  BDNFfl/fl   (Bdnftm3Jae/J,  
Stock   #   004339);;   R26R-­EYFP   (B6.129X1-­Gt(ROSA)26Sortm1(EYFP)Cos/J,   Stock   #  
006148.   Animals   with   myeloid   specific   deletion   of   BDNF   (LysMcre:BDNF-­/-­)   were  
generated   in   our   facility   by   crossing  mice   heterozygous   for   the  myeloid   -­specific   cre  
transgene   (LysMcre)   with   mice   homozygous   for   floxed   BDNF.   Reporter   mice   were  
generated  by  crossing  LysMcrex  BDNFflfl  x  R26R-­EYFP.  Animals  were  housed  3-­5  to  a  
cage   providing   for   socialization,   in   a   monitored   temperature   and   humidity-­controlled  
environment  with  12/12hr  light/dark  cycle.  Cages  were  replaced  weekly,  ad  libitum  access  
to   food  and  water  was  maintained.     For  all  studies  animals  were  sacrificed  using  CO2  
followed  by  cervical  dislocation.  
Dietary  fat  interventions  and  food  intake  
Adult   male   LysMcre:BDNF-­/-­   mice   were   a   45%   HFD   diet   from   Research   Diets   (New  
Brunswick,  NJ)  for  up  to  11  weeks.  Mice  were  housed  2-­3  per  cage,  at  room  temperature.  
Body  weight  was  measured  weekly.  Food   intake  was  measured  daily   for  7  days,   then  







Metabolic   cage   analyses   were   conducted   in   a   Comprehensive   Laboratory   Animal  
Monitoring  System  (CLAMS;;  Columbus  Instruments,  Columbus,  OH),  for  measurement  
of  oxygen  consumption   (VO2)  and  carbon  dioxide  production  (VCO2),   from  which  both  
respiratory   exchange   ratio   (RER),   and   energy   expenditure   (heat)   were   calculated:  
RER=VCO2/VO2;;  Energy  expenditure  (heat)  =  CV  *  VO2    cal/hr,  where  CV  is  the  “caloric  
value”  as  given  by  CV  =  (3.815  +  1.232)  *  RER.  Animal  were  single  housed  in  a  bedding  
free  cage,  at  room  temperature  on  a  12hr  light/dark  cycle.    Mice  were  acclimated  for  24-­
48hrs,  after  which  VO2,  VCO2,  RER,  and  Heat  were  measured  every  15min  for  3  days  
(72hrs).  Waveform  analysis  of  CLAMS  data  was  performed  by  matching  every   15min  
measurement   across   all   three   24hr-­cycles.   Two-­way   repeated   measures   analysis   of  
variance  (RM,  ANOVA)  was  performed  for  average  VO2,  VCO2,  RER,  and  Heat  per  group.  
An  uncorrected  Fisher’s  Least  Significance  Difference  test  was  performed  for  each  time  
point  between  dietary  groups  as  a  post-­hoc  test.  Interaction  P  values  are  reported,  which  
represent  differences  in  24hr  data  between  groups,  as  well  as  multiple  comparison  results  
for  differences  which  were  only  day/night  phase  specific.  
Cold  Exposure  Experiments  
All  cold  exposure  was  carried  out  in  a  diurnal  incubator  (Caron,  Marietta,  OH,  USA)  at  
5°C,  and  a  12hr  light/dark  cycle.  Animals  were  housed  two  to  a  cage  and  continuously  






Adult  (12-­13  week  old)  male  C57BL/6  mice  received  daily  i.p.  injections  of  ADRβ3  
agonist  CL316,243  (Tocris  Bioscience,  Bristol,  U.K.;;  Cat  #  1499),  at  1.0  mg/kg  BW  or  an  
equivalent  amount  of  sterile  saline,  for  10-­14  days.  
Glucose  Tolerance  Test  (GTT)  
Animals  were  fasted  overnight  for  16hr,  after  which  they  received  an  intraperitoneal  (i.p.)  
bolus  injection  of  1g/kg  glucose.  Blood  glucose  was  measured  using  tail  vein  blood  with  
a  hand-­held  glucometer  (OneTouch  UltraMini,  LifeScan,  Milpitas,  CA,  Johnson&Johnson,  
New  Brunswick,  NJ),  at  time  0  and  at  intervals  of  15  minutes,  30  minutes,  and  60  minutes  
after  injection.    
Western  Blot  
Protein   lysates  were  prepared  by  homogenizing   frozen  whole  adipose  depots   in  RIPA  
buffer   using   a   Bullet   Blender   (Next   Advance,   Averill   Park,   NY),   followed   by   Bradford  
Assay,  and  preparation  of  equal-­concentration  lysates  in  Laemmli  buffer.  60ug  of  protein  
was   loaded  per   lane  of  a  10%  polyacrylamide  gel,  and   following  gel   running,  proteins  
were  transferred  to  PVDF  membranes  for  antibody  incubation.  Primary  antibodies  used  
included:  anti-­PGP9.5  (Abcam,  Cambridge,  U.K.  Cat.  #10404  and  #108986)  used  at  a  
1:1000   and   1:500   dilutions   respectively;;   anti-­UCP1   (Abcam,   Cambridge,   U.K.   Cat.  
#10983)   used   at   1:1000   dilution,   anti-­TH   (Millipore   Cat.   #   AB152;;   Merck   Millipore,  
Burlington,  MA),  anti-­b-­tubulin   (Cell  Signaling  Technology,  Danvers,  MA,  USA;;  Cat.   #  




Signaling  Ct   #   7074),   used  at   a  1:3000  dilution.  Blots  were   visualized  with   enhanced  
chemiluminescence  (ECL;;  Pierce)  on  a  Syngene  G:BOX.    Protein  expression  of  PGP9.5,  
TH,  and  UCP1  was  normalized  to  either  -­b-­tubulin  or  β-­actin  and  quantified  in  Image  J.  
Collection  of  adipose  secretions  and  BDNF  ELISA  
BAT  depots  were  dissected,  weighed  and  minced  in  a  petri  dish  containing  
DMEM  (high-­glucose,  serum-­free).  Minced  tissue  was  transferred  to  a  15mL  conical  
tube,  with  5mL  DMEM  (loosely  capped  to  keep  tissue  oxygenated)  and  placed  in  a  
shaking  water  bath  at  37°C.  Secretions  were  collected  at  time  0,  1hr,  2hrs,  and  3hrs  
(1mL  collected  from  conical  tube  at  each  time  point  and  replaced  with  1mL  fresh  
DMEM).  Secretions  were  stored  at  -­80°C  until  processing.  For  ELISA,  protein  secretions  
were  concentrated  using  Amicon  ®  Ultra  Centrifugal  Filters,  Ultracel  ®  -­100K  (Millipore,  
Burlington,  MA  USA;;  Cat.  #  UFC510096),  per  manufacturer’s  instructions.  Mouse  BDNF  
PicoKine™  ELISA  Kit  (Boster  Biological  Technology,  Pleasanton,  CA,  USA;;  Cat#  
EK0309)  was  used  per  manufacturer’s  instruction  to  determine  amount  of  BDNF  present  
in  adipose  active  secretions.  
Thyroid  hormone  ELISA  
Mouse  sera  were  used  to  measure  circulating  levels  of  thyroxine  (T4)  and  triiodothyronine  




Assays   (ELISA)   at   Maine   Medical   Center   Research   Institute’s   Core   Facilities  
(Scarborough,  ME).    
SVF  isolation    
Bilateral  whole  inguinal  adipose  depots  were  quickly  dissected  and  weighed.  Tissue  was  
minced  in  37°C  pre-­warmed  DMEM  (high  glucose,  serum  free)  containing  2mg/mL  Roche  
Collagenase   A   (Millipore-­Sigma,   St.   Louis,   MO;;   Cat#   10103586001)   at   a   volume   of  
10mL/depot.  Minced   tissue  with  collagenase  containing  DMEM  was  placed   in  a  50mL  
conical  tube  and  transferred  to  a  shaking  water  bath  (350/min  rotation)  at  37°C.  Every  
10min  cells  were  dispersed  by  vortex  and  pipette  mixing.  Full  dissociation  was  usually  
achieved  within  2hrs,  when  adipocytes  were  clearly  visible  and  all  tissue  was  dissociated.  
Dissociated  media   was   poured   through   100um   cell   strainers,   rinsed   with   DMEM   and  
centrifuged   at   500g   for   10min   to   separate   adipocytes   from   SVF.   After   centrifugation  
adipocytes  were   collected   (found   floating   on   top);;   remainder   of   DMEM  was   removed  
sparing  the  SVF  pellet.  SVF  pellet  was  incubated  with  500uL  of  RBC  lysis  buffer  on  ice  
for  2min,  after  which     2mL  od  DMEM  with  serum  was  added  to  stop   lysis.  Cells  were  
centrifuged   at   500g   for   5min   at   4°C,   and   either   collected   for   RNA   or   resuspended   in  
FACS/MACS  buffer  for  cell  sorting.  
Magnetic-­activated  Cell  Sorting  (MACS)  
SVF  from  bilateral  whole  inguinal  adipose  depots  was  isolated  as  described  above  and  
resuspended  in  degassed  buffer  (1XPBS  pH7.2,  0.5%  BSA  and  2mM  EDTA).  Single-­cell  
suspensions  were   sorted  on   the  MidiMACS  Quadro  magnetic-­activated   cell   separator  




instructions.  Briefly,  cells  were  stained  with  primary  PE-­conjugated  antibody,  CD11b-­PE  
(Cat  #130-­098-­087);;  a  1:10  antibody  dilution  per  107  cells  was  used.  Cells  were  incubated  
for  10min  at  4-­8°C,  washed,  and  centrifuged  at  300g  for  10min.  Washed  cell  pellet  was  
resuspended   in  a  1:10  dilution  of  anti-­PE  microbeads   included   in  Anti-­PE  MultiSort  Kit  
(Cat.   #130-­090-­757).   Following   15min   incubation   at   4-­8°C,   cells   were   washed   and  
centrifuged  as  dercribed  above.  Cells  were  resuspending  in  500µL  of  buffer  and  passed  
through   LS   columns   of   the  MACS   separator.   LS   colums   were   prepped   according   to  
manufacturer’s  suggestion.  Cells  were  washed  3  times,  collected  cells    (CD11b-­)  were  
collected.  LS  colums  were  removed  from  the  MACS  separator  and  flushed  with  5mL  of  
buffer   to   release   the   magnetically   labeled   cell   fraction   (CD11b+).   MicroBeads   were  
removed  using  MicroSort  release  reagent  included  in  Anti-­PE  MultiSort  Kit  (Cat.  #130-­
090-­757).    MicroBead  free  CD11b+  cell  fraction  was  labeled  for  the  secondary  marker,  
Anti-­F4/80-­APC  (Cat.  #130-­102-­942),  following  the  same  procedure  as  described  for  the  
primary  marker,  except  that  Anti-­APC  MicroBeads  (Cat.  #130-­090-­855)  were  used.    
Fluorescence-­activated  Cell  Sorting  (FACS)    
SVF  from  bilateral  whole  inguinal  adipose  depots  was  isolated  as  described  above.  Cells  
were  resuspend  in  FACS  buffer  (HBSS,  5mM  EDTA,  2  %FBS).  Single  cell  suspensions  
were  incubated  in  an  “antibody  cocktail”  against  23  cell  surface  markers  for  20min  at  4°C.  
Cells  were   centrifuged  at  500g   for   10min,  washed,   resuspended  and   sorted  with   flow  
cytometry  on  a  five-­laser  30-­parameter  FACSymphony  A5  cytometer  (BD  Biocsiences,  
San  Jose,  USA).  For  sorted  cells,  SVF  was  gated  on  CD45  and  CD11b;;  CD45+CD11b-­  
represented  the  non-­myeloid  population;;  CD45+CD11b+  myeloid  fraction  was  gated  on  




Gene  Expression  (qPCR)  
RNA  was  isolated  from  whole  tissue  depots  using  Trizol  reagent,  and  total  RNA  extracted  
using  a  Zymo   (Irvine,  CA)   kit.  RNA  yield  was  determined  on  a  Nanodrop;;   cDNA  was  
synthesized  using  a  High  Capacity  Synthesis  Kit  (Applied  Biosystems,  Foster  City,  CA).  
Real-­time  quantitative  (q)PCR  was  performed  with  SYBR  Green  (Bio-­Rad,  Hercules,  CA)  
on  a  CFX96  instrument  (Bio-­Rad,  Hercules,  CA).    
Histology  
   Adipose    
Immunofluorescent   staining   of   10%   buffered   formalin   fixed,   paraffin-­embedded,   7uM  
sections   of   adipose   tissues   was   performed   for   detection   of   UCP1   (1:500,   Abcam,  
Cambridge,  UK.  Cat.   #10983).  Alexa  488   (2.5µg.mL,  Molecular  Probes,  Eugene,  OR,  
USA,  Cat.  #  A11070)    was  used  as  secondary  antibody.  Typogen  Black  staining  was  used  
to   quench   tissue   autofluorescence   (prior   to   antibody   incubation)   and   also   provided  
visualization   of   cell   size,   browning   (multilocularity)   and   crown-­like   structures.   Stained  
sections  were  mounted  using  Millipore  mounting  fluid  (Burlington,  MA  USA;;  Cat.  #  5013)  
and  1  1/5  coverslips,  and   imaged  on  a  Nikon  Eclipse  E400  epiflourescent  microscope  
equipped  with  Nikon  DS-­fi2  camera.      
   Neuromuscular  junction  immunofluorescence,  imaging,  and  analysis  
Soleus  and  medial  gastrocnemius  muscles  were  removed  and  fixed  in  a  2%  PFA  at  4°C  
for   2   hours.   Tissues   were   rinsed   with   1XPBS   and   incubated   in   blocking   buffer  




blocking  muscles  were   teased,   tendons  and  fat   removed,  and   tissue  was   flattened  by  
being   placed   between   two   tightly-­bound   glass   slides   for   at   least   30  minutes   at   4°C.    
Tissues   were   transferred   to   fresh   blocking   buffer   at   4°C   for   at   least   12   hours.  
Immunostaining  of  innervation  with  primary  antibodies  was  performed  overnight  at  4°C,  
followed  by  1XPBS  washes  on  a  rotating  platform  at  4°C  replacing  PBS  every  1hr  for  a  
total  of  4-­6hrs.  Tissues  were  incubated  with  secondary  fluorescent  antibodies  in  similar  
fashion  as  primary  antibodies.  Primary  antibodies  included:  neurofilament-­M  (2H3,  1:500)  
and   synaptic   vesicles   (SV2,   1:250)   from   Developmental   Studies   Hybridoma   Bank,  
(University   of   Iowa,   USA).   Secondary   antibodies   included:   Alexa   Fluor   488   at   1:500  
(A21121)   and   alpha-­bungarotoxin   (BTX)-­conjugated   to   Alexa   Fluor   594   at   1:1000  
(B13423)   from   Molecular   Probes   (Eugene,   OR,   USA).   Tissues   were   mounted   on  
microscope  slides  using  Millipore  mounting  fluid  (Burlington,  MA  USA;;  Cat.  #  5013)  and  
1  1/5  coverslips  then  sealed  and  allowed  to  set  overnight.  Stained  sections  were  imaged  
on  a  Nikon  Eclipse  E400  epiflourescent  microscope  equipped  with  Nikon  DS-­fi2  camera.    
Brightness,  contrast,  and  sharpness  were  adjusted  in  Microsoft  PowerPoint.  Up  to  100  
NMJs   were   counted   for   each   tissue,   statistics   were   conducted   in   GraphPad   PRISM  
software  (La  Jolla,  CA,  USA)  using  the  multiple  t-­tests  (one-­per  row)  function.  
Statistical  Analysis  
For   all   animal   experiments,  mice  were   randomized   to   treatment   groups   to   ensure   no  
difference   in   starting   body   weight.      All   plots   represent   mean   +/-­SEM.      Statistical  
calculations  were  carried  out  in  Excel  or  GraphPad  Prism  software  (La  Jolla,  CA,  USA),  
utilizing   ANOVA,   Linear   Regression,   or   Student’s   T-­test   as   indications   of   significance  




housekeeper   and   analyzed   by   either   ANOVA   or   by   Student’s   t-­test,   two-­tailed,   using  
Welch’s  correction  when  variance  was  unequal.  Error  bars  are  SEMs.  For  all  figures,  *p  
<  0.05,  **p  <  0.01,  ***p  <  0.001,  ****p  <  0.0001.    
Ethical  Statement  
All  procedures  and  handling  of  animals  were  performed  in  accordance  with  the  University  
of  Maine’s   Institutional  Animal  Care   and  Use  Committee   (IACUC),   to   comply  with   the  
guidelines  of  the  PHS  Policy  on  Humane  Care  and  Use  of  Laboratory  Animals,  and  Guide  
for  the  Care  and  Use  of  Laboratory  Animals.    This  study  was  approved  by  the  University  
of  Maine’s  IACUC,  under  protocol  A2017-­09-­04.  
  
Results  
BDNF  is  expressed  in  adipose  SVF    
We  previously  demonstrated  that  BDNF  levels  increase  in  adipose  tissue  in  response  to  
noradrenergic   stimulation   [8].   Administration   of   the   β-­3   adrenergic   receptor   (ADRβ3)  
agonist  CL  316,243  to  the  inguinal  scWAT  resulted  in  an  increase  of  BDNF  secretion  in  
the  tissue  [8].  We  also  showed  that  adeno-­associated  virus  (AAV)-­mediated  gene  delivery  
of  BDNF  to  inguinal  scWAT  of  BTBR  ob/ob  mice  (which  we  exhibited  adipose  neuropathy)  
served  to  increase  innervation  within  the  adipose  tissue  [8]  and  is  a  potential  treatment.  
We  now  endeavored   to   determine  which   adipose   compartment  and   cell   type  was   the  
source  of  local  BDNF  secretion  in  scWAT.    Adipose  tissue  is  a  heterogeneous  organ  and  




stromal  vascular  fraction  (SVF)  of  adipose  tissue.    Adipose  SVF  consists  predominantly  
of  hematopoietic  lineage  cells  including  ATMs  [36,  37]    but  also  contains  preadipocytes,  
vascular   endothelial   cells,   and   pericytes.   To   determine   the   compartmental   source   of  
adipose  BDNF,  adult  male  C57BL/6  mice  were  cold  exposed  and  SVF  was  isolated  from  
mature  adipocytes  of  inguinal  scWAT.  Gene  expression  analysis  revealed  that  Bdnf  was  
almost  exclusively  expressed  in  the  SVF,  while  other  common  NFs  showed  no  difference  
of  expression  between  SVF  and  mature  adipocyte  fractions  (Fig.  1A).  These  data,  along  
with  other  previous  findings  [8],  suggested  neuroimmune  interactions  in  adipose  tissue.    
   To  further  probe  the  role  of  BNDF  in  adipose  tissue,  we  created  a  knock-­out  (KO)  
mouse  model   using  Cre-­Lox   technology.  LysMcre/-­:mice  were   bred   to  BDNFfl/fl  mice   to  
generate  LysMcre/-­:BDNFfl/fl   (KO)  animals,  which   lacked  BDNF  in  myeloid   lineage  cells.  
Compared   to   littermate   controls,   KO   animals   exhibited   a   significant,   although   not  
complete,  decrease  of  Bdnf  in  adipose  SVF  as  measured  by  gene  expression  (Fig.  1B).    
Since  myeloid  lineage  cells  are  expressed  in  the  brain,  and  BDNF  has  been  shown  to  
play  a  role  in  energy  balance  via  CNS  control  of  satiety,  we  also  investigated  whether  our  
KO  model  affected  BDNF  expression  in  the  hypothalamus.  Gene  expression  of  Bdnf  in  
the  hypothalamus  did  not  differ  between  KO  animals  and  their   littermate  controls  (Fig.  
1C).    
LysMcre/-­:BDNFfl/fl   (KO)   mice   show   lowered   energy   expenditure   under   basal  
conditions  and  impaired  response  to  cold  exposure  
Physiological   assessment   using  metabolic   cages   performed   on   KO   animals   and   their  




expenditure  (Fig.  1D)  despite  showing  no  difference  in  body  weight  or  adiposity  (Suppl.  
Fig.   S1A).   Since   a   decrease   in   energy   expenditure   could   be   indicative   of   impaired  
sympathetic   drive,   we   stimulated   sympathetic   nerve   activity   via   cold   exposure.  When  
adult  (22-­23  week  old)  male  mice  were  cold  challenged  at  5°C  for  4  days,  KO  and  control  
animals  maintained  similar  body  weight  (Fig.  2A,  left  panel).    However,  KO  animals  had  
significantly   increased   adiposity   (Fig.   2A,   right   panel).   As   cold   exposure   stimulates  
catecholamine-­induced   lipolysis,   mediated   through   sympathetic   nerves,   we   next  
investigated  innervation  of  the  inguinal  scWAT  depot  following  a  7-­day  cold  challenge.  
Protein  expression  of  the  pan-­neuronal  marker  PGP9.5  was  markedly  reduced  in  inguinal  
scWAT  of  male  KO  mice  compared   to   littermate  controls   (Fig.  2B,   left  panel).  Protein  
expression  of   tyrosine  hydroxylase  (TH),  a  marker  of  sympathetic  activation,  was  also  
drastically  reduced  in  inguinal  scWAT  of  KO  animals  compared  to  controls  (Fig.  2B,  right  
panel).  Cold  exposure  induces  expression  of  uncoupling  protein  1  (UCP1)  as  it  is  required  
for  adaptive   thermogenesis,  due  to   its  ability   to  uncouple   the  mitochondrial   respiratory  
chain  resulting  in  a  proton  leak  and  heat  production.  UCP1  is  therefore  a  unique  marker  
of  BAT  and  browning  in  scWAT.  Gene  expression  of  Ucp1   in  inguinal  scWAT  of  7-­day  
cold  exposed  mice  was  reduced  in  KO  animals  compared  to  littermate  controls  (Fig.  2C).  
Thyroid  hormone  potentiates  SNS  activation  of   thermogenesis   in  BAT;;  no  changes   in  
thyroid  hormone  were  observed  between  KO  and  CON  animals  (Fig.  2D).  Histological  
assessment   of   inguinal   scWAT   revealed   what   appeared   like   increased  multilocularity  
suggestive  of  browning  in  KO  animals  (Fig.  2E,  Typogen  Black  staining).  However,  there  
was   a   strikingly   lack   of   UCP1   expression   in   these   areas   (Fig.   2E).   Considering  




areas   in   increased   preadipocytes.   Taken   together,   these   data   suggested   a   genetic  
denervation  of  inguinal  scWAT  and  diminished  thermogenic  response  in  inguinal  scWAT  
in  KO  mice.      
Genetic  denervation  of  scWAT  in  LysMcre/-­:BDNFfl/fl  (KO)    mice  is  depot  specific  
We  next  sought  to  determine  whether  genetic  denervation  of  scWAT  in  KO  animals  
was  restricted  to  adipose  tissue  or  extended  to  other  organs.  BDNF  is  a  known  myokine,  
and   muscle   is   an   energy   expending   tissue.   We   assessed   innervation   of   fast   twitch  
(gastrocnemius)   and   slow   twitch   (soleus)   muscle   in   CON   and   KO,   by   investigating  
occupancy  of  neuromuscular   junctions   (NMJs)  at  basal  conditions   in  adult  male  mice.  
Immunostaining   of   the   presynaptic   nerve   and   vesicles   (neurofilament   and   SV2,  
respectively),   and   postsynaptic   acetylcholine   receptors   was   performed   to   allow  
visualization  of  MNJ  (Suppl.  Fig.  S1B,  left  panel).    Following  counts  of  occupied,  partially  
occupied,   and   unoccupied   NMJs   it   was   determined   that   there   was   no   evidence   of  
neurodegeneration  in  the  NMJ  of  KO  animals  (Suppl.  Fig.  S1B,  right  panel).  In  the  same  
animals  we  also  assessed  axon  numbers  of  spinal  (L5  ventral  root),  motor,  and  sensory  
nerves  through  cross-­section  imaging  (Suppl.  Fig.  S1C).  A  lower  axon  count  could  reflect  
neuronal  death,  but  no  difference  was  observed  between  CON  and  KO  animals.    
Although  thyroid  hormones  were  similar  between  CON  and  KO  animals  (Fig.  2D),  
suggesting  no  effect  of  our  KO  on  BAT  thermogenesis,  myeloid  cells  are  present  in  this  
tissue.    We  therefore  wanted  to  evaluate  whether  a  lack  of  BDNF  in  BAT  myeloid  cells  
would  have  an  effect  on  tissue  function.  BAT  of  7-­day  cold  exposed  12-­25  week  old  male  




differ  between  KO    mice  and  littermate  controls  (Suppl.  Fig.  S2A),  which  suggested  BAT  
function  was  neither  impaired  nor  was  the  tissue  denervated.    Histological  assessment  of  
BAT  revealed  no  difference  in  cellular  morphology,  or  UCP1  expression  (Suppl.  Fig.  S2B).  
These  results  suggested  that  BDNF  may  not  play  a  modulatory  role  in  BAT  innervation.  
Indeed,   when   adult   male   C57BL/6   mice   were   cold   exposed   or   treated   with   the  
pharmacological  β-3 adrenergic receptor (ADRβ3) agonist, CL316,243,  no  difference  in  
BDNF  secretion  for  BAT  was  observed  when  compared  to    basal  conditions  (Suppl.  Fig.  
S2C).    Together,  these  data  supported  scWAT  depot  specificity  of  our  genetic  denervation  
model.  
HFD  feeding  exacerbates  fat  mass  accumulation  in  LysMcre/-­:BDNFfl/fl  (KO)  Mice    
Loss  of  sympathetic   innervation   to   inguinal  scWAT  has  been  shown  to   increase  depot  
mass  [43],    however  in  our  genetic  model  of  scWAT  innervation,  no  difference  in  adiposity  
was  observed  under  basal  conditions  (Suppl.  Fig.  S1A  )  despite  the  observed  decrease  
in  energy  expenditure  (Fig.  1D).    We  next  metabolically  challenged  CON  and  KO  through  
administration  of  a  45%  high  fat  diet  (HFD).  Adult  (25  week  old)  male  CON  and  KO  mice  
were  placed  on  a  HFD  for  3-­11  weeks,  to  assess  adipose  integrity  and  energy  balance.  
At  3  weeks  of  HFD  feeding  animals  were  assessed  in  metabolic  cages.  HFD  resulted  in  
only  a  slight  decrease  in  energy  expenditure  in  KO  mice    compared  to  littermate  controls  
(Fig.  3A,  top  panel).  However,  KO  mice  showed  a  higher  RER  than  CON  animals  during  
the  light  cycle,  indicative  of  preferential  metabolism  of  carbohydrates  over  lipids  for  fuel  
(Fig.  3A,  bottom  panel).  These  data  fits  with  studies  demonstrating  that  adipose  nerves  




carbohydrates.      These  physiological   differences  between  CON  and  KO  animals  were  
observed  despite  no  difference  in  food  intake  or  change  in  body  weight  (Fig.  3B).    After  6  
weeks  of  HFD,  KO  mice  displayed  worsened  glucose  control  compared  to  CON  animals  
(Fig.   3C).   By   11   week   of   HFD   feeding   KO   animals   displayed   greater   adiposity   than  
littermate  controls  (Fig.  3D).    Taken  together,  the  challenge  of  HFD  feeding  exacerbated  
fat  accumulation  in  inguinal  scWAT  of  KO  animals,  possibly  contributing  to  the  observed  
impairment  of  glucose  control.    
Cold-­induced   neuroimmune   cells   (CINCs)   are   recruited   to   scWAT   and   express  
BDNF  
  After  demonstrating  the  significance  of  myeloid  derived  BDNF  to  scWAT  we  sought  to  
determine  which  myeloid  cells  were  the  source  of  BDNF.  Considering  their  multifaceted  
role   in   adipose   tissue   and   source   of   BDNF   in   the   brain,   we   hypothesized   that  
macrophages   were   the   leading   source   of   BDNF   in   scWAT.   Since   previous   studies  
indicated  that  BDNF  is  increased  in  scWAT  with  noradrenergic  stimulation  [8]  CD11b+  
F4/80+  macrophages  were   isolated   from  SVF  of   inguinal  scWAT  of   room  temperature  
and  5-­day  cold  exposed  C57BL/6  adult  (12  week  old)  male  mice.  Bdnf  gene  expression  
did  not  differ  between  room  temperature  and  cold  exposed  CD11b+  F4/80+  macrophages  
(Fig.  4A).  Although  F4/80+  is  considered  a  pan-­macrophage  marker,  it  was  too  broad  to  
reveal  subpopulation  changes,  and  does  not  effectively  mark  monocytes  (macrophage  
precursors),  that  could  be  infiltrating  the  tissue.    Based  on  these  findings  we  applied  a  
different  approach  to  determining  which  myeloid  cells  are  the  source  of  scWAT  BDNF.  
Adult  (12  week  old)  female  control  animals  were  maintained  at  room  temperature  or  cold  




antibody  cocktail  against  myeloid  lineage  cells.  Surprising,  cold  exposure  did  not  have  an  
effect  on  either  M1  or  M2  ATMs  (Fig  4B).  Instead,  the  greatest  increase  in  macrophage  
related  cell  populations  was  in  Ly6c+  monocytes.  Both  Ly6C+  CCR2+  and  Ly6C+  CCR2+  
Cx3cr1+  increased  in  inguinal  scWAT  following  cold  exposure  (Fig.  4C).  Spanning-­tree  
Progression   Analysis   of   Density-­normalized   Events   (SPADE)   analysis   of   room  
temperature   and   cold   exposed  SVF  was  performed   to  assess   changes   throughout   all  
myeloid  lineage  cells  in  response  to  cold  (Fig.  D).  SPADE  analysis  revealed  cold-­induced  
enrichment   in   CCR2+   and   Cx3cr1+   populations.   SPADE   analysis   also   revealed   that  
Mrc1/CD64hi  cells  decrease  in  response  to  noradrenergic  stimulation,  the  significance  of  
which  remains  to  be  investigated  (Fig.  4D).    
To   confirm   that  CCR2+  Cxc3cr1+  monocytes/macrophages  were   the   source  of  
BDNF,   we   sorted   out   Ly6c+CCR2+Cx3cr1+   and   Ly6c+CCR2+Cx3cr1-­   from   inguinal  
scWAT  SVF  of  14  day  cold  exposed  adult  (12-­13  week  old)  male  C57BL/6  mice.  Although  
the   previously   observed   cold   induced   elevation   of   Ly6c+CCR2+Cx3cr1-­   in   inguinal  
scWAT   was   not   observed   in   the   male   cohort,   Ly6c+CCR2+Cx3cr1+   did   increase   in  
response   to   cold   (Fig.   4E).   We   measured   Bdnf   gene   expression   in   cold   induced    
Ly6c+CCR2+Cx3cr1+   (Cx3cr1+)   cells   and   found   that   they   showed   a   mild   trend   for  
increased  expression  of  Bdnf  compared  to  cold  exposed  non-­myeloid  cells  (Fig.  4F).    
Adrβ3    gene  expression  in  Cx3cr1+  cells  confirmed  the  presence  of  norepinephrine  (NE)  
receptor  on  these  cells  indicating  the  potential  to  be  responsive  to  SNS  stimulation  (Suppl.  




Taken  together,  these  data  indicated  that  Cx3cr1+  cells  are  cold-­induced  neuroimmune  




Here  we  present  evidence  of  the  necessity  of  myeloid-­derived  BDNF  in  maintaining  
inguinal  scWAT  innervation.  Loss  of  BDNF  from  LysM+  myeloid  cells  resulted  in  a  severe  
decrease   in   total   innervation   of   the   inguinal   adipose   tissue  as  measured   by   the   pan-­
neuronal  marker  PGP9.5,  and  a  near  complete  denervation  of  sympathetic  nerves  (as  
measured  by  TH  protein  expression  (Fig.  2B).  We  attribute  this  ‘genetic  denervation’  as  
a   cause   for   the   observed   decrease   in   energy   expenditure   exhibited   under   basal  
conditions  (Fig.  1D),  impaired  thermogenic  potential  evidenced  by  lack  of  UCP1  induction  
and  impaired  lipolysis  during  cold  stimulation  (Fig  2A,  C,  E),  and  worsened  response  to  
HDF  (Fig.  3).  These  phenotypes  fit  with  the  known  roles  of  adipose  nerves  in  regulating  
proper   adipogenesis,   lipolysis,   thermogenesis   and  overall  metabolic   health   in   adipose  
tissues.    
Loss  of  sympathetic  innervation  to  adipose  tissue  inevitably  results  in  a  decrease  
in  catecholamine   induced   lipolysis,  as  sympathetic  nerve-­released  NE  signals   through  
ADRβ3  on  adipocytes  to  initiate  a  signaling  cascade  that  results  in  increased  activity  of  
adipose   triglyceride   lipase   (ATGL)   and   hormone-­sensitive   lipase   (HSL),   key   enzymes  
involved   in   intracellular   breakdown   of   triacylglycerols   [45].   Cold   exposure   suggested  




controls   (Fig.2   A).      Cold   exposure   leads   to   SNS   stimulation   of   scWAT   resulting   in  
browning   and   lipolysis.   Lipolysis   of   scWAT   provides   lipids   to   BAT   via   the   circularity  
system   which   are   used   as   fuel   for   adaptive   thermogenesis.   This   usually   result   in  
deceased  scWAT  fat  mass.    HFD  feeding  also  resulted  in  greater  accumulation  of  scWAT  
mass   in  KO  mice  compared  to  controls  (Fig.  3D).  This,  combined  with  HFD  RER  data  
indicating  preferential  metabolism  of  carbohydrates  as  fuel  in  KO  animals  (Fig.  3A)  further  
suggests  impaired  lipolysis  in  scWAT.    
Under   basal   conditions   KO   animals   showed   lower   energy   expenditure   as  
measured  by  heat  production  (Fig  1D)  than  when  challenged  by  HFD  (Fig.  3A).  However,  
obesity  often  results  in  excess  lipid  accumulation  in  BAT  and  ectopic  lipid  storage  [46].  
This  may  be  providing  BAT  with  an  increased  fuel  source,  resulting  in  the  HFD  induced  
partial  recovery  of  the  decreased  energy  expenditure  observed  under  basal  conditions.  
Amongst  the  physiological  pressures  of  a  HFD,  there  are  alterations  to  the  immune  milieu  
within   adipose   tissue.   Diet-­induced   obesity   results   in   chromic   low   grade   adipose  
inflammation  due  to  infiltration  of  pro-­inflammatory  immune  cells  to  the  tissue,  and  ATM  
content   increase   from   10-­15%   (present   in   lean   mice)   to   ~50%   [31,   47].   Phenotypic  
switching  of  CD4+  T  cells,  recruitment  T  cell  and  B  cells  precedes  macrophage  infiltration,  
and   macrophage   polarity   is   affected   to   exhibit   a   more   inflammatory   phenotype.   The  
interactions  between  these  infiltrating  cells  and  BDNF  secreting  myeloid  cells  is  unknown;;  
and   are   potential   caveats   to   the   observed   phenotype   of   our  myeloid   BDNF   knockout  





We   initially   hypothesized   that   anti-­inflammatory   (M2)  ATMs  were   the   source  of  
scWAT  BDNF.  However,  we  observed  no  changes  in  M1  or  M2  populations  in  scWAT  
after   cold   exposure   (Fig.   4B),   instead   we   saw   an   increase   in   Ly6c+CCR2+Cx3cr1+  
monocytes  in  both  male  and  female  mice  (Fig.  4C-­D).  We  have  named  tense  cells  CINCs  
since   they  are  recruited   to  scWAT  by  cold,  and  express  BDNF.     Surprisingly,   it  would  
appear  that  CINCs  are  a  pro-­inflammatory  cell  type  as  Ly6C+  is  a  marker  of  inflammatory  
monocytes.      Although   pro-­inflammatory   cell   infiltration   to   adipose   tissue   is   usually   a  
harbinger   of   metabolic   dysfunction,   an   acute   inflammatory   response   is   necessary   in  
wound   healing   and   tissue   remodeling.   By   utilizing   an   unbiased   23   antibody   labeling  
approach  to  assessing  adipose  SVF,  we  have  discovered  subsets  of  myeloid  cells  that  
respond  to  environmental  stimuli  providing   further  granularity   to   the  myriad  of   immune  
cells  types  active  in  adipose.  
Recently,  a  Cx3cr1+  population  of  ATMs  had  been  described  in  association  with  
sympathetic   nerves   in   adipose   tissue   [48].   These   sympathetic   nerve   associated  
macrophages  (SAMs)  were  found  to  regulate  catecholamine  levels  on  adipose  tissue  by  
phagocytosing  and  degrading  norepinephrine   (NE)   [48].  Whether  SAMs  are   the  same  
cells   as   our  CINCs   remains   uncertain,   as   other   distinguishing  markers   like   Ly6C  and  
CCR2  were  not  assessed.  Similar  to  CINCs,  SAMs  do  exhibit  pro-­inflammatory  markers.    
SAMs   hone   to   WAT   in   the   obese   state   but   we   see   CINCs   hone   to   WAT   with  
cold/noradrenergic-­stimulation,  indicating  they  may  have  opposing  roles.    Fitting  with  this,  
SAMs  sequester  NE  while  CINCs  express  BDNF.    One  could  speculate  then,  that  SAMs  
serve  to  decrease  SNS  input  to  the  tissue  while  CINCs  serve  to  increase  innervation  of  




even   opposing   roles   in   the   intestines   [49],   a   phenotypic   plasticity   which  may   also   be  
present   in  adipose   tissue.  One  thing   that   is  clear   is   that   the  M1/M2  paradigm  of  ATM  
classification   is   an   oversimplification   of   the   functionally   distinct   populations   of  
macrophages  active   in  adipose  tissue.  However,   further  markers  beyond  Cx3cr1+  are  
necessary  to  fully  understand  and  phenotype  the  rich  variety  of  macrophages  in  adipose.  
Compounding   the   difficulty   in   clearly   delineating   macrophage   populations   is   that  
macrophage   activation   is   a   dynamic   process.   Phenotypic   switching   appears   to   be  
sequential,   responding   to   microenvironment   stimuli   [50]   and   may   be   dependent   on  
spatiotemporal   differences   in   tissue   resident   immune   cell   subtypes   [51].   Single-­cell  
RNAseq  of  adipose  immune  cells  may  provide  more  precise  information  necessary  for  
further  phenotyping  CINCs.    
   We   postulate   that   CINCs   contribute   to   nerve   remodeling   under   noradrenergic  
stimulation,  leading  to  BDNF  release.  However,  BDNF  can  also  be  secreted  by  nerves,  
and  it  remains  unclear  what  the  relationship,  if  any,  is  between  CINC  secreted  BDNF  and  
BDNF  that  may  be  released  from  adipose  nerves.  Cao,  et  al  have  recently  suggested  that  
sympathetic  nerve  plastically   is  dependent  on  cold   induced  adipose  derived  NGF  [52].    
Although  they  provide  evidence  that  NGF  is  involved  to  some  degree  in  promoting  cold  
induced  sympathetic  nerve  density  and  browning  of  scWAT,  there  is  insufficient  evidence  
as  to  the  cellular  source  of  NGF.  After  determining  that  NGF  gene  expression  increased  
in  the  first  couple  of  days  of  cold  exposure,  Cao,  et  al  used  an  NGF  neutralizing  antibody  
to  prevent  NGF  activity  and  observed  decreased  sympathetic  nerve  density  in  response  
to  cold.    Several  caveats  to  this  study  exist,  cold-­induced  sympathetic  nerve  density  was  




exist   from   our   previous   works   as   well   as   others   [53].   Furthermore,   NGF   neutralizing  
antibody  was  administered  systemically,  and  there  was  no  control  for  off-­target  effects,  
including  any  that  may  have  affected  hypothalamic  control  of  sympathetic  drive  to  scWAT.  
However,   their   approach   in   preventing   TrkA   receptor   function   in   adipose   nerves   and  
showing  decreased  browning  and  sympathetic  nerve  density  lends  credence  to  the  notion  
that  NGF  plays   a   role   in   adipose   innervation.  Considering   the   variety   of  NFs  and   the  
multitude  of  cell  types  in  adipose  tissue  it  would  not  be  surprising  if  both  NGF  and  BDNF  
play  a  role  in  adipose  innervation  through  different  mechanisms,  and  the  presence  of  one  
NFs  within  as  tissue  does  not  have  to  preclude  the  physiological  role  of  another.    
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Figure  1.    BDNF  is  expressed  in  the  SVF  of  adipose;;  LysMcre/-­:BDNFfl/fl  (KO)  mice  
have  lower  energy  expenditure.  Adult  male  CB57/BL6  mice  were  cold  exposed  at  5°C  
for  XX  days  and  SVF  was  isolated  from  mature  adipocytes  of  the  inguinal  scWAT  depot.  
Differences  in  gene  expression  between  adipose  compartments  of  neurotrophic  factors,  
Bdnf,  Ngf,  and  Vegfa,  is  shown  (A).  Data  analyzed  by  Student’s  t-­test,  two-­tailed,  N=4.  
BDNF   gene   expression   in   adipose   SVF   of   LysM-­/-­:BDNFfl/fl   (CON)   versus   LysMcre/-­
:BDNFfl/fl   (KO)  mice   (B).  Data  analyzed  by  Student’s   t-­test,   two-­tailed,  N=4  per  group.  
Gene   expression   of   Bdnf   in   hypothalamus   of   LysM-­/-­:BDNFfl/fl   (CON)   versus   LysMcre/-­
:BDNFfl/fl  (KO)  mice.  Data  analyzed  by  Student’s  t-­test,  two-­tailed,  N=5  CON;;  N=6  KO.  
Adult   (8-­12   week   old)   male   CON   and   KO   mice   were   assessed   in   metabolic   cages  
(CLAMS).   Waveform   analysis   of   metabolic   cage   measurements   taken   at   15min  
increments  for  48  hrs  (D).    Time  of  day  is  indicated  on  the  x-­axis,  animals  were  maintained  
on  a   12  hr   light/dark   cycle   (black   bars   indicate   dark   cycle).  KO  mice  displayed   lower  
energy  expenditure  represented  as  heat  calculated  from  measures  of  VO2  and  VCO2  over  
the  whole  24hr  (D).  For  all  error  bars  are  SEMs.    
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Figure  2.    LysMcre/-­:BDNFfl/fl  (KO)  have  increased  adiposity  and  impaired  response  
to  cold  due   to  genetic  denervation  of  scWAT.  Adult   (22-­23  week  old)  male  LysM-­/-­
:BDNFfl/fl  (CON)  and  LysMcre/-­:BDNFfl/fl  (KO)  mice  were  cold  exposured  at  5°C  for  4  days;;  
body  weight  and  adiposity  were  compared  between  CON  and  KO  groups  (A).  Body  and  
tissue  weight  data  were  analyzed  by   two-­tailed  Student’s  T-­Test,  N=5  CON,  N=8  KO.  
Protein   expression   of   PGP9.5   and   tyrosine   hydroxylase   (TH)   in   inguinal   scWAT   was  
measured   by  western   blotting   from  adult   (12-­25  week  old)   7-­day   cold   (5°C)   exposed  
WT/CON   and   KO   male   animals   (B).   b-­tubulin   was   used   as   a   loading   control   for  
normalization.  Data  were  analyzed  by   two-­tailed  Student’s  T-­Test,  N=3  WT/CON,  N=4  
KO,  *  denotes  data  that  was  removed  from  analysis  due  to  lack  of  expression  of  loading  
control.  Gene  expression  of  UCP1  was  measured  in  adult  (12-­25  week  old)  7-­day  cold  
(5°C)  exposed  WT/CON  and  KO  males  (C).  Data  were  analyzed  by  two-­tailed  Student’s  
T-­Test,   N=5   WT/CON,   N=5   KO.   Circulating   thyroid   hormones,   thyroxine   (T4)   and  
triiodothyronine  (T3),  were  measured  by  ELISA  from  serum  of  adult  (22-­23  week  old)  4-­
day  cold  (5°C)  exposed  CON  and  KO  male  mice  (D).  Data  were  analyzed  by  One-­way  
ANOVA,  with  Tukey’s  multiple  comparisons  test,  N=5  CON,  N=8  KO.  Immunofluorescent  
staining  for  UCP1  was  performed  on  inguinal  scWAT  sections  of  adult  (22-­23  week  old)  
male  CON  and  KO  mice  following  4-­day  cold  (5°C)  exposure  (E).  Typogen  black,  used  to  
quench   lipid  autofluorescence,  provided  staining  cell  morphology  which  was  visualized  
under   brightfield   microscopy.   Images   were   acquired   with   a   10X   objective   for   a   total  
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Figure  3.  LysMcre/-­:BDNFfl/fl  (KO)  showed  accelerated  fat  accumulation  on  an  45%  
HFD.  Adult  (25  week  old)  male  LysM-­/-­:BDNFfl/fl  (CON)  and  LysMcre/-­:BDNFfl/fl  (KO)  were  
challenged  with  a  45%  HFD  for  3  weeks  before  undergoing  physiological  assessment  in  
metabolic  cages  (A).    Energy  expenditure  as  measured  by  heat  was  lower  for  KO  versus  
CON  only  for  a  short  period  during  the  dark  cycle  (A,  top  panel).  Respiratory  exchange  
as  a  ratio  (RER)  between  the  two  groups,  indicated  greater  use  of  carbohydrates  for  fuel  
by   KO   animals   during   the   light   cycle.      Data   presented   as   waveform   analysis   of  
measurements  taken  at  15min  increments  for  3  days.    Time  of  day  is  indicated  on  the  x-­
axis,  and  animals  were  maintained  on  a  12  hr  light/dark  cycle  (black  bars  indicate  dark  
cycle).  Data  analyzed  by   two-­way   repeated  measures  ANOVA  with  Fisher’s  LSD   test;;  
N=4  per  group.    Adult  (25  week  old)  male  CON  and  KO  animals  were  placed  on  a  45%  
HFD,   daily   food   intake   (represented   as   cumulative   food   intake)   (B,   top   panel)   was  
measured  for  the  first  week  of  HFD  feeding.  Percent  change  in  body  weight  (B,  bottom  
panel)  was  measured  for  the  first  7  days  of  HFD  feeding.  Data  were  analyzed  by  two-­
tailed  Student’s  T-­Test,  N=6  CON,  N=4  KO.  Glucose  tolerance  testing  was  performed  at  
6  weeks  of  HFD  feeding   (C).     Data  were  analyzed  by  Two-­way  ANOVA,  with  Tukey’s  
multiple  comparisons  test,  N=4  CON,  N=4  KO.  Adiposity  was  measured  for  CON  and  KO  
animals  after  11  weeks  of  HFD  feeding  as  a  percentage  of  scWAT  over  body  weight  (D).  
Data  were  analyzed  by  two-­tailed  Student’s  T-­Test,  N=4  CON,  N=4  KO.  For  all  error  bars  
are  SEMs.  *p  <  0.05,  **p  <  0.01,  ***p  <  0.001,  ****p  <  0.0001.  
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Figure  4.    Cold  induced  neuroimmune  cells  (CINCs)  hone  in  to  inguinal  scWAT  and  
express   Bdnf.   Adult   (12   week   old)   male   C57BL/6   were   either   maintained   at   room  
temperature  (RT)  or  cold  exposed  (5°C)  for  5  days,  ATMs  from  inguinal  scWAT  depots  
were   isolated   using   magnetic-­activated   cell   sorting   (MACS)   by   positive   selection   of  
CD11b+   followed   by   F4/80+   cells.   Bdnf   gene   expression   in   doubly   labeled   CD11b+  
F4/80+  macrophages  was  compared  between  RT  and  cold  exposed  animals  (A).  Data  
were  analyzed  by  two-­tailed  Student’s  T-­Test,  N=4  per  group.  Adult  (12  week  old)  female  
control  animal  were  either  maintained  at  room  temperature  (RT)  or  cold  exposed  (5°C)  
for  10  days,  SVF  from  bilateral  inguinal  scWAT  was  isolated  and  FACS  sorted  using  a  23  
cell   surface  marker  panel   for  myeloid   lineage   immune  cells   (B-­D).  Changes   in  M1/M2  
polarity  (B)  and  Ly6C+  macrophage  precursors/monocytes  (C)  were  measured  between  
RT  and  cold  exposed  animals.  Data  were  analyzed  by  two-­tailed  Student’s  T-­Test,  N=3  
per  groups.  Spanning-­tree  Progression  Analysis  of  Density-­normalized  Events  (SPADE)  
analysis  was  performed  to  identify  myeloid  lineage  cell  population  changes  in  response  
to  cold  exposure;;    Ly6c+CCR2+  and    Ly6c+CCR2+Cx3cr1+  were  identified  as  adipose  
cold  induced  neuroimmune  cells  (CINCs)  (E).  Data  representative  of  N=3  per  group.  Adult  
(12-­13  week  old)  male  C57BL/6  were  either  maintained  at  room  temperature  (RT)  or  cold  
exposed  (5°C)  for  14  days;;  SVF  from  bilateral   inguinal  scWAT  was  isolated  and  FACS  
sorted   (E-­F).   Previously   identified   CINCs,   Ly6c+CCR2+Cx3cr1-­   and  
Ly6c+CCR2+Cx3cr1+  cells  were  compared  between  RT  and  cold  exposed  animals  (E).  
Bdnf  gene  expression  was  measured  in  Ly6c+CCR2+Cx3cr1+  cells  (F).  Data  analyzed  
by  two-­tailed  Student’s  T-­Test,  N=4  per  group.  For  all  error  bars  are  SEMs.    *p  <  0.05,  
**p  <  0.01,  ***p  <  0.001,  ****p  <  0.0001.  
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Supplemental   Figure   S1.      Further   basal   phenotyping   of   LysMcre/-­:BDNFfl/fl   (KO)  
animals.  Adult   (29  week  old)  male  LysM-­/-­:BDNFfl/fl   (CON)  and  LysMcre/-­:BDNFfl/fl   (KO)  
were  assessed  under  basal  condition  for  body  weight  and  subcutaneous  adiposity  (A).  
Data  analyzed  by  two-­tailed  Student’s  T-­Test,  N=5  CON,  N=6  KO.  Immunostaining  of  the  
presynaptic   nerve   and   vesicles   (neurofilament   and   SV2,   in   green)   and   postsynaptic  
acetylcholine  receptors  (in  red)  was  performed  on  fast  twitch  (medial  gastrocnemius)  and  
slow  twitch  (soleus)  muscles  to  allow  visualization  and  assessment  of  the  neuromuscular  
junction  (NMJ)  (B).    Data  analyzed  by  two-­tailed  Student’s  T-­Test,  and  representative  of  
male   23-­25  week  old  CON  and  KO  mice,  N=3  per   group.  For   the   same  group,   axon  
numbers  of  spinal   (L5  ventral   root),  motor,  and  sensory  nerves  were  counted   through  
cross-­section  electron  microscopy  imaging  (C).  For  all  error  bars  are  SEMs    
  












































B. BAT histology and UCP1 







































Supplemental  Figure  S2.     Assessment  of  BAT   in  LysMcre/-­:BDNFfl/fl  (KO)  animals.  
Adult  (12-­25  week  old)  male  LysM-­/-­:BDNFfl/fl  (CON)  and  LysMcre/-­:BDNFfl/fl  (KO)  animals  
were  cold  (5°C)  exposed  in  diurnal  chambers  for  5-­7  days  (A-­B).  Protein  expression  of  
UCP1,  tyrosine  hydroxylase  (TH)  and  PGP9.5  in  BAT  was  compared  between  CON  and  
KO   mice   (A).   Data   analyzed   by   two-­tailed   Student’s   T-­Test,   N=6   CON,   N=8   KO.    
Immunostaining  for  UCP1  (green)  was  performed  on  paraffin  embedded  cut  sections  of  
BAT   from  CON  and   KO   animals   (B).   Typogen   black   staining   shows   cell  morphology,  
images  taken  with  40X  objective  for  total  magnification  of  400X.  Data  representative  of  
N=6  CON,  N=8  KO.  Adult   (12-­13  weeks  old)  male  C57BL/6J  mice  were  maintained  at  
room  temperature  (RT)  or  cold  exposed  (5°C)  for  10  days,    or  received  either  daily  i.p.  
injections  of  ADRβ3  agonist  CL316,243  (at  1.0  mg/kg  BW),  or  vehicle    for  14  days.  Ex  
vivo  secretions  (collected  at  1hr  and  2hr)  from  BAT  explants  were  measured  for  BDNF  by  
ELISA,  and  not  analyzed  due  to  low  N  of  control  animals,  N=2  RT/VEH,  N=4  Cold/CL.  
  





Supplemental  Figure  S3.    Adrβ3  gene  expression  in  CINCs.  Adult  (12-­13  week  old)  
male  C57BL/6  were  either  maintained  at  room  temperature  (RT)  or  cold  exposed  (5°C)  
for  14  days;;  SVF  from  bilateral  inguinal  scWAT  was  isolated  and  FACS  sorted  to  isolate  
CINCs.  Adrβ3  gene  expression  was  measured  in  Rt  and  cold  exposed  
Ly6c+CCR2+Cx3cr1+  cells  (F).  Data  analyzed  by  two-­tailed  Student’s  T-­Test,  N=4  per  
group.  For  all  error  bars  are  SEMs.      
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   The  work  presented  here  intensifies  to  our  understanding  of  brain-­adipose  
communication  and  brings   to   light  many  more  questions.  We  have  provided  a  deeper  
knowledge  of  adipose  neuroanatomy;;  and  by  gaining  a  fuller  appreciation  of  form  we  are  
allowed  more  insight  into  function,  thus  informing  further  mechanistic  studies  regarding  
adipose   innervation  and  the  role   it  plays   in  maintaining  energy  homeostasis.  We  have  
shown  that  adipose  innervation  is  heterogenous  within  a  depot,  yet  overall  patterned,  and  
that  it  can  undergo  remodeling  under  certain  conditions.  Although  we  see  adipose  nerves  
within  parenchymal  space,  and  interacting  with  vasculature  and  cells  within  the  SFV,  we  
have  yet  to  establish  how  and  where  synaptic  connections  are  formed  in  adipose  tissue,  
and   what   affects   their   establishment.   Formation   of   these   synaptic   contacts   under  
pathophysiological   conditions   remains   to   be   investigated.   We   have   shown   adipose  
neuropathy  under  conditions  of  obesity,  diabetes,  dietary  toxicity,  and  aging.  However,  
the  etiology  of  each  requires  further  probing.    We  have  shown  that  the  neurotrophic  factor  
BDNF  is  diminished  in  neuropathic  adipose  tissue,  and  that  AAV-­mediated  BDNF  gene  
therapy  may  be  beneficial   in  reestablishing  adipose  innervation  under  obesity/diabetes  
related  adipose  neuropathy.    Although,  we  do  not  yet  know  what  mechanisms  drive  this  
observed  decrease   in  BDNF,   it   is  clear   that  BDNF  plays  an   important   role   in  adipose  
innervation.    We  have  presented  evidence  that  myeloid  cell  derived  BDNF  is  required  for  
adult  adipose  innervation,  and  that  animals  that  lacking  BDNF  in  myeloid  cells  exhibit  a  
genetic  denervation  of  their  subcutaneous  adipose  tissue.    As  with  surgical  or  chemical  
adipose   denervation,   this   genetic   denervation   is   accompanied   by   impaired   energy  




We  have  also  shown  in  mouse  models  that  adipose  BDNF  is  increased  by  exercise  
and   cold   exposure,   and   that   this   increase   is   accompanied  by   an   increase   in   adipose  
innervation.  These  findings  further  implicate  BDNF  as  a  regulator  of  adipose  innervation.  
During  our  search  for  the  source  adipose  BDNF,  we  discovered  a  subset  of  immune  cells,  
CINCs,   that   hone   into   adipose   tissue   in   response   to   cold   exposure   and   express  
adrenergic   receptors   as   well   as   BDNF.   We   believe   these   cells   represent   the  
neuroimmune   junction   in  regulating  adipose   innervation.  Further   investigation   into  how  
CINCs  are   recruited   to  adipose  and   the  evidence  of   their   sexual  dimorphism   requires  
continued  investigation.    Insight  into  the  recruit  of  CINCs  may  come  from  investigating  the  
adipose  lymph  node.  The  subiliac  lymph  node  is  the  main  drainage  lymph  node  in  inguinal  
adipose  tissue,  and  a  nexus  of  immune  cells.  As  interstitial  fluid  drains  though  the  lymph  
node,  fatty  acids,  hormones,  neurotransmitters,  and  other  solutes  interact  with  immune  
cells   in   the   lymph   nodes.   This   provides   another   point   of   communication   between   the  
adipose  organ  and  the  rest  of  the  body  as  lymphatic  vessels  return  tissue  fluid  to  blood  
vessels.  Through  our  exploration  of  adipose  neuroanatomy,  we  made   the  observation  
that  the  subiliac  lymph  node  is  highly  innervated.  This  innervation  made  be  critical  in  the  
lymph  node’s  ability   to  properly  drain  adipose   interstitial   fluid  which  may  be  harboring  
critical  information  regarding  the  needs  of  the  adipose  organ.    The  role  of  the  lymphatic  
system   in   adipose   innervation   is   currently   understudied   and   should   be   considered   in  
future  studies  of  neuroimmune  interactions.    
A   common   thread   in   the   pathophysiological   conditions   of   adipose   neuropathy  
observed   is   inflammation.      Obesity,   diabetes,   and   dietary   toxicity   from   a   peroxidized  




associated  with   the  pro-­inflammatory  senescence  associated  secretory  profile  (SASP).  
Further  studies  aimed  at  resolving  chronic  inflammation  in  the  adipose  tissue  may  prove  
insightful   in  providing  a  mechanism  for   the  onset  of  adipose  neuropathy.   Interestingly,  
inflammation  may  also  play  a  role  in  promoting  adipose  innervation.  Under  conditions  of  
exercise  and  cold  exposure  mediated  noradrenergic  stimulation  the  body  undergoes  an  
acute  state  on  inflammation.  Furthermore,  the  CINCs  which  we  propose  secrete  BDNF  
to  mediate  neurite  outgrowth  in  adipose  tissue,  exhibit  a  pro-­inflammatory  profile.    This  
combined  with  the  potential  involvement  of  the  lymphatic  system  in  adipose  innervation  
opens   new   areas   of   inquiry   in   the   study   in   neuroimmune   interactions   in   adipose  
innervation.  




APPENDIX  A:  Supplemental  Material  Chapter  2  
Extended  Materials  and  Methods  
Mice,  Metabolic  Phenotyping,  and  in  vivo  Analyses  
   Dietary  fat  interventions  and  food  intake  
Six  diets  enriched  for  either  low  or  high  saturated  fatty  acids  (SFA),  low  or  high  omega-­6  
polyunsaturated  fatty  acids  (n-­6  PUFA)  and  low  or  high  omega-­3  polyunsaturated  fatty  
acids  (n-­3  PUFA),  with  equal  sugar  and  protein  content  were  designed  (with  Research  
Diets,  New  Brunswick,  NJ;;  Table  1).  Low  and  high  SFA  and  n-­6  PUFA  diets  were   the  
same  as  our  previously  published  diets  [1].  Coconut  oil,  a  common  source  of  saturated  
fat   in  obesity  and  diabetes  studies   [2],  was  used  as   the  source  of  saturated   fat   in  our  
custom  diets.   n-­3  PUFA  diet  was   created  with  menhaden   fish   oil,   supplied   by  Nordic  
Naturals  (Watsonville,  CA).  The  menhaden  oil  provided  by  Nordic  Naturals  was  produced  
in  adherence  with  the  European  Pharmacopoeia  Standard  and  voluntary  standards  set  
by  the  Global  Organization  for  EPA  and  DHA  Omega-­3  (GOED),  the  International  Fish  
Oils  Standards  (IFOS)  program,  World  Health  Organization  (WHO)  fish  oil  monograph,  
and  California’s  Proposition  65  (PROP  65)  to  ensure  purity  and  quality.  Menhaden  oil  was  
maintained  under  a  protective  nitrogen  environment  (oxygen-­free)  until  the  custom  diet  
manufacturing  process  began  to  reduce  risk  of  peroxidation.  The  manufacturing  process  
itself,  carried  out  by  Research  Diets,  used  heatless  mechanical  pellet   formation  which  
relied  solely  on  pressure.  Upon  manufacture,  diets  were  maintained  at  -­20°C  in  airtight  
containers,  and  thawed  in  small  batches  for  daily  feeding.  All  custom  diets  were  fed  to  
adult  (10  week  old)  C57BL/6J  male  mice  for  16  weeks,  concurrent  with  body  weight  and  




which  had  8  animals.  For  the  duration  of  the  study,  mice  were  caged  2-­3  per  cage.  Food  
intake  was  measured  every  day  for  7  days,  then  weekly  until  28  days,  and  values  for  each  
cage  were  divided  by  the  number  of  mice  per  cage  to  obtain  a  daily  intake  per  mouse.  
Special   care  was   taken   to   ensure   accurate   food   intake   data   by   thoroughly   searching  
bedding   for   crumbled   food   pellets   to   obtain   accurate   food   weights.   Adiposity   was  
assessed  at  the  end  of  the  study,  and  hypothalamus,  subcutaneous  white  adipose  tissue  
(scWAT)  and  intrascapular  brown  adipose  tissue  (iBAT)  depots  were  harvested  and  sent  
for  lipidomic  analysis  with  Berg,  which  included  a  measure  of  non-­enzymatic  (peroxidized)  
lipids.    
   Power  Analysis    
Numbers  of  mice  per  group  were  based  on  power  calculations  and  previously  published  
data  using  a  subset  of  these  diets  [1],  given  the  predicted  difference  between  groups  
that  is  expected  (in  terms  of  natural  variations  in  body  weight  due  to  diet).  For  these  
studies,  we  used  the  G*Power  3.1  software,  with  an  effect  size  of  5,  power  of  0.85,  an  
alpha  level  of  0.05  and  10  degrees  of  freedom.  We  calculated  based  on  the  endpoint  of  
variation  in  body  weight,  based  on  data  from  our  previous  experiments  and  wanting  to  
detect  a  difference  of  5g  body  weight  for  3  groups  (ie:  all  high  fat  or  all  low  fat,  thus  an  
effect  size  of  5.    This  gave  us  N=6  per  group.  
CLAMS  
Metabolic   cage   analyses   were   conducted   in   a   Comprehensive   Laboratory   Animal  
Monitoring   System   (CLAMS;;   Columbus   Instruments,   Columbus,   OH),   allowing   for  
measurement  of  oxygen  consumption  (VO2)  and  carbon  dioxide  production  (VCO2),  from  




calculated:  RER=VCO2/VO2;;  Energy  expenditure  (heat)  =  CV  *  VO2    cal/hr,  where  CV  is  
the  “caloric  value”  as  given  by  CV  =  (3.815  +  1.232)  *  RER.  Each  animal  was  placed  in  a  
bedding  free  CLAMS  cage  and  acclimated  for  24-­48hrs,  after  which  VO2,  VCO2,  RER,  
and   Heat   were   measured   every   15min   for   3   days   (72hrs).   Throughout   the   CLAMS  
assessment   animals   were   housed   at   room   temperate   on   a   12hr   light/dark   cycle.  
Waveform   analysis   of   CLAMS   data   was   performed   by   matching   each   15min  
measurement  for  each  of  the  three  24hr  time-­points  measured  for  each  animal.  A  two-­
way  repeated  measures  analysis  of  variance  (RM,  ANOVA)  was  performed  showing  the  
average  VO2,  VCO2,  RER,  and  Heat  per  group,  allowing  for  better  analysis  of  variation.  
An  uncorrected  Fishers  Least  Significance  Difference  test  was  performed  for  each  time  
point  between  dietary  groups  as  a  post-­hoc  test.  Interaction  P  values  are  reported,  which  
represent  differences  in  24hr  data  between  groups,  as  well  as  multiple  comparison  results  
for  differences  which  were  only  day/night  phase  specific.  
Glucose  Tolerance  Test  (GTT)  
Animals  were  fasted  overnight  for  16hr,  after  which  they  received  an  intraperitoneal  (i.p.)  
bolus  injection  of  1g/kg  glucose.  Blood  glucose  was  measured  using  tail  vein  blood  with  
a  hand  held  glucometer  (OneTouch  UltraMini,  LifeScan,  Milpitas,  CA,  Johnson&Johnson,  
New  Brunswick,  NJ),  at  time  0  and  at  intervals  of  15  minutes,  30  minutes,  and  70  minutes  
after  injection.    
Thiobarbituric  Acid  Reactive  Substances  (TBARS)  Assay  
To   independently   determine   peroxidation   of   our   n-­3   PUFA   diets,   a   malondialdehyde  
(MDA,  a  common  by-­product  of  lipid  peroxidation)  production  assay  was  performed  using  




Several  common  fish   food  products  along  with  omega-­3   fish  oil  supplements  (both   for  
human  consumption)  were  assayed  concurrently  with  the  mouse  diets.    
Histology  
Hematoxylin   staining   of   paraffin-­embedded,   10uM   slices   of   adipose   tissues   was  
performed  to  determine  cell  size  and  to  assess  browning  (multilocularity)  and  crown-­like  
structures.   With   hematoxylin   staining   lipofuscin   appears   as   yellow-­brown   granules.  
Trichrome  staining  was  performed  using  a  kit  for  connective  tissue  (Abcam,  Cambridge,  
UK).  Autofluorescence  of  lipofuscin  in  paraffin-­embedded  adipose  tissues  was  detected  
using   a   Nikon   Eclipse   E400   epiflourescent   microscope   equipped   with   Nikon   DS-­fi2  
camera.      
ELISA  
Mouse   sera   were   used   to   measure   circulating   levels   of   Interleukin   10   (IL10)   and  
adiponectin  (High  molecular  weight  (HMW)).    Circulating  concentrations  were  determined  
by  Enzyme-­Linked  Immunosorbant  Assays  (ELISA)  at  Maine  Medical  Center  Research  
Institute’s  Core  Facilities  (Scarborough,  ME).    
Western  Blot  
Western  blotting  analysis  was  performed  to  measure  protein  expression  of  tyrosine  
hydroxylase  (TH)  in  whole  adipose  tissue  depots.  Protein  lysates  were  prepared  by  
homogenizing  frozen  tissue  in  RIPA  buffer  using  a  Bullet  Blender  (Next  Advance,  Averill  
Park,  NY).  Primary  antibodies  utilized  included  anti-­TH  (Millipore  Cat.  #  AB152;;  Merck  
Millipore,  Burlington,  MA)  and  anti-­â-­actin  (Abcam  Cat.  #  ab8227)  as  housekeeper,  
which  were  both  used  at  1:1000  dillutions.  Secondary  antibody  was  anti-­rabbit  HRP  




enhanced  chemiluminescence  (ECL;;  Pierce)  on  a  Syngene  G:BOX.    TH  protein  
expression  was  normalized  to  â-­actin  and  quantified  in  Image  J.  
Gene  Expression  (qPCR)  
RNA  was  isolated  from  whole  tissue  depots  using  Trizol  reagent;;  a  Bullet  Blender  was  
used  to  enhance  cell  lysis,  and  total  RNA  extracted  using  a  Zymo  (Irvine,  CA)  kit.  RNA  
yield  was   determined  on   a  Nanodrop;;   cDNA  was   synthesized  using   a  High  Capacity  
Synthesis  Kit  (Applied  Biosystems,  Foster  City,  CA).  Real-­time  quantitative  (q)PCR  was  
performed  with   SYBR  Green   (Bio-­Rad,   Hercules,   CA)   and   the  CFX96   real-­time  PCR  
detection   system   (Bio-­Rad,   Hercules,   CA).   Relative   quantification   analysis   and   fold  
change   was   performed   with   all   values   normalized   to   levels   of   a   housekeeper   gene  
(cyclophilin).  Primer  sequences  are  listed  in  Supplemental  Table  S1.  
Statistical  Analysis  
   For  all  animal  experiments,  mice  were  randomized  to  treatment  groups  in  order  to  
avoid  starting  differences  in  body  weight.    All  plots  represent  mean  +/-­SEM.    Statistical  
calculations  were  carried  out  in  Excel  (Micosoft,  Redmond,  WA)  or  GraphPad  (La  Jolla,  
CA)  Prism  programs,  utilizing  ANOVA  or  Student’s  T-­test  as  indications  of  significance.  
GTT   was   analyzed   by   two-­way   ANOVA   with   Uncorrected   Fisher’s   Least   Significant  
Difference  test  used  to  make  multiple  comparisons  between  dietary  groups.  TBARs  data  
were  analyzed  by  ANOVA  with  Bonferroni’s  post  hoc  test.  Gene  and  protein  expression  
data  were  normalized  to  a  housekeeper  and  analyzed  by  either  ANOVA  or  by  Student’s  
t-­test,  two-­tailed,  using  Welch’s  correction  when  variance  was  unequal.  To  test  the  effects  
of  diet  and  tissue  type,  we  used  non-­metric  multidimensional  scaling  (NMDS)  ordination  




differences  in  abundances  of  lipid  species,  were  calculated  on  loge(+1)-­transformed  data.  
Differences  in  lipid  species  structure  between  diet,  tissue  type,  and  their  interaction  was  
tested  using  permutational  multivariate  analysis  of  variance  (PERMANOVA)  with  9999  
permutations  using  the  adonis  function  in  the  vegan  package  [3]  in  R  [4].    Other  statistical  
analyses  are  described  in  the  relevant  Methods  section  above.    Error  bars  are  SEMs.  For  
all  figures,  *p  <  0.05,  **p  <  0.01,  ***p  <  0.001,  ****p  <  0.0001.    
Ethical  Statement  
All  procedures  and  handling  of  animals  were  performed  in  accordance  with  the  University  
of  Maine’s   Institutional  Animal  Care   and  Use  Committee   (IACUC),   to   comply  with   the  
guidelines  of  the  PHS  Policy  on  Humane  Care  and  Use  of  Laboratory  Animals,  and  Guide  
for  the  Care  and  Use  of  Laboratory  Animals.      
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Supplemental Figure S1: Body weight gain over time 
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Supplemental  Figure  S1:  Body  weight  gain  over  time.  (A)  Body  weight  represented  
as   percent   change   over   time.   By   week   2   the   high   n-­3   PUFA   group   had   significantly  
diverged  from  high  SFA  and  high  n-­6  PUFA  (p=0.0014  and  p=0.0065  respectively).  By  
week  16  the  change  in  body  weight  from  the  start  of  diet  treatment  had  further  diverged  
for  the  high  n-­3  PUFA  animals  when  compared  to  high  SFA  and  high  n-­6  PUFA  (p>0.0001  
and  p=0.0012,  respectively).  Percent  change  in  body  weight  was  comparable  between  
high  SFA  and  high  n-­6  PUFA,  and  within  all  the  low  fat  diets.  (B)  Average  body  weight  (in  
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VCO2 low fat Two-way ANOVA , not RM
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Supplemental  Figure  S2:  Metabolic  cage  measurements  for  low  PUFA  groups.  (A-­
C)   Oxygen   consumption   (VO2),   carbon   dioxide   production   (VCO2),   and   energy  
expenditure  (heat)  did  not  vary  between  low  n-­3  PUFA  and  low  n-­6  PUFA  diet  groups.  
(D)   Interaction   of   time  and  dietary  group  was  observed   for   respiratory   exchange   ratio  
(RER),  indicating  a  preference  for  lipid  fuel  utilization  of  the  low  n-­3  PUFA  animals  during  
the  dark  phase.  Data  presented  as  waveforms  of  a  24hr  cycle  with  measurements  taken  
over  3  days,  analyzed  by   two-­way  ANOVA  with  uncorrected  Fisher’s  LSD;;  black  bars  
represent  dark  phase,  N=4  per  group.  Error  bars  are  SEMs.  *p  <  0.05,  **p  <  0.01,  ***p  <  
0.001,  ****p  <  0.0001.  





     
Supplemental Table S1: Primers used for qPCR
qPCR Primers
Gene Forward Sequence Reverse Sequence
atgl GTGAAGCAGGTGCCAACATTAT AAACACGAGTCAGGGAGATGC 
bdnf CAG GTG AGA AGA GTG ATG ACC ATT CAC GCT CTC CAG AGT CCC
elovl3 GCCTCTCATCCTCTGGTCCT TGCCATAAACTTCCACATCCT
hsl TCATGGCTCAACTCCTTCCT GCTGCCTCAGACACACTCCT 
il4 GGTCAACCCCCAGCTAGT GCCGATGATCTCTCTCAAGTGAT






synapsin I CATGGCACGTAATGGAGACTACCGCA CCGCCAGCATGCCTTC
synapsin II GCCACCAGGTTAAGCTCTGA TTCCAGGAAGGCCAAGGT
synaptophysin TGACTTCAGGACTCAACACCTC CAGGAGCTGGTTGCTTTTCT
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APPENDIX  B:  Supplemental  Material  Chapter  3  
Supplemental  Methods  
Von  Frey  Analysis  
A  Von  Frey  mechanical  nociceptive  assay  was  performed  on  BTBR  mice  ranging  from  
12-­24  weeks  of  age,  to  determine  tactile  sensitivity  of  hind  paw  skin,  according  to  protocol  
described  by  Feldman  et  al.  2009.  Briefly,  each  mouse  was  subjected  to  five  filaments  
(Semmes-­Weinstein  evaluators)  at  varying  strengths  (4.56,  4.31,  4.08,  3.61,  2.36),  which  
corresponded  to  specific  target  forces  (4,  2,  1,  0.4,  0.02  –  grams  of  force  (g),  (Stoelting  
Co.,  Wood  Dale,  IL)).  For  the  Von  Frey  evaluations,  mice  were  placed  on  top  of  a  grid  
platform   into   individual   clear-­walled   compartments   and   allowed   to   acclimate   with   no  
stimulus  for  at  least  20  minutes.  After  the  acclimation  period,  trials  began  and  filaments  
were  applied  in  order  of  decreasing  strength.  Each  filament  was  applied  to  the  mid-­plantar  
surface  of  the  hind  paw  and  slight  pressure  applied  until  the  mouse  showed  a  response  
or   the   filament   bent   with   force.   Mouse   response   was   recorded   as   either   positive  
(immediate  paw  removal  or  paw  licking  when  filament  is  applied),  neutral  (delayed  paw  
removal),  or  negative  (no  reaction),  and  each  filament  strength  test  was  performed  in  5  
cycles.    
DRG  collection  
Animals  were  euthanized  and  T13-­L1  DRGs  were  extracted  as  previously  described[1].  
Briefly,  muscle,  fat  and  soft  tissue  is  cut  away  from  the  spinal  column;;  the  T13  DRG  pair  
is  readily  located  caudal  to  the  most  caudal  ribs  which  were  used  as  orienting  landmarks.  




the  spinal  cord  was  removed  in  a  rostral  to  caudal  direction.  Meninges,  which  cover  the  
ganglia   were   carefully   removed   as   well.   Bilateral   T13-­L1   DRGs   were   collected   and  
immediately   frozen   in   liquid   nitrogen,   for   further   processing   as   described   in   RNA  
Extraction  and  Gene  Expression  section  below.  
CL  Injections  
Adult  (12-­13  week  old)  male  C57BL/6  mice  received  daily  i.p.  injections  of  ADRβ3  agonist  
CL316,243   (Tocris   Bioscience,   Bristol,   U.K.;;   Cat   #   1499),   at   1.0  mg/kg   BW   or   an  
equivalent  amount  of  sterile  saline,  for  10-­14  days.    
Collection  of  adipose  secretions  and  BDNF  ELISA  
Inguinal  scWAT  depots  were  dissected,  weighed  and  minced  in  a  petri  dish  containing  
DMEM  (high-­glucose,  serum-­free).  Minced  tissue  was  transferred  to  a  15mL  conical  tube,  
with  5mL  DMEM  (loosely  capped  to  keep  tissue  oxygenated)  and  placed   in  a  shaking  
water   bath   at   37°C.   Secretions   were   collected   at   time   0,   1hr,   2hrs,   and   3hrs   (1mL  
collected   from   conical   tube   at   each   time   point   and   replaced  with   1mL   fresh  DMEM).  
Secretions  were   stored  at   -­80°C  until   processing.   For  ELISA,   protein   secretions  were  
concentrated   using   Amicon®   Ultra   Centrifugal   Filters,   Ultracel®-­100K   (Millipore,  
Burlington,  MA  USA;;  Cat.  #  UFC510096),  per  manufacturer’s  instructions.  Mouse  BDNF  
PicoKine™   ELISA   Kit   (Boster   Biological   Technology,   Pleasanton,   CA,   USA;;   Cat#  
EK0309)  was  used  per  manufacturer’s  instruction  to  determine  amount  of  BDNF  present  





BDNF  Mulitplex  ELISA  
BDNF  expression  in  protein  lysates  of  inguinal  scWAT  from  3-­day  cold  exposed  adult    (16  
weeks   old)  male   and   female  C57BL/6J  was  measured   using  MILLIPLEX  MAP  Mouse  
Myokine  Magnetic  Bead  Panel  (Millipore,  Burlington,  MA  USA,  Cat.  #  MMYOMAG-­74K;;  
MILLIPLEX  Magnetic  Microspheres  Cat.  #  RBDNF-­MAG).  Protein  lysates  were  prepared  
as   described   under  Western   Blotting   (below).   The   Luminex   xMAP  MAGPIX®   system  
(Austin,  TX,  USA)  was  used  to  detect  BDNF  in  protein  samples,  data  was  analyzed  with  
MILLIPLEX®  Analyst  5.1  software  (Millipore,  Burlington,  MA  USA)  accounting  for  then  2-­
fold  dilution,  then  normalized  to  total  protein  (previously  determined  by  Bradford  Assay).    
AAV  Vector  Construction  and  Package  
HA-­tagged   human   BDNF   cDNA   was   subcloned   into   a   novel   AAV   plasmid   of   dual  
cassettes  that  restricts  off-­target  transduction  in  liver  [2].    The  rAAV  plasmid  contains  a  
vector  expression  cassette  consisting  of  the  CMV  enhancer  and  CBA  promoter,  WPRE,  
and  bovine  growth  hormone  (bGH)  poly-­A   flanked  by  AAV2   inverted   terminal   repeats.  
Engineered   hybrid   serotype   Rec2   vectors   were   packaged   and   purified   as   described  
previously  [3].    
AAV-­BDNF  delivery  
16  week  old  male  BTBR  MUT  mice  were  injected  once  in  the  left   inguinal  scWAT  with  
1x1010   vg   of   AAV-­BDNF,   while   the   right   inguinal   scWAT   received   an   equal   volume  
injection   of   vehicle   (AAV  buffer).  Virus  was   constructed  by  Dr.   Lei  Cao  as   previously  
described  [2].  Animals,  were  carefully  observed  and  scored  for  malaise  for  48  hours  after  




After   2   weeks   animals   were   sacrificed,   inguinal   scWAT   depots   were   harvested   and  
processed  for  western  blot  analysis.    
Mouse  adipose  tissue  collection  and  analyses;;  immunostaining  
Mice  were  euthanized,  whole  subcutaneous  white  adipose  tissue  (scWAT)  depots  were  
carefully   removed   to   remain   intact   depots,   and   fixed   in   2%  PFA  at   4°C   for   4hr-­12hrs  
depending  on  thickness  of  tissue.  The  tissues  were  then  rinsed  for  10  minutes  with  1X  
PBS   w/   10u/mL   heparin,   twice   at   4°C.   Tissues   were   incubated   in   blocking   buffer  
(1XPBS/2.5%  BSA/0.5-­1%  Triton)  at  4°C  at   least   overnight   but   no  more   than  7   days,  
depending  on  tissue  size,  with  blocking  buffer  replaced  every  24hr  period.  After  blocking  
period,   tissues  were   flattened   by   being   placed   between   two   large   glass   slides   bound  
tightly   together,   for  at   least  30min  but  no  more   than  1.5hrs  at  4°C.  Tissues  were  next  
incubated  with  0.03%  Typogen  Black  for  20  minutes  at  room  temperature  on  a  rotating  
platform  to  minimize  autofluorescence.  Following  Typogen  Black  incubation,  tissues  were  
washed  with  1X  PBS  w/  10u/mL  heparin  on  rotating  platform  at  4°C  replacing  PBS  every  
1hr   for   a   total   of   4-­6hrs,   or   until   all   unbound   stain   was   removed.   Immunostaining   of  
innervation  with  primary  antibodies  was  performed  overnight  at  4°C,  and  the   following  
day  tissues  were  washed  with  1XPBS  on  a  rotating  platform  at  4°C,  replacing  PBS  every  
1hr  for  a  total  of  4-­6hrs  followed  by  incubation  with  secondary  fluorescent  antibodies.    
Primary  antibodies  included:  PGP9.5  (1:1000,  Abcam,  Cambridge,  U.K.  Cat.  #10404  and  
#108986);;  post  synaptic  density  protein  95  (1:1000-­1:5000,  Abcam,  Cambridge,  U.K.  Cat.  
#18258);;   TH   (1:250,   Millipore,   Burlington,   MA   USA;;   Cat.   #   AB152);;   NAv1.8   (1:500,  




beta-­3   tubulin,   (6G7,   1:250)   and   synaptic   vesicles   (SV2,   1:250)   from   Developmental  
Studies   Hybridoma   Bank,   (University   of   Iowa,   USA).      Secondary   antibodies   included  
Alexa  Fluor   488  at  1:500  and  Alexa  Fluor   594  at   1:1000   from  Molecular  Probes.  For  
vascular  autofluorescence  visualization  tissues  were  not  washed  in  1X  PBS  w/  10u/mL  
heparin,  prior   to  further   immunostaining.  For  vascular  staining,   tissues  were   incubated  
with  isolectin  IB4  stain  conjugated  to  Alexa  594  (ThermoFisher  Scientific,  Waltham,  MA,  
USA;;  Cat   #   I21413)   at  1μg/mL   concentration   overnight   at   room   temperature.  Tissues  
were  washed   in   1X  PBS   and  mounted   on   slides.   Images  were   acquired  using  Nikon  
Eclipse  E400  epiflourescent  microscope,  Nikon  A.1  confocal  microscope  (Nikon,  Minato,  
Tokyo,   Japan)   or   Leica   TCS   SP8   (Leica   Microsystems,   Wetzler,   Germany)   digital  
lightsheet/confocal  microscope.  
Neuromuscular  junction  immunofluorescence,  imaging,  and  analysis  
Following  protocols  provided  by  Greg  Cox  and  Robert  Burgess  at  Jackson  Laboratory,  
mice   were   euthanized,   both   soleus   and  medial   gastrocnemius   tissues   were   carefully  
removed  and  fixed  in  a  2%  PFA  at  4°C  for  2  hours.  The  tissues  were  then  gently  rinsed  
with  1XPBS  and  incubated  in  blocking  buffer  (1XPBS/2.5%BSA/0.5-­1%Triton)  at  4°C  for  
at  least  24  hours  but  no  more  than  7  days.  After  blocking  period  muscles  were  teased,  
tendons  and  fat  were  removed  and  muscle  tissue  was  flattened  by  being  placed  between  
two   tightly-­bound   glass   slides   for   at   least   30   minutes   at   4°C.      Tissues   were   next  
transferred  to  fresh  blocking  buffer  at  4°C  for  at  least  12  hours,  but  no  more  than  7  days.  
Immunostaining  of  innervation  with  primary  antibodies  was  performed  overnight  at  4°C,  
the  following  day  tissues  were  washed  with  1XPBS  on  a  rotating  platform  at  4°C  replacing  




fluorescent  antibodies  overnight  and  washed  again   in  1XPBS  on  a  rotating  platform  at  
4°C   replacing   PBS   every   1hr   for   a   total   of   4-­6hrs.   Primary   antibodies   included:  
neurofilament-­M   (2H3,  1:500)  and  synaptic  vesicles   (SV2,  1:250)   from  Developmental  
Studies   Hybridoma   Bank,   (University   of   Iowa,   USA).   Secondary   antibodies   included:  
Alexa  Fluor  488  at  1:500  (A21121)  and  alpha-­bungarotoxin  (BTX)-­conjugated   to  Alexa  
Fluor  594  at  1:1000  (B13423)  from  Molecular  Probes  (Eugene,  OR,  USA).  Tissues  were  
next  mounted  on  microscope  slides  using  Millipore  mounting  fluid  (Burlington,  MA  USA;;  
Cat.  #  5013)  and  1  1/5  coverslips  then  sealed  and  allowed  to  set  overnight.  All  images  
were  acquired  with  Nikon  Eclipse  E400  epiflourescent  microscope  using  an   integrated  
‘Real   Time  Manual   EDF’   acquisition   tool   in  Nikon   Elements   Software   (Nikon,  Minato,  
Tokyo,  Japan).  Insert  images  were  cropped  in  FIJI.  Brightness,  contrast,  and  sharpness  
were  adjusted   in  Microsoft  PowerPoint.  Up  to  100  NMJs  were  counted   for  each  tissue  
and  statistics  were  conducted  in  GraphPad  PRISM  software  (La  Jolla,  CA,  USA)  using  
the  multiple  t-­tests  (one-­per  row)  function.  
RNA  Extraction  and  Gene  Expression  
Total  RNA  was  isolated  from  tissues  using  a  Trizol  reagent  (Zymo,  Irvine,  CA,  USA;;  Cat.  
#  R2050-­1-­200),  Bullet  Blender  for  lysis,  and  Zymo  Miniprep  kit  (Zymo,  Irvine,  CA,  USA;;  
Cat.  #  R2052).  RNA  yield  was  determined  on  a  Nanodrop  and  cDNA  synthesized  using  
High  Capacity  Synthesis  Kit  (Applied  Biosystems,  Foster  City,  CA,  USA;;  Cat#  4368813).  
Real-­time  quantitative  (q)PCR  was  performed  with  SYBR  Green  (Bio-­Rad)  and  CFX96  
real-­time  PCR  detection  system  (Bio-­Rad,  Hercules,  CA,  USA).  Relative  quantification  
analysis   and   fold   change   was   performed   with   all   values   normalized   to   levels   of   a  





Protein  expression  was  measured  by  western  blotting  analysis  of  tissue  lysates.  Whole  
adipose  depots  were   homogenized   in   RIPA  buffer   with   protease   inhibitors   in   a   Bullet  
Blender,  followed  by  Bradford  Assay,  and  preparation  of  equal-­concentration  lysates  in  
Laemmli  buffer.    60ug  was  loaded  per  lane  of  a  10%  polyacrylamide  gel,  and  following  
gel   running   proteins   were   transferred   to   PVDF   membranes   for   antibody   incubations.    
Tyrosine  hydroxylase  (TH)  antibody  (Millipore  Cat.  #  AB152)  at  1:1000  dilution  was  used  
with   both   mouse   and   human   protein   lysates.   Anti-­PGP9.5   antibody   (Abcam   Cat.  
#ab10404  and  #ab108986)  was  used  at  a  1:1000  and  1:500  dilutions  respectively,  were  
used  with   both  mouse  and  human  protein   lysates.  Anti-­PSD95  antibody   (Abcam  Cat.  
#ab18258)  at  1:750  dilution  was  used  with  both  mouse  and  human  protein  lysates.  TH,  
PGP9.5,   and   PSD95   protein   expression   was   normalized   to   one   of   the   following  
housekeeping   proteins,   all   at   1:1000   dilutions:   b-­tubulin   (Cell   Signaling   Technology,  
Danvers,  MA,  USA;;  Cat.  #  2146BC),  b-­actin  (Abcam,  Cambridge,  U.K.;;  Cat.  #  ab8227),  
cyclophilin  B  (Abcam,  Cambridge,  U.K.;;  Cat.  #ab16045).  Secondary  antibody  anti-­rabbit  
HRP-­linked   (Cell   Signaling   Technology,   Danvers,   MA,   USA;;   Cat.   #   7074)   at   1:3000  
dilution  was  used  for  conjugation  with  all  primaries.  Blots  were  visualized  on  a  Syngene  
G:BOX  (Frederick,  MD,  USA).  Ponceau  S  staining  was  performed  after  immunoblotting  







Cold  Exposure  Experiments  
All  cold  exposure  was  carried  out  in  a  diurnal   incubator  (Caron,  Marietta,  OH,  USA)  at  
5°C.  Animals  were  housed  two  to  a  cage  and  continuously  cold  exposed  for  3  -­  14  days.    
For  whole  adipose   innervation   imaging,  18-­22  week  old  control  male  mice  on  a  mixed  
genetic  background  were  housed  either  at  room  temperature,  cold  exposed  for  10  days,  
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Supplemental  Figure   S1:  Adiposity  &  Neuropathy  of   BTBR  ob/ob  mutant   (MUT)  
mice.     Male   and   female   BTBR  MUT  mice  were   assessed   for   total   body   weight   and  
adiposity  (inguinal  scWAT/body  weight),  and  compared  to  WT  or  HET  animals  in  a  pilot  
cohort  (a).  Female  BTBR  WT,  HET,  and  MUT  were  assessed  for  tactile  allodynia  via  the  
Von  Frey  assay,  an  indirect  measure  of  peripheral  neuropathy  (b).  Protein  expression  of  
PGP9.5   (c)   and   TH   (d)   in   inguinal   scWAT   of   HET,   MUT,   and   WT   BTBR   mice   was  
measured  via  western  blotting.  For  (a-­d),  males:  MUT  N=2;;  WT  N=3;;  HET  N=3;;  females:  
MUT:  N=1;;  WT:  N=3;;  HET:  N=3;;  all  mice  were  12-­24  weeks  old.  Data  represents  a  pilot  
cohort  to  compare  HET  to  MUT  mice,  and  males  to  females,  thus  statistical  analyses  were  
not  performed  due  to  small  sample  sizes.  Sample  Ponceau  S  staining   to  demonstrate  
equal  protein  loading  (e).  Whole  BAT  depots  were  compared  between  female  and  male  
BTBR  HET,  MUT,  and  WT  mice  (f).   Images  are  representative,  males:  MUT  N=2;;  WT  
N=3;;  HET  N=3;;  females:  MUT  N=1;;  WT  N=3;;  HET  N=3;;  all  mice  were  12-­24  weeks  old.  
Gene  expression  analysis  of  BAT,  inguinal  scWAT,  and  prWAT  (g-­i).  Gene  expression  
data  were  analyzed  by  two-­tailed  Student’s  t-­test,  using  Welch’s  correction  when  variance  
was  unequal,  N=4-­5  per  group.  Error  bars  are  SEMs.    





     






























Supplemental  Figure  S2:    Adipose  neuropathy  of  BTBR  ob/ob  mutant  (MUT)  mice.    
Neuromuscular  Junction  (NMJ)  Analysis  (a-­b).  Immunofluorescent  staining  of  male  BTBR  
WT  and  MUT  neuromuscular   junctions  of   the  medial   gastrocnemius   (MG)  and   soleus  
(SOL)  muscles  was  performed  using  neurofilament  M  (2H3)  and  synaptic  vesicles  (SV2)  
(in  green)  to  visualize  the  pre-­synaptic  area,  and  α-­bungarotoxin  (in  red)  to  visualize  the  
post-­synaptic  area.  Representative  images  at  40x  magnification  of  BTBR  ob/ob  wild-­type  
(WT)  medial  gastrocnemius  (MG)  (top  left  panel),  and  soleus  (bottom  left  panel).  Mutant  
(MUT)  MG  (top  right  panel)  and  SOL  (bottom  right  panel)  (a).  Inserts  are  of  occupied  (left  
panels)   and  partially   occupied   (partially   occupied)  NMJs   in   representative   images   (a).  
Percent   of   total   NMJs   for  WT   and  MUT   animals   in   both   MG   and   SOL  muscles   was  
calculated  as  an  indicator  of  neuropathic  state  (b).  Analysis  shows  multiple  t-­tests  (per  
row)  of  replicate  cohorts;;  N=7  for  WT  MG,  N=6  for  MUT  MG,  N=7  for  WT  SOL,  and  N=4  
for  MUT  SOL.    Error  bars  are  SEMs.  *p  <  0.05,  **p  <  0.01,  ***p  <  0.001,  ****p  <  0.0001.    





Supplemental Figure S3 – Human scWAT cell size and omental adipose innervation 




























































Cell Diameter of scWAT Correlated to 
PGP9.5 When Assessed by BMI (Fig. 1k)





























Cell Diameter of scWAT Correlated to 
PGP9.5 When Assessed by Age (Fig. 1l)





























Average Cell Diameter of Human scWAT Correlated to BMI and Age











































Supplemental  Figure  S3.  Human  scWAT  cell  size  and  omental  adipose  innervation.    
Average  cell  diameter  in  scWAT  of  human  samples  when  assessed  by  BMI  or  age  (a),  
and  normalized  protein  expression  plotted  against  average  cell  size  for  either  BMI  or  age  
cohorts  (b),  corresponds  to  western  blot  data  in  Fig.  1g-­h.  Cell  diameter  measured  from  
images  of  histological  cross-­sections  of  adipose  tissue  from  each  patient,  averaged  (n=3),  
and  analyzed  by  linear  regression.  Human  omental  adipose  samples  were  analyzed  for  
protein  expression  of  PGP9.5  via  western  blotting  (c-­d).  Linear  regression  was  performed  
with  respect  to  BMI  (c)  or  age  (d).  Protein  expression  was  normalized  to  β-­Actin  and  band  
intensities  were  quantified  in  Image  J.  Due  to  limitations  of  available  samples  from  the  
BNORC  adipose  tissue  core  at  Boston  Medical  Center,  the  BMI  distribution  of  omental  
adipose  was  clustered  around  40.  Error  bars  are  SEMs.    





     
Supplemental Figure S4 – Body weight, inguinal scWAT, and BAT  innervation of 
young/aged and sedentary/exercised (Run) mice
b.
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Supplemental   Figure   S4:   Body   weight   and   inguinal   scWAT   innervation   of  
young/aged  and  sedentary/exercised   (run)  C57BL/6J  mice.  Body  weight,  adiposity  
(inguinal  scWAT/body  weight  &  pgWAT/body  weight),  and  quadricep  muscle  weight  was  
measured  for  young  (12  weeks  old)  and  aged  (16  month  old)  mice  under  sedentary  (sed)  
and  exercised  (run)  conditions  (a).  Young  and  aged  sedentary  (sed)  groups,  N=4;;  young  
and   aged   exercised   (run)   groups  N=5.   Body   and   tissue  weight   analyzed  by   one-­way  
ANOVA,  with  Tukey  post  hoc,  groups  labeled  with  the  same  letter  (A  or  B)  are  statistically  
similar,  for  body  weight:  p=0.0473  for  young  sed  v.  aged  sed;;  p=0.0240  for  young  run  v  
aged   run.  Protein  expression  PGP9.5   (b)  and  TH   (c)   in   inguinal  scWAT  of  young   run  
versus   aged   run   mice   was   determined   by   western   blotting.   Protein   expression   was  
normalized   to   β-­Actin   or   Cyclophilin   B;;   band   density   was   quantified   in   Image   J   and  
analyzed  by   two-­tailed  Student’s   t-­test.  Protein  expression  of  PGP9.5  (d),  TH  (e),  and  
PSD95  (f)  in  BAT  of  young  (12  week  old)  sedentary  (young  sed)  versus  young  exercised  
(young  run)  mice  was  determined  by  western  blotting.  Protein  expression  was  normalized  
to  β-­tubulin  or  cyclophilin  B;;  band  density  was  quantified  in  Image  J  and  analyzed  using  
a  two-­tailed  Student’s  t-­test.  Gene  expression  analysis  of  BAT  from  young  (12-­15  week  
old)   sedentary   (young   sed)   versus   young   exercised   (young   run)  male  mice   (g),   gene  
expression  was  analyzed  by  two-­tailed  Student’s  t-­test,  N=4  for  sedentary  and  N=6  for  
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Supplemental  Figure  S5:  Innervation  of  vasculature  in  young  sedentary/exercised  
(run)  mice.    Body  weight,  adiposity  (inguinal  scWAT/body  weight  &  pgWAT/body  weight),  
and  quadricep  muscle  weight  was  measured   for  young   (12-­15  weeks  old)  mice  under  
sedentary  (sed)  and  exercised  (run)  conditions  (a).  Body  and  tissue  weight  analyzed  by  
one-­way  ANOVA  with  Tukey  post  hoc.  N=4  for  sedentary  and  N=5  for  run  groups.  Protein  
expression   for   PSD95   in   axillary   scWAT  was   determined   by  western   blotting.   Protein  
expression  was  normalized   to  β-­Tubulin;;   band  density  was  quantified   in   Image   J   and  
analyzed  by  two-­tailed  Student’s  t-­test.  Gene  expression  analysis  of  inguinal  scWAT  from  
young  (12-­15  week  old)  sedentary  (young  sed)  versus  young  exercised  (young  run)  male  
mice  (g),  gene  expression  was  analyzed  by  two-­tailed  Student’s  t-­test,  N=4  for  sedentary  
and  N=5  for  run.  Error  bars  are  SEMs.  Whole  inguinal  scWAT  depots  were  collected  from  
young   C57BL6/J   mice   under   sedentary   and   exercised   (run)   conditions.   Tissue   was  
stained  with  PGP9.5  (green)  and  Isolectin  Ib-­4  (red)  to  analyze  nerve  and  blood  vessel  
interactions  in  WAT  with  exercise.  Tissues  were  scanned  at  10x  for  blood  vessels  50um  
or  greater  in  diameter.  Up  to  twenty  blood  vessels  were  evaluated  for  innervation  in  each  
tissue  (d-­e).  Percentage  of  innervated  vessels  with  a  diameter  of  ≥  50um  were  evaluated  
per  tissue  (d,  left  panel).  Analyzed  with  two-­tailed  Student’s  T-­Test.  Error  bars  are  SEMs.  
Innervation  was  further  characterized  by  the  number  of  resident  nerves  per  blood  vessel  
(d,   right   panel).   Data   was   analyzed   using   a   two-­way   ANOVA   and   Tukey’s   multiple  
comparison  test.  Error  bars  are  SEMs.  Fluorescent  imaging  of  blood  vessel  and  nerve  
interactions  at  4x,  10x,  and  40x  using  an  Nikon  E400  epifluorescent  microscope  (e).    
    

















































Supplemental  Figure  S6  –  AAV  mediated  BDNF  delivery  to  inguinal  scWAT  of  
BTBR  MUT  mice.  Adult  (16  week  old)  male  BTBR  MUT  mice  (N=3)  received  single  
injection  of  AAV-­BDNF  (1x1010  vg)  into  their  left  inguinal  scWAT  and  an  equal  volume  of  
vehicle  into  their  right  inguinal  scWAT.  Two  weeks  post-­injection,  protein  expression  of  
TH  (a)  and  PSD95  (b)  in  inguinal  scWAT  was  measured  by  western  blotting.  Protein  
expression  was  normalized  to  cyclophilin  or  b-­tubulin,  band  intensity  was  quantified  in  
Image  J  and  analyzed  by  two-­tailed  Student’s  T-­Test.  Error  bars  are  SEMs.  
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Supplemental Figure S7 – Adipose innervation: Sex and depot comparison
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Supplemental  Figure  S7:  Adipose  innervation:  Sex  and  depot  comparison  
Adult  (16  week  old)  male  and  female  control  mice  on  a  C57BL/6J  background  were  cold  
exposed  (5°C)  for  3  days.  Protein  expression  of  TH  (a)  and  PDS95  (b)  were  measured  in  
inguinal  scWAT  and  BAT  via  western  blotting.  Protein  expression  of  PGP9.5  (c)  and  pan-­
neuronal  marker  TH  (d)  was  measured  in  axillary  and  inguinal  scWAT  for  both  sexes  via  
western  blotting.    Protein  expression  was  normalized  to  β-­Tubulin  or  Cyclophilin  B,  band  
density  was  quantified  in  Image  J  and  analyzed  using  a  two-­tailed  Student’s  t-­test.  Error  
bars  are  SEMs.  BDNF  expression  in  inguinal  scWAT  was  measured  for  both  sexes  via  
multiplex  ELISA  assay  (e).    




Supplemental  Table  S1  -­  Human  Cohort  Data  by  Age1  
  
Used  in    















1h,  S2a-­c   25   40   no  data   170   158   53   85   5.2  
1h,  S2c  (age)   27   29   no  data   192   44   33   93   5.7  
S2a-­b   28   40.78   96   154   158   51   71   5.1  
1h,  S2c  (age)   30   21.69   no  data   no  data   no  data   no  data   no  data   no  data  
S2a-­b   31   76.88   97   179   93   41   119   5.5  
1h,  S2c  (age)   32   27.55   95   185   108   54   109   5.3  
1g-­h,  S2a-­c   33   35.17   no  data   200   145   41   130   no  data  
1h,  S2c  (age)   34   24   no  data   no  data   no  data   no  data   no  data   no  data  
1g-­h,  S2c   34   40.4   no  data   no  data   no  data   no  data   no  data   no  data  
1h   35   26.82   no  data   no  data   no  data   no  data   no  data   no  data  
1h,  S2c  (age)   38   25   87   no  data   no  data   no  data   no  data   no  data  
S2a-­b   38   37.7   98   175   132   39   110   6.3  
1g,  S2c  (BMI)   40   30.7   82   no  data   no  data   no  data   no  data   no  data  
1g,  S2a-­b,  c  
(BMI)   41   42   no  data   no  data   no  data   no  data   no  data   no  data  
S2a-­b   42   46.32   109   147   155   40   76   6  
1g,  S2c  (BMI)   47   30.64   93   no  data   no  data   no  data   no  data   4.9  
1g,  S2c  (BMI)   47   45.74   64   169   191   44   87   4.8  
1g,  S2c  (BMI)   51   30   no  data   no  data   no  data   no  data   no  data   no  data  
1g,  S2c  (BMI)   60   38.38   93   no  data   no  data   no  data   no  data   no  data  
1g,  S2c  (BMI)   63   36   no  data   200   92   62   120   6.7  
  
  
     
                                                                                                                          
1  Metabolic  data  from  patients  whose  adipose  tissues  were  assessed  for  innervation,  data  
sorted  by  ascending  age  BMI  =  body  mass  index;;  BG  Rand  =  random  blood  glucose;;  HDL  =  




Supplemental  Table  S2  -­  Human  Characteristic  Data2  
Used  in  Figure  #   Tissue     Sex   Procedure     Race/  Ethnicity     Diabetes    
1h,  S2c  (age)   sqWAT   F   Panniculectomy   Hispanic   Non-­diabetic  
1g-­h,  S2c   sqWAT   F   Panniculectomy   Hispanic   Non-­diabetic  
1h,  S2c  (age)   sqWAT   F   Panniculectomy   African  American   Diabetic  
1h,  S2c  (age)   sqWAT   F   Panniculectomy   Hispanic   Non-­diabetic  
1g,  S2c  (BMI)   sqWAT   F   Panniculectomy   Hispanic   Non-­diabetic  
1g,  S2c  (BMI)   sqWAT   F   Panniculectomy   African  American   Non-­diabetic  
1h,  S2c  (age)   sqWAT   F   Panniculectomy   Unknown   Pre-­diabetic  
1g,  S2c  (BMI)   sqWAT   F   Panniculectomy   Hispanic   Non-­diabetic  
1g,  S2c  (BMI)   sqWAT   F   Abdominoplasty   Unknown   Non-­diabetic  
1h,  S2c  (age)   sqWAT   F   Abdominoplasty   Hispanic   Non-­diabetic  
1h   sqWAT   F   Panniculectomy   African  American   Diabetic  
1g,  S2c  (BMI)   sqWAT   F   Panniculectomy   Hispanic   Diabetic  
1g,  S2c  (BMI)   sqWAT   F   Panniculectomy   African  American   Diabetic  
1g,  S2a-­b,  c  (BMI)   sqWat,  Omental   F   Gastric  Bypass   African  American   Non-­diabetic  
1g-­h,  S2a-­c   sqWat,  Omental   F   Gastric  Bypass   Unknown   Non-­diabetic  
1h,  S2a-­c   sqWat,  Omental   F   Gastric  Bypass   Hispanic   Non-­diabetic  
S2a-­b   Omental     F   Gastric  Bypass   Hispanic   Non-­diabetic  
S2a-­b   Omental   M   Gastrectomy  Sleeve   Hispanic   Non-­diabetic  
S2a-­b   Omental   F   Gastric  Bypass   Hispanic   Pre-­diabetic  
S2a-­b   Omental   F   Gastric  Bypass   Hispanic   Non-­diabetic  
                                                                                                                          
2  Patient  tissue  type  analyzed,  sex,  elective  surgical  procedure,  race  or  ethnicity,  and  diabetic  
state  are  presented  along  with  which  figure  samples  were  used  in.  sqWAT  =  subcutaneous  




Supplemental  Table  S3  –  Human  Cohort  Data  Total  Statistics3  
  
Percent  of  Total  
Gender   Male   5  
     Female   95  
Ethnicity/Race   Hispanic   60  
     African  American   25  
     White   0  
     Unknown   15  
Age   20-­29   15  
     30-­39   45  
     40-­49   25  
     50-­59   5  
     60+   10  
Menopausal   Premenopausal   70  
     Postmenopausal   1  
     Unknown   15  
Diabetes   Pre-­diabetic   10  
     Diabetic   20  
     Nondiabetic   70  
BMI   Normal:  <25.0   10  
     Overweight:  25.0-­29.9   20  
Obese   Class  I:  30.0-­34.9   15  
Obese   Class  II:  35.0-­39.9   20  
Obese   Class  III:  >40.0   35  
Procedure   Panniculectomy   55  
     Gastric  Bypass   30  
     Abdominoplasty   10  
     Gastrectomy  Sleeve   5  
  
     
                                                                                                                          





Supplemental  Table  S4  -­  qPCR  Primers  
  
qPCR  Primers  
Gene   Forward  Sequence   Reverse  Sequence  
bdnf   CAGGTGAGAAGAGTGATGACC   ATTCACGCTCTCCAGAGTCCC  
cd31   ACGCTGGTGCTCTATGCAAG   TCAGTTGCTGCCCATTCATCA  
cidea   ATCACAACTGGCCTGGTTACG   TACTACCCGGTGTCCATTTCT  
cgrp   CCTGCAACACTGCCACCTGCG  
GAAGGCTTCAGAGCCCACATT
G  
cyclophilin     CAAATGCTGGACCAAACACAA   AAGACCACATGCTTGCCAT  
dio2   CAGTGTGGTGCACTGCTCCAATC   TGAACCAAAGTTGACCACCAG  
il4   GGTCAACCCCCAGCTAGT  
GCCGATGATCTCTCTCAAGTGA
T  
il10   CTATGCTGCCTGCTCTTACTGAC   CGGAGAGAGGTACAAACGAGG  
il13   CCTGGCTCTTGCTTGCCTT   GGTCTTGTGTGATGTTGCTCA  
nyp   AAGCCGGACAATCCGGGCCGAGG   GCTTTCCTCATTAAGAGGTCT  
pacap   TACTGTGTGTGTAACTGTGTGGG   GCCAGCCGTAAGTAGATGCTC  
penk   TTCAGCAGATCGGAGGAGTTG   AGAAGCGAACGGAGGAGAGAT  
pgc1a   CCCTGCCATTGTTAAGACC   TGCTGCTGTTCCTGTTTTC  
pomc   AGA  CCT  CCA  TAG  ATG  TGT  GGA  
AGC  GGA  AGT  GAC  CCA  TGA  
CGT  
psd95   GCGGTGCTAAAATCGAATGC   ACAGAGAGGGGCAGGCAGT  
sox10   AGATCCAGTTCCGTGTCAATAA   GCGAGAAGAAGGCTAGGTG  
synapsin  I  
CATGGCACGTAATGGAGACTACCGC
A   CCGCCAGCATGCCTTC  
synapsin  II   GCCACCAGGTTAAGCTCTGA   TTCCAGGAAGGCCAAGGT  
synaptophysi
n   TGACTTCAGGACTCAACACCTC   CAGGAGCTGGTTGCTTTTCT  
tac1   TGGCCAGATCTCTCACAAAAGGCA  
TCGTAGTTCTGCATCGCGCTTC
T  
ucp1   AGGCTTCCAGTACCATTAGGT  
CTGAGTGAGGCAAAGCTGATT
T  
vegfa   AACAAAGCCAGAAAATCACTGTGA  
CGGATCTTGGACAAACAAATG
C  
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